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ABSTRACT/RESEARCH SUMMARY: 
Allodynia is an abnormal state in which pain is triggered by innocuous 
sensory stimuli. Previous work in our laboratory has shown that L5/L6 spinal 
nerve ligation (SNL) induces robust mechanical allodynia in the rat which 
consists of two distinct phases: a) an early spinal prostaglandin (PG)-dependent 
phase lasting approximately seven to ten days; and b) a delayed PG-
independent phase lasting at least seventy days. Importantly, the former is a pre-
requisite to and a trigger for the more complex and time-dependent changes 
underlying long-term, irreversible allodynia. Interfering with critical signaling 
events early after nerve injury is a logical strategy by which chronic neuropathic 
pain might be prevented. Such an approach requires a clear understanding of the 
sequence, time-course and pharmacology of these early signals. 
In light of the apparent pathogenic role of spinal PG early after nerve 
injury, the present research investigated the SNL-induced changes in spinal PG 
synthesis and signaling, their relevance to the development of spinal 
hyperexcitability and allodynia, and the mechanisms underlying the changes in 
PG synthesis and signaling in the spinal PG-dependent phase. The specific 
objectives were: 
1. To characterize the effect of SNL on A- and C-fiber mediated reflex 
responses (AFRR and CFRR, respectively) in the affected hind 
limb, and to determine the temporal and spatial relationship of 
these changes to SNL-induced allodynia. 
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2. To determine if the SNL-induced changes in the AFRR and CFRR 
(i.e. spinal hyperexcitability) are spinal PG-dependent, and if so, to 
determine the relevant cyclooxygenase (COX) isoform(s). 
3. To determine if SNL triggers the activation of nuclear factor kappa-
S (NFKB) in the affected spinal cord which initiate the delayed 
induction of spinal COX-2. 
4. To determine if the sensitivity to PG E type (PGE2) is exaggerated 
during spinal PG-dependent allodynia, and if this abnormal state is 
limited to the affected spinal cord three days after SNL. 
5. To determine if PG-dependent spinal hyperexcitability and 
mechanical allodynia are mediated by E-type prostaglandin (EP) 
receptors, and to investigate the changes in the expression of 
spinal EP1-3 receptor subtypes and the glycine-a3 receptor subunit 
(GL Y-a3R) three days after SNL. 
6. To determine if disrupting spinal PG synthesis/signaling 
immediately after SNL (i.e. pre-emptive treatment) prevents the 
development of PG-dependent spinal hyperexcitability and 
mechanical allodynia. 
7. To determine if spinal PG-dependent hyperexcitability is affected by 
the SNL-induced generation of spinal nitric oxide (NO), and if so, to 
investigate relevant NO synthase (NOS) isoform(s). 
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8. To determine if, and how, spinal NO-mediated activity affects spinal 
PG-dependent spinal hyperexcitability and mechanical allodynia. 
Male Sprague-Dawley rats were initially fitted with intrathecal (i.t.) 
catheters for drug delivery near the dorsal L 1-L3 segments. Three days later, 
animals were anesthetized with halothane and the left L4 and L5 spinal nerves 
separated. In the SNL group, the L5 and L6 spinal nerves were tightly ligated 
with 6-0 silk thread. In sham-controls, the L5 and L6 spinal nerves were isolated 
but not ligated. Allodynia, defined as a paw withdrawal threshold (PWT) of S4g, 
was confirmed using von Frey filaments. The decrease in PWT from baseline 
(>15g) was evident in the ipsilateral hind paw 24h after SNL, and remained 
stable for at least twenty days. It was also accompanied by the protective 
posturing (i.e. elevation above the cage floor and cupping) of the affected hind 
paw. Allodynic animals were otherwise healthy and exhibited normal behaviour 
and weight gain. 
Objective 1. To characterize the effect of SNL on A- and C-fiber mediated 
reflex responses (AFRR and CFRR, respectively) in the affected hind limb. 
Electrophysiologic responses evoked by transcutaneous A- or C-fiber 
electrical stimulation were recorded in the biceps femoris flexor reflex (AFRR and 
CFRR, respectively) one, three and ten days after SNL or sham surgery. PWT, 
measured immediately before the experiment, confirmed the presence and 
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absence of allodynia in SNL and sham-controls, respectively. The AFRR and 
CFRR were recorded using accepted activation and conduction criteria, and 
validated by their differential sensitivity to the inhibitory effects of i.t. morphine. 
These responses were highly reproducible within each treatment group, and 
unaffected by the presence of the spinal catheter. There were no significant 
electrophysiologic changes in sham-controls, with or without a spinal catheter, 
compared to na"ive animals. In SNL (i.e. allodynic) animals, the AFRR and CFRR 
were characterized by a significant decrease in the respective activation 
threshold, and a corresponding increase in spike integration (i.e. response 
magnitude) in the ipsilateral, but not the contralateral hind limb. These 
exaggerated responses were evident one day after SNL, peaked at three days, 
and persisted for at least ten days, paralleling the time course-course of 
decreased PWT in the ipsilateral hind paw. The central sensitization induced by 
repeated A-fiber stimulation in SNL animals, indicative of abnormal sensory 
processing, is consistent with the known role of Aj3-afferent fibers in mechanical 
allodynia. These results demonstrate the reproducibility, reliability and validity of 
the AFRR and CFRR as quantitative measures of A- and C-fiber mediated spinal 
hyperexcitability (i.e. central sensitization), as well as their temporal and spatial 
relationships to mechanical allodynia in the SNL model. 
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Objective 2. To determine if the SNL-induced changes in the AFRR and 
CFRR (i.e. spinal hyperexcitability) are spinal PG-dependent, and if so, to 
determine the relevant COX isoform(s). 
The activeS(+)- or inactive R(-)-enantiomers of ibuprofen, a non-selective 
cyclooxygenase (COX) inhibitor, were given i.t. three days after SNL or sham 
surgery (i.e. time of maximum SNL-induced changes in the activation threshold 
and response magnitude of the AFRR and CFRR). S(+)-ibuprofen, but not the 
R(-)-enantiomer or vehicle, dose-dependently attenuated the changes in the 
AFRR (1050=36.31-Jg) and CFRR (50.81-Jg). This inhibitory effect was similar to the 
selective COX-2 inhibitor, SC-236. In contrast, the selective COX-1 inhibitor, SC-
560 given three days after SNL had no significant effect on the AFRR and CFRR. 
When these experiments were repeated one day after SNL, SC-560 matched the 
effect of S(+)-ibuprofen while SC-236 was without effect. The results indicate that 
SNL-induced hyperexcitability is dependent on PG synthesis in the spinal cord up 
to three days after nerve injury. They also reveal an apparent shift in the 
dominant isoform responsible for spinal PG synthesis during the acute nerve 
injured state. 
Given that both COX-1 and COX-2 are expressed constitutively in the 
spinal cord (COX-1 > COX-2), the apparent shift in the dominant COX isoform 
could reflect the delayed induction of COX-2 in affected spinal cord. To test this 
hypothesis, the expression of COX-1 and COX-2 protein was determined in the 
spinal cord one and three days after surgery. One day after SNL, Western 
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analysis revealed a significant increase in COX-1, but not COX-2 protein in the 
ipsilateral compared to the contralateral lumbar dorsal horn (L-DH). The 
expression of COX-1 and COX-2 was unchanged in the contralateral L-DH and 
bilateral ventral horns of SNL animals compared to sham-controls. Three days 
after SNL, COX-2 (but not COX-1) protein was significantly up-regulated in the 
ipsilateral L-DH. It is concluded that SNL affects the spinal expression of COX-1 
and COX-2 in a manner which is temporally and spatially correlated with the 
emergence of PG-dependent spinal hyperexcitability and mechanical allodynia, 
and includes an early shift in the dominant enzyme responsible for PG synthesis. 
Objective 3: To determine if SNL triggers the activation of nuclear factor 
kappa-B (NFKB) in the affected spinal cord which initiate the delayed 
induction of COX-2. 
NFKB modulates the transcription of the COX-2 gene and is known to be 
activated by nerve injury. To determine if SNL triggers the activation of NFKB in 
the affected spinal cord, nuclear extracts were prepared from the left and right 
dorsal and ventral quadrants of the lumbar spinal cord twelve hours, one and 
three days after surgery. NFKB was significantly increased in the ipsilateral L-DH 
twelve hours after SNL compared to sham-controls. This effect preceded the 
increased expression of COX-2 and was still present three days later. NFKB was 
unchanged in the contralateral L-DH or bilateral ventral horns of SNL animals 
compared to sham-controls. Treatment with ammonium pyrrolidedithiocarbamate 
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(PDTC; 1001-Jg i.t.), an inhibitor of NFKB activation, immediately after SNL, 
prevented the expression of spinal COX-2 in the ipsilateral L-DH three days later. 
The up-regulation of COX-2 was unchanged in vehicle-treated animals indicating 
that COX-2 expression in the affected spinal cord is secondary to NFKB 
activation, beginning immediately after nerve injury. 
Objective 4. To determine if the sensitivity to PGE2 is exaggerated in and 
limited to the affected spinal cord three days after SNL (i.e. during spinal 
PG-dependent allodynia) . 
Slices from the lumbar, thoracic and cervical spinal cord were prepared 
three days after SNL or sham surgery for the determination of PGE2-evoked 
glutamate release. PWT, measured immediately prior to spinal cord extraction, 
confirmed the presence and absence of allodynia in SNL and sham-controls, 
respectively. Addition of PGE2 yielded a bell-shaped concentration-response 
curve (CRC) characteristic of prostanoids regardless of the spinal segment. With 
lumbar, but not cervical or thoracic slices from SNL animals, there was a marked, 
parallel leftward shift in the CRC compared to sham-controls. This corresponded 
to a 2855-fold decrease in the ECso of PGE2 three days after SNL. There were no 
differences in the peak effect of PGE2 regardless of the surgery or spinal slice. In 
separate experiments, the concentration of PGE2 determined in the incubation 
fluid containing lumbar slices from SNL animals was found to be up to 1 00-fold 
greater than the corresponding and verified concentration added to the bath. 
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These in vitro data suggest that PGE2 can trigger its own synthesis in lumbar 
slices from allodynic animals. To test this hypothesis, lumbar slices prepared 
three days after SNL or sham surgery were pre-incubated for 20min with S(+)- or 
R(-)-ibuprofen. The disparity between the added versus bath concentration of 
PGE2 was significantly attenuated using slices from SNL animals pretreated with 
S(+)- but not R(-)-ibuprofen or vehicle. In addition, the corresponding PGE2 CRC 
exhibited a significant and parallel but incomplete rightward shift towards that of 
control. All three pre-treatments were without effect in slices prepared from 
sham-controls. Similar results were observed in vivo. There was a 362-fold 
decrease in the EDso of i.t. PGE2 on brush (BR)-evoked nociceptive-like behavior 
in allodynic animals compared to sham-controls. Pre-treatment (20min) with i.t. 
S(+)-ibuprofen three days after SNL shifted the PGE2 dose-response curve 
significantly to the right compared to i.t. R(-)-ibuprofen or vehicle. These results, 
demonstrating a marked increase in the sensitivity to PGE2 in the lumbar spinal 
cord, three days after SNL (i.e. time of maximum PG-dependent spinal 
hyperexcitability), are consistent with the SNL-induced up-regulation of COX-2. 
They also suggest the amplification of PG-signaling in the affected spinal cord. 
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Objective 5. To determine if PG-dependent spinal hyperexcitability and 
mechanical allodynia are mediated by E-type prostaglandin (EP) receptors, 
and to investigate changes in the expression of spinal EP1•3 receptor 
subtypes and the glycine-a3 receptor subunit (GL Y-a3R) three days after 
SNL. 
Animals were treated with the non-selective EP receptor antagonist, SC-
51322 (1 OOJ,Jg i.t.) or vehicle three days after nerve injury. All SNL-induced 
changes (i.e. PWT, the AFRR and CFRR, and the sensitivity to PGE2 both in vitro 
and in vivo) were significantly attenuated in SC-51322- but not vehicle-treated 
rats. Subsequent Western blot analysis revealed a significant increase in the 
expression of EP1 , EP2 and EP3 receptors in the ipsilateral versus contralateral L-
DH of SNL animals. There were no changes in the contralateral L-DH or bilateral 
ventral horns of SNL animals compared to sham-controls. The up-regulation of 
spinal EP1-3 receptors was evident one day after SNL and increased over the 
next two days. There was also a significant increase in the expression of GL Y-
a3R protein in the ipsilateral but not the contralateral L-DH three days after SNL. 
GL Y-a3R expression was unchanged in the contralateral L-DH or bilateral ventral 
horns of SNL animals compared to sham-controls. These results demonstrate: a) 
the critical role of spinal EP receptor subtypes in established PG-dependent 
spinal hyperexcitability and mechanical allodynia; b) their progressive up-
regulation three days after SNL; and c) the temporal and spatial similarities in the 
expression of EP receptors and COX-1/COX-2 in the affected spinal cord. They 
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are also consistent with increased spinal PGE2/EP2/GL Y-a3R signaling in the 
acute nerve injured state. The latter is consistent with the robust allodynia 
induced by i.t. strychnine (a selective glycine receptor antagonist) in otherwise 
normal animals, and the depletion of glycine-receptor immunoreactive cells in the 
spinal cord following chronic constriction injury. 
Objective 6. To determine if disrupting spinal PG synthesis/signaling 
immediately after SNL (i.e. pre-emptive treatment) prevents spinal PG-
dependent allodynia. 
S(+)-ibuprofen, R(-)-ibuprofen or vehicle were given i.t. immediately after 
SNL or sham surgery. S(+)-ibuprofen prevented the SNL-induced activation of 
NFKB, the up-regulation of COX-2, the increased sensitivity to PGE2 in the 
affected spinal cord, the exaggeration of the AFRR and CFRR, and decrease in 
PWT. In contrast, the R(-)-isomer and vehicle had no effect on these SNL-
induced changes. In separate experiments, identical treatment with PDTC, but 
not vehicle, blocked the exaggeration of A- and to a lesser extent C-fiber 
mediated responses, as well as the decrease in PWT three days after SNL. 
PDTC and vehicle were without effect in sham-controls. Thus, blocking the 
activation of spinal NFKB, either directly with PDTC or indirectly with S(+)-
ibuprofen, prevented the SNL-induced expression of COX-2 and the 
development of PG-dependent spinal hyperexcitability and mechanical allodyina 
three days later. The results indicate that the SNL-induced activation of NFKB 
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and the induction of spinal COX-2 are critical antecedents in the development of 
PG-dependent spinal hyperexcitability and mechanical allodyina. They also 
suggest that spinal PG facilitate the activation of NFKB beginning immediately 
after SNL thereby explaining the pre-emptive effect of S(+)-ibuprofen (an inhibitor 
of COX activity) on spinal COX expression. 
Objective 7. To determine if, and how spinal NO contributes to spinal PG-
dependent al/odynia. 
NO is known to be recruited in the spinal cord by nerve injury. NFKB also 
modulates the transcription of NOS. SNL significantly increased nNOS and iNOS 
expression in the ipsilateral L-DH one and three later compared to sham-
controls. Pre-emptive treatment with PDTC ( 1 OO~g i. t.) blocked the increases in 
NFKB, nNOS, and iNOS three days later. These results indicate that NFKB 
activation not only produces COX up-regulation, but also NOS up-regulation in 
the affected spinal cord early after SNL. Given that SNL induced the up-
regulation of NOS enzymes, an affect of blocking NOS activity on spinal 
hyperexcitability was examined. Treatment with N-nitro-L-arginine methylester (L-
NAME), but not the D-isomer (D-NAME) or vehicle, dose-dependently attenuated 
the SNL-induced effect on PWT, AFRR and CFRR three days after surgery. 
Likewise, pre-emptive treatment with L-NAME (100~g i.t.), but not the D-
isomer (D-NAME) or vehicle, prevented the SNL-induced effect on PWT, AFRR 
and CFRR. These results indicated that NOS activity, in addition to COX activity, 
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was increased early after SNL and significantly contribute to spinal 
hyperexcitability and mechanical allodynia. In an attempt to determine if NO-
signaling is enhanced early after SNL, the expression of cyclic guanosine 
monophosphate (cGMP) and protein kinase G (PKG) was investigated. 
Expression of cGMP and PKG protein was significantly increased in the 
ipsilateral L-DH of SNL animals compared to sham-controls. This result 
combined with the effect of L-NAME on spinal hyperexcitability and allodynia 
indicated that spinal NO-signaling is significantly enhanced early after SNL. 
The results of this research support the hypothesis that spinal PG play an 
early pathogenic role in the emergence and early maintenance of spinal 
hyperexcitability and mechanical allodynia following SNL. They revealed a time-
dependent shift in the COX isoform primarily responsible for spinal PG synthesis, 
identified the inter-relationships between NFKB, PG and NO synthesis/signaling 
in affected spinal cord, and characterized the nature of the interaction between 
PG and NO in this model of NP. 
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1.0 INTRODUCTION 
1.1 PROSTAGLANDINS 
Prostaglandins (PG) belong to a family of lipids derived from arachidonic 
acid (AA), a 20-carbon fatty acid . Unlike many biological mediators, PG are not 
stored in advance but are synthesized de novo as required. The initial and rate-
limiting step in the biosynthesis of PG is the intracellular liberation of AA from the 
phospholipid membrane (Smith, 1992). This is normally accomplished by 
phospholipase A2 (PLA2), but phospholipase C and D serve a similar function 
(Smith, 1992). Once released, AA is available for conversion to PGG2 by the 
enzyme, cyclooxygenase (COX). This bifunctional enzyme then catalyzes PGG2 
to PGH2 via its peroxidase activity. The resulting biologically active products, 
PGD2, PGE2, PGF2a. PGI2, or TxA2 (Hara et al. , 1994; Kuwamoto et al. , 1997; 
Suzuki et al., 1997; Jakobsson et al. , 1999; Smith et al. , 2000) are then able to 
diffuse from the cell, or exit by means of a carrier-mediated process (Chan et al. , 
1998). They are then able to bind to PG-specific receptors on the plasma 
membrane (Ushikubi et al. , 1998; Breyer et al. , 2001 ). Some PG remain 
intracellularly where they are able to bind to PG receptors on the nuclear 
membrane (Negishi et al., 1995; Kliewer et al. , 1997; Lim et al., 1999). 
There are two primary isoforms of coxt (i.e. COX-1 and COX-2) which 
are both associated with intracellular membranes. COX-1 and COX-2 were 
t Each isomer exists as a homodimer, composed of three independent folding units: a) the active 
enzymatic domain within a long hydrophobic channel; b) a membrane-binding domain; and c) an 
epidermal growth factor-like domain (Smith et al. , 2000). The most striking differences in amino 
acid sequence occur within the membrane-binding domains (Otto and Smith, 1996; Spencer et 
al. , 1999). 
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initially thought to subserve physiological and pathophysiological functions, 
respectively. It is now recognized that each can fulfill either role, depending on 
the cell type and the prevailing conditions. While COX-2, and to a lesser extent 
COX-1, contribute to inflammatory and nociceptive response (see Sections 1.2 
and 1.4 below), both isoforms are known to play a role in homeostatic regulation. 
Likewise, the early classification of COX-1 and COX-2 as constitutive and 
inducible enzymes, respectively is now recognized to be an over-simplification. 
While COX-1 is the predominant constitutive enzyme in most cell types, its 
expression can increase in response to cellular conditions (see Sections 1.4 and 
1.7 below). COX-2 is subject to rapid up-regulation (see Sections 1.4 and 1.7 
below) but it is constitutively expressed in some cell types (e.g. central neurons 
and glia). 
PG are chemically unstable and subject to rapid catabolism in vivo (Smith, 
1992). As a result, PG exert their biological effects in close proximity to their site 
of synthesis; effects mediated by specific prostanoid receptors. For example, 
PGE2 acts through E-type prostanoid (EP) receptors of which there are four 
subtypes- EP1, EP2, EP3 and EP4 (Coleman et al., 1990, 1994). While PG bind 
with highest affinity to their cognate receptor, cross-reactivity (e.g. PGE2 
signaling via F-type prostanoid receptors) is known to occur (Breyer et al., 2001; 
Wise et al., 2002). The most common product of COX-mediated AA metabolism 
is PGE2 which has been implicated in many conditions, including pain and 
inflammation (Khanapure et al., 2007; Zeilhofer, 2007). 
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1.2 SPINAL PG AND NOCICEPTION 
As early as 1971, studies suggested that non-steroidal anti-inflammatory 
drugs (NSAIDs) effect their analgesic and antihyperalgesic actions through the 
inhibition of peripheral PG synthesis (Vane, 1971; Smith and Willis 1971 ). Some 
twenty years later, PG were shown to also be synthesized in central nervous 
system (CNS) in response to peripheral tissue injury (Malmberg and Yaksh, 
1992a, 1995a). That is, at central sites removed from the locus of injury and 
inflammation. For example, NSAIDs injected directly into spinal subarachnoid 
space of conscious rats dose-dependently inhibited the behavioral responses 
triggered by formalin injection in the foot pad (Malmberg and Yaksh, 1992a, 
1995a). Importantly, spinal NSAIDs were 100 to 1000 times more potent than 
systemic administration in inhibiting the second phase of the formalin test 
(Malmberg and Yaksh, 1992a). These results indicated that NSAIDS can effect 
antinociception within the spinal cord using peripheral inflammatory pain models. 
The stereo-selective nature of this outcome (Malmberg and Yaksh, 1995a) 
further indicated that spinal antinociception was the result of COX inhibition. 
That spinal PG synthesis is evoked by nociceptive input was subsequently 
confirmed in vivo and in vitro. Using an i.t. microdialysis catheter, Yang et al. 
(1996) showed that the injection of carrageenan/kaolin into the knee joint of the 
rat evoked persistent nociceptive behavior and a time-dependent increase in the 
concentration of PGE2 in spinal dialysate ([PGE2lcsF ). An increase in [PGE2lcsF 
was also reported during the first- and second-phase of the rat formalin test 
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(Malmberg and Yaksh, 1995a, b); an effect triggered by C-fiber input (Hua et al. , 
1997). Both nociceptive behavior and the increase in [PGE2]csF were attenuated 
by i.t. S(+)-ibuprofen (IBU), but not the inactive R(-)-enantiomer (Malmberg, 
1995b; Yang, 1996). Using an in vitro superfusion model, Dirig and Yaksh (1999) 
showed that spinal cord tissue, harvested from rats given kaolin/carrageenan in 
the knee joint, exhibited increased release of PGE2 compared to age-matched 
naive cohorts. These results strongly suggested that peripheral inflammation 
could trigger the synthesis and release of PGE2 from the spinal cord of 
experimental animals. The temporal correlation between spinal PG synthesis and 
release and nociceptive behaviour following peripheral inflammation further 
suggests that spinal PG may be critical in the induction of pain at the spinal level. 
That PG modulate nociceptive signaling in the spinal cord was supported 
by the localization of COX in the dendrites of central excitatory neurons 
(Yamamoto, 1993), and the abundance of PGE2 binding sites in the spinal dorsal 
horn (DH; Matsumura, 1992, 1995). The latter almost completely disappeared 
following dorsal rhizotomy indicating their location on the terminals of primary 
afferent fibers. This pattern of PGE2 receptor-binding is consistent with the 
presynaptic facilitation of neuronal signaling. While it is known that the machinery 
for PG synthesis and signaling is located in key areas vital for transmission of 
nociceptive information in the spinal cord and COX inhibition results in 
antinociception, less is known regarding the cellular events underlying the critical 
role of spinal PG in the induction of pain. 
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1.3 CELLULAR EFFECTS OF SPINAL PG IN NOCICEPTION 
The exact mechanisms by which spinal PG enhance nociceptive signaling 
have yet to be elucidated. One strong possibility is that PG exert their effects 
through excitatory receptors on primary afferent terminals that form synaptic 
connections with second order neurons and/or excitatory interneurons in the 
spinal DH (Millan, 1999). Using cultured avian neurons, Nicol et al. ( 1992) 
showed that 1 !JM PGE2 yielded a 2-fold increase in substance P release. Whole-
cell patch clamp recordings of rat embryonic sensory neurons revealed a 
significant decrease in outward K+ current following exposure to PGE2 (Nicol et 
al., 1997), and Gold et al. ( 1996) reported that PGE2 increased tetrodotoxin-
resistant Na+ currents recorded from cultured DRG cells. These ion channel 
effects would be conducive to an overall increase in cellular excitability. PGE2 
has also been shown to evoke Ca2+ -dependent glutamate release from 
synaptosomes prepared from rat spinal cord (Nishihara, 1995), and substance P 
release from cultured rat dorsal root ganglion (DRG) cells (Vasko, 1994) and rat 
spinal cord slices (Vasko et al., 1995). Perfusion with low concentrations of PGE2 
has also been shown to facilitate capsaicin- or bradykinin-evoked release of 
substance P or calcitonin gene-related peptide from rat spinal cord slices 
(Hingtgen et al. , 1995; Vasko et al., 1995). Collectively, these results indicate that 
PGE2, acting through G-protein-coupled receptors, can directly modulate 
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neurotransmitter release from the spinal cord, as well as augment the release of 
neuropeptides from the spinal terminals of C-fibers. 
PG may also enhance the excitability of DH neurons to afferent input 
through a direct postsynaptic effect. In an early study, injection of PGE1 onto 
motor neurons and interneurons in the isolated spinal cord of the frog produced 
an abrupt excitatory effect (Coceani et al. , 1975). In addition, PGE2 was shown to 
induce a long-lasting facilitation of evoked excitatory postsynaptic currents 
(EPSCs) in mouse DH neurons (Minami et al. , 1999). Baba et al. (2001) showed 
that PGE2 caused a direct activation of DH neurons in vitro, suggesting that this 
was a post-synaptic effect mediated through the prostaglandin EP2 receptor 
subclass. The "wind-up" of a spinal C-fiber nociceptive reflex, induced by 
repeated electrical stimulation of the sural nerve, was also dose-dependently 
inhibited by i.t. or i.v. indomethacin, and by i.v. administration of the selective 
COX-2 inhibitor, SC-58125 (Bustamante et al., 1997; Willingale et al., 1997). 
These pharmacological studies provide further support for the modulatory effect 
of PG on spinal neurotransmission in nociception, raising the possibility of 
enhanced spinal PG synthesizing capacity in the acute pain state. 
1.4 SPINAL PG BIOSYNTHESIS IN NOCICEPTION 
COX-1 and COX-2 mRNA and protein are constitutively expressed in 
many regions of the central nervous system (CNS), including the dorsal and 
ventral grey matter of the spinal cord. Immunocytochemical and autoradiographic 
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studies confirmed the presence of COX-1 in spinal nociceptive pathways 
(Goppelt-Struebe et al., 1997; Willingale et al., 1997; Beiche et al. , 1998a, b). 
COX-2 is present in neurons throughout the spinal cord, and is especially 
abundant in the superficial DH where nociceptive primary afferents are known to 
terminate. The presence of COX-1 in neurons is more controversial but COX-1-
immunoareactivty (IR) was described in a subpopulation of putative nociceptive 
DRG neurons (Chopra et al., 2000). COX-1 and COX-2 are also expressed in 
astrocytes in the spinal cord (Vane et al., 1998). 
The hypothesis that PG facilitate spinal nociceptive signaling is further 
supported by the rapid induction of COX-2 in the spinal cord following peripheral 
inflammation, secondary to tissue injury. A 2-fold increase in COX-2 mRNA and a 
smaller increase in COX-2 protein were detected bilaterally in the lumbar spinal 
cord of the rat following the acute injection of carrageenan in the footpad of the 
hind paw (Goppelt-Struebe et al., 1997; Hay and de Belleroche, 1997; lchitani et 
al., 1997). Western analysis revealed a 1.6-fold increase in the level of COX-2 
protein in the L-DH (lamina II-III) twenty-two days after the injection of Complete 
Freud's Adjuvant (CFA)(Goppelt-Struebe et al., 1997; Seiche et al. , 1998a, b). 
Samad et al. (2001) reported a peak increase (16-fold) in COX-2 mRNA 6 h after 
CFA injection in the ipsilateral hind paw. Bilateral induction of COX-2 mRNA and 
protein were also noted in the same animals 12 h after injection (Samad et al., 
2001 ). The increased expression of COX-2 was both neuronal and non-neuronal 
in nature (Seiche et al., 1998a, b; Maihofner et al. , 2000; Samad et al. , 2001; 
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Tegeder et al., 2001 ). Where investigated, these increases coincided with a 
significant elevation in spinal PG concentration (Maihofner et al., 2000; Samad et 
al., 2001; Tegeder et al., 2001 ). These results indicate that spinal COX-2 is not 
only inducible, and therefore influenced by peripheral inflammatory nociceptive 
events, but is likely responsible for the early increase in spinal PG synthesis and 
signaling. 
In summary, it is well established that PG, synthesized in the spinal cord 
in response to noxious stimuli (i.e. at central sites removed from the locus of 
injury and inflammation), facilitate nociceptive transmission. That PG exert a 
central nociceptive action independent of their peripheral inflammatory and 
analgesic effects raises important questions about their possible role in 
neuropathic pain (NP) states. 
1.5 NEUROPATHIC PAIN 
NP is defined by the International Association for the Study of Pain (IASP) 
as pain initiated by a primary lesion or dysfunction in the nervous system 
(Merskey and Bogduk, 1994 ). It is an abnormal sensory state arising from trauma 
or disease affecting peripheral nerves, posterior spinal roots, the spinal cord 
itself, or certain regions of the brain. Examples include phantom limb pain, 
central post-stroke pain, diabetic-neuropathy, post-herpetic neuralgia, and reflex 
sympathetic dystrophy (Wasner et al., 2003; Calcutt and Backonja, 2007; 
Giummarra et al., 2007; Dworkin et al., 2008; Henry et al., 2008). While 
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comprehensive epidemiological data are not available, current pooled estimates 
suggest that NP may affect as much as 3% of the population (Heliovaara et al. , 
1987; Schmader, 2000; Davis and Walsh, 2004; Verma et al. , 2005). As a 
chronic and often debilitating condition, NP is a major burden on the healthcare 
system (Arner and Meyerson, 1988; Rowbotham et al., 1991; Baron and Saguer, 
1993; Schmader, 1998). People with the condition have been found to generate 
3-fold higher health care costs compared with matched controls (Berger et al., 
2004 ). Moreover, the indirect costs associated with chronic pain conditions 
including NP (e.g. absenteeism, decreased productivity at work, etc.) are 
estimated to be more than $150 billion annually in the United States alone (Turk, 
2002; McCarberg and Billington, 2006), of which almost $40 billion is attributable 
to NP. 
The clinical features of NP are distinct from those of 'normal' nociceptive 
pain. The onset is often delayed for weeks to months after the causative event. 
Once established, NP is largely irreversible persisting for decades after the initial 
injury has healed (Tasker, 1990; Taylor, 2006). The stimuli eliciting NP are also 
unusual. Normally innocuous stimuli such as a cold draft of air or the light touch 
of clothing acquire the ability to evoke excruciating pain; a condition known as 
allodynia (Merskey, 1986). This is the most common and troublesome symptom 
of NP (Campbell et al., 1988; Raja et al., 1988). Allodynia is frequently described 
by patients with NP as a ripping, and/or tearing sensation; descriptors not 
normally associated with 'normal' nociceptive pain. Finally, NP generally 
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responds poorly to current pharmacotherapy, including drugs that exhibit 
analgesic effects only in NP states (e.g. tricyclic anti-depressants, anti-
convulsants, barbiturates, various channel blockers, etc.). There is marked inter-
individual variability in treatment response and even in patients who respond 
favorably, analgesia is incomplete. Surgical interventions intended to alleviate NP 
usually provide only temporary relief (Tasker et al. , 1992; Eide, 1998). 
Consequently, NP remains a serious clinical and socio-economic problem 
(Eide, 1998; McCarberg and Billington, 2006) whose unique clinical 
characteristics suggest complex and ultimately irreversible changes in 
somatosensory processing. 
1.6 ALLODYNIA ARISES FROM ALTERED SOMATOSENSORY 
PROCESSING 
Early clinical studies showed that allodynia in the affected dermatome(s) 
of patients with NP, as well as the sensation of light touch in adjacent normal 
skin, are both mediated by A~-fibers (Campbell et al. , 1988; Price et al. , 1989). 
Temperature discrimination in the same regions was unaffected (Campbell et al., 
1988) suggesting minimal contributions from Ao- and C-fibers in mechanical 
allodynia. Given that A~-fibers do not normally trigger pain, their participation in 
NP provided the first evidence of altered somatosensory processing following 
nerve injury. 
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In animal models, mechanical allodynia is generally measured as a 
reduction in the threshold force required to evoke withdrawal of the affected paw 
(paw withdrawal threshold; PWT). In nerve-injured animals, a PWT of~ 4 g from 
a baseline of 15 g is routinely observed along with protective posturing of the 
affected paw. This exaggerated reflex response to an otherwise innocuous 
peripheral stimulus supports the enhanced responsiveness of spinal neurons to 
low-threshold (i.e. Aj3-fiber) input. Peripherally, Aj3-fibers display spontaneous 
and persistent electrical activity (Bulka et al., 2002). Their central terminals have 
also been shown to sprout into lamina I and II of the spinal DH; laminae normally 
receiving input from smaller diameter nociceptive fibres (Woolf et. al. , 1992; Bao 
et al., 2002; Shehab et al., 2003; Hu et al., 2004). Large diameter Al3-fibers also 
begin to express neurotransmitters normally associated with nociceptive 
transmission, such as substance P and brain-derived neurotrophic factor 
(Noguchi et al,. 1994, 1995; Michael et al. , 1999). The array of 
electrophysiologic, morphologic, and phenotypic changes occurring days to 
weeks after nerve injury reflect the complex, time-dependent and ultimately 
irreversible changes triggered by nerve injury (Beydoun and Backonja, 2003; 
Dworkin et al., 2003; Takeda et al., 2005). They also underlie the challenges in 
treating clinical NP effectively once it is established. 
These time-dependent adaptations are initiated by signaling events in the 
spinal cord beginning immediately after nerve injury. Disrupting/inhibiting the 
latter provides, in principle, an opportunity to prevent the establishment and/or 
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severity of allodynia. If successful, this would represent a more advantageous 
and cost-effective strategy than trying to treat the outcomes of nerve injury 
weeks, months or even years later. However, any pre-emptive strategy requires 
a thorough understanding of the time-course, pharmacology and mechanisms 
underlying the development of long-term allodynia. Given the recognized role of 
spinal PG in 'normal' nociception, and the clinical availability of drugs with which 
to disrupt their effects, spinal PG represent an interesting and logical pre-emptive 
target. Indeed, there is growing evidence implicating spinal PG in the 
development of allodynia following experimental nerve injury. 
1.7 SPINAL PG AND ALLODYNIA 
The earliest and most direct evidence of a pro-allodynic effect elicited by 
spinal PG was provided by Uda et al. (1990) and Minami et al. (1992, 1994a, 
1995a). They reported dose-dependent, touch-evoked agitation in conscious 
mice following the i.t. injection of PGE2, PGD2 or PGF2a; an effect blocked by the 
EP-receptor antagonist, NON-NT -012 (Minami et al. 1995b ). Similarly, the 
delivery of PGE2 to the rat spinal subarachnoid space triggered behaviorally-
defined allodynia, whose onset and decline was temporally correlated with an 
increase and decrease in the concentration of glutamate, aspartate, taurine, 
glycine and gamma-aminobutyric acid (GABA) in spinal dialysate samples, 
respectively (Malmberg and Yaksh, 1995a). Thus, the introduction of exogenous 
PG into the spinal subarachnoid space of otherwise normal animals induced 
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temporary neurochemical and behavioral effects indicative of allodynia. 
Conversely, pretreatment with i.t. S(+)-IBU suppressed the brush (BR)-evoked 
neurochemical and physiological responses arising from spinal glycine-
disinhibition in the i.t. strychnine model of allodynia (Hall et al., 1999). The R(-)-
enantiomer was without effect suggesting the attenuation of these BR-evoked 
responses was related to the inhibition of COX in the lumbar spinal cord. In the 
GABA-disinhibitory model, focal application of NS-398 (COX-2 inhibitor) or SC-
51322 (EP receptor antagonist) 20 minutes before bicuculline application to the 
dorsal surface of the rat spinal cord produced a highly localized anti-allodynia 
(Zhang et al., 2001 ). These results indicate that the inhibition of spinal PG 
synthesis or the blockade of spinal EP-receptors before the onset of glycine- or 
GABA-disinhibition in the rat L-DH prevents the development of allodynia. 
Similar results have been reported using injury models of allodynia. For 
example, SNL elicits robust mechanical allodynia (PWT s 4 g) in the ipsilateral 
hind paw (Kim and Chung, 1992); an effect fully expressed 24 h after injury 
(Hefferan et al., 2003a, b). Mild brushing on the plantar surface of the ipsilateral 
hind paw two days after SNL significantly increased [PGE2JcsF compared to 
sham-controls (Hefferan et al. , 2003a, b). The effect declined by day 5 and was 
absent by day 10, even though BR-evoked allodynia persisted for up to twenty 
days (i.e. independent of any detectable change in [PGE2JcsF ). In the absence of 
brushing, or when brushing was applied away from the affected dermatome(s), 
there was no increase in [PGE2]csF at any time point after SNL (Hefferan et al., 
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2003a, b). These results indicate that: a) spinal PGE2 release is dependent on 
central synaptic activity evoked by brushing the affected dermatome(s); b) SNL 
does not effect a tonic increase in spinal PGE2 synthesis; and c) BR-evoked 
release of PGE2 is not sustained, in contrast to the allodynia arising from SNL. 
SNL-induced allodynia was dose-dependently reversed by the daily 
injection of i.t. S(+)-IBU, SC-236 or SC-51322 (Hefferan et al. , 2003a, b). This 
effect, beginning two days after injury, persisted for a further five days. In 
contrast, R(-)-IBU or SC-560 had no significant anti-allodynic effect, irrespective 
of the treatment day (Hefferan et al., 2003a, b). Systemic (i.v. or i.p.) 
administration of i.t. doses of S(+ )-IBU, or i.t. delivery to the mid-cervical spinal 
cord also had no effect in SNL animals (Hefferan et al., 2003a, b). Thus, the 
stereo-selective inhibition of PG synthesis or the blockade of EP receptors in the 
lumbar spinal cord attenuated 'established' allodynia up to seven days after SNL. 
The results suggest that COX-2 is primarily, if not exclusively responsible for 
spinal PG synthesis beginning two days after SNL. The time-course of PG-
dependent and PG-independent allodynia in the SNL model is summarized in 
Figure 1.1. 
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Figure 1.1. SNL-induced Allodynia consists of two phases: an early phase that 
is PG-dependent and a delayed phase that is PG-independent. Time course of 
PWT following tight ligation of the left L5/L6 spinal nerves (day 0) is also shown 
with allodynia being stable for at least twenty days. Data are presented as the 
mean ± SEM of seven animals. Shading represents the change in PG-
dependence (Hefferan et al., 2003b). 
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1.8 SPINAL PG ARE CRITICAL TO THE DEVELOPMENT OF SNL-
INDUCED, PG-INDEPENDENT ALLODYNIA 
Treatment with i.t. S(+)-IBU or SC-560 (beginning 1 h after SNL and 
repeated every 2 h for 8 h) completely prevented the SNL-induced decrease in 
PWT for up to twenty days (Hefferan et al., 2003b). Comparable treatment with 
R(-)-ibuprofen or SC-236 had no effect. The selective effect of i.t. S(+)-IBU in the 
SNL model supports the hypothesis that spinal PG are critical early signals in the 
acute nerve injured state, and their possibility as pre-emptive targets. This effect 
was matched by a COX-1 selective (SC-560), but not a COX-2 selective (SC-
236) inhibitor, suggesting that pathogenic PG in the spinal cord are derived from 
COX-1, at least up to 8 h after SNL. That PG synthesis coincides with the onset 
of nerve injury is consistent with immediate afferent barrage triggered by 
peripheral nerve injury, the abnormal release of neurotransmitters (particularly 
glutamate) in the spinal DH (Farooque et al., 1996; Kawamata and Omote, 
1996), the subsequent activation of postsynaptic NMDA receptors (Kajander et 
al. , 1992; Yoon et al. , 1996), and corresponding intracellular events effecting the 
release of AA and the early synthesis of spinal PG by constitutive enzymes 
(COX-1 ~ COX-2). After diffusion into the extracellular space, spinal PG enhance 
the excitability of adjacent cells (Willingale et al. , 1997; Saba et al., 2001) and the 
sustained activation of NMDA receptors. The latter underlies the central induction 
of COX-2 by primary afferent (i.e. non-immune) input (Vanegas and Schaible, 
2001). 
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Transcription of the COX-2 gene is modulated by nuclear factor kappa-B 
(NFKB). Spinal COX-2 protein is also is known to be increased by peripheral 
nerve injury. This up-regulation of COX-2 may reflect the abnormal activation of 
NFKB in the affected spinal cord, consistent with exaggerated glutamate release 
and the subsequent increase in intracellular Ca2+ concentration in the acute 
nerve-injured state. 
1.9 RELATIONSHIP BETWEEN SPINAL PG AND NFKB IN ALLODYNIA 
NFKB is a ubiquitous modulator of gene transcription which is made up of 
the following proteins, p52, p50, ReiB, c-Rel, Re1A(p65). They reside in the 
cytoplasm of most cells as a complex with the inhibitory subunit, IKB. 
Phosphorylation of IKB by IKB kinase (IKK) results in polyubiquitination, the 
degradation of IKB by the proteasome, and the release of active NFKB (Perkins, 
2000). The latter is then able to translocate into the nucleus where, in the 
presence of other transcription factors, it binds to the specific DNA fragments 
activating the expression of target genes. This process can be triggered by 
neurotransmitters (e.g. glutamate), cytokines, growth factors, drugs and 
chemicals, as well as conditions such as infection and stress (Grilli and Memo, 
1999; Pahl, 1999; Shi et al., 1999; Perkins, 2000). Once activated, NFKB is 
known to regulate many genes including those coding for cytokines, apoptotic 
and survival proteins (e.g. Bcl-2, Bcl-xl, Bcl-xs, Bax, p53), adhesion molecules, 
COX-2, manganese superoxide dismutase, inducible NO synthase (iNOS), and 
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cyclin-01 (Clemens et al., 2000). The fate of the cell appears to be governed by 
a host of factors including the nature of the activation and the set of target genes 
affected (Barkett and Gilmore, 1999). 
In the CNS, NFKB influences survival, apoptosis and plasticity (Aibensi & 
Mattson, 2000; Shishodia and Aggarwal, 2002; Bubici et al., 2006; Piva et al., 
2006). NFKB is an important factor regulating gene expression triggered by Ca2+-
dependent synaptic transmission (Meffert et al., 2003), including that evoked by 
nerve injury. However, its exact role remains unclear (Marini et al. , 2004). Its 
potential role in nerve injury-induced allodynia was first suggested in 
experimental studies using inhibitors of NFKB activation. Systemic or i.t. injection 
of ammonium pyrrolidedithiocarbamate (PDTC) or an oligonucleotide decoy 
attenuated the mechanical allodynia arising from chronic constriction of the 
sciatic nerve (Ebersberger et al., 2006), spinal cord injury (La Rosa et al. , 2004; 
Jimenez-Garza et al., 2005), or treatment with i.t. dynorphin (Laughlin et al., 
2000). However, their inhibiton of NFKB activation in the CNS, and the relevance 
of this mechanism to their anti-allodynic effect were not investigated. Moreoever, 
the relationship between NFKB activation, the subsequent induction of COX-2, 
the synthesis of spinal PG, and the development of hyperexcitability in the 
affected spinal cord are unkown. The possibility that spinal PG, generated 
immediately after SNL, facilitate the initial activation of NFKB and, in turn, its 
downstream transcriptional effect on COX-2 have not been investigated. 
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Given that NFKB also modulates iNOS gene expression, it is possible that 
spinal NO synthesis and signaling, like that of spinal PG, might be affected in the 
acute nerve injured state. 
1.10 RELATIONSHIP BETWEEN SPINAL PG AND NITRIC OXIDE IN 
ALLODYNIA 
Unlike other neuromodulators, NO is a diffusible messenger whose 
excitatory activity is neither mediated by membrane-bound cell surface receptors 
nor limited by their cellular distribution (Millan, 1999; Petersen-Zeitz & Basbaum, 
1999). NO is also thought to subserve important neuromodulatory functions in 
the CNS (Millan, 1999). The effects mediated by NO include the modulation of 
neurotransmitter release, gene expression, learning, memory, and PG synthesis 
(Bredt and Snyder, 1992; Haley et al., 1992; Mollace et al., 1995; Wang and 
Robinson, 1997; Garthwaite et al. , 1988). 
Extensive evidence links spinal NO to nociceptive processing. For 
example, incubation of an astroglial cell line with NMDA produced a dose-
dependent increase in NO, PGE2 and cGMP; effects inhibited by L-NAME 
(Mollace et al., 1995). The NO donor, sodium nitroprusside, evoked release of 
CGRP and substance P from DH slices (Garry et al. , 1994). In contrast, L-NAME 
blocked thermal hyperalgesia in the rat tail flick and tail immersion tests 
(Radhakrishnan et al., 1995) as well as PGE2-induced allodynia and 
hyperalgesia (Minami et al., 1995b; Park et al. , 2000). Dolan and Nolan (1999) 
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reported that i.t. NMDA-induced allodynia in sheep is blocked by either L-NAME 
(2 ~mol i.t.) or the COX-2 inhibitor, DFU (200 nmol i.t.). 
The relevance of spinal NO to NP is supported by pharmacological and 
molecular studies. Mechanical allodynia was attenuated in the spinal cord 
ischemia and the spinal cord ligation models by L-NAME (Hao and Xu, 1996; 
Yoon et al., 1998; Hefferan and Loomis, 2004). The amount of NO markedly 
increased after acute traumatic injury in the spinal cord (Nakahara et al., 2002) 
and nNOS staining in the superficial dorsal horn was dramatically increased after 
nerve injury (Ma and Eisenach, 2007). Given that NOS and COX are co-activated 
by NMDA receptor activation secondary to exaggerated glutamate release, that 
they exhibit similar changes in expression after injury, and that their expression is 
modulated by NFKB, raises the likelihood that spinal NFKB, NO and PG may 
work in concert to effect spinal hyperexcitability early after nerve injury. 
1.11 RESEARCH HYPOTHESIS AND SPECIFIC OBJECTIVES 
Research implicating spinal PG early in allodynia appears at odds with 
anecdotal reports suggesting that NSAIDs provide little, if any, benefit to patients 
with established allodynia. However, previous work in our laboratory (Hefferan et 
al., 2003a, b) indicates that the timing of treatment and the very purpose for 
which they are used are critical factors influencing the effectiveness of NSAIDs in 
allodynia. Specifically, they indicate that NSAIDs need to be given within hours of 
injury, not to relieve NP per se (i.e. as analgesics), but to mitigate its emergence. 
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To date, NSAIDs have been given long after nerve injury as adjuncts for 
symptom management. In short, NSAIDs have not been used clinically for the 
purpose suggested in this thesis research, and what limited experience that there 
is, does not refute the validity of the proposed research hypothesis. On the 
contrary, the implications of this research for NP are novel and very intriguing. 
Arguably the most important clinical feature of neuropathic pain is 
allodynia, which is known to be triggered by input from low-threshold primary 
afferent (A~) fibers not normally involved in pain processing. While the 
mechanisms underlying this debilitating condition are poorly understood, there is 
a growing body of evidence that PG, generated in the spinal cord after nerve 
injury, may play an integral role in the early pathogenesis of mechanical 
allodynia. There is additional evidence that NO, generated in the spinal cord after 
nerve injury, works in concert with spinal PG to alter sensory processing, 
resulting in the miscoding of low-threshold input as pain. 
Previous work in our laboratory has shown that SNL induces robust 
mechanical allodynia in the rat which consists of two distinct phases: a) an early 
spinal PG-dependent phase lasting approximately seven to ten days; and b) a 
delayed PG-independent phase lasting up to seventy days. Importantly, the 
former is a pre-requisite to and a trigger for the more complex and time-
dependent changes underlying long-term, irreversible mechanical allodynia. The 
latter, which is long-term and largely irreversible, comprises very complex 
mechanisms, including gene transcription, phenotypic and anatomical changes in 
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both the peripheral and central nervous systems (Millan, 1999). Interfering with 
critical signaling events early after nerve injury is a logical strategy by which 
chronic neuropathic pain might be prevented. Such an approach requires a clear 
understanding of the sequence, time-course and pharmacology of these early 
signals. Investigating the potential advantage of intervening pharmacologically, 
before allodynia becomes chronic and irreversible in nature (i.e. pre-emptive 
treatment of allodynia), represents the ultimate goal of this thesis research. 
In light of the apparent pathogenic role of spinal PG early after nerve 
injury, the present research investigated the SNL-induced changes in spinal PG 
synthesis and signaling, their relevance to the development of spinal 
hyperexcitability and mechanical allodynia, and the mechanisms underlying the 
changes in PG synthesis and signaling in the spinal PG-dependent phase. These 
hypotheses were tested using the L5/L6 spinal nerve ligation (SNL) model of NP 
(Kim and Chung, 1992) in which the L5 and L6 spinal nerves are tightly ligated 
(unilaterally) just distal to the DRG. This experimental NP model was selected 
because: a) mechanical allodynia develops within the first 24 h after injury and 
last for at least four months; b) it elicits pronounced mechanical allodynia while 
maintaining good animal health; and c) of the high reproducibility from one 
animal to another. This consistency, as well as absence of spontaneous recovery 
from allodynia, provided an excellent animal model to use in the present 
research. The specific objectives were: 
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1. To characterize the effect of SNL on A- and C-fiber mediated reflex 
responses (AFRR and CFRR, respectively) in the affected hind 
limb, and to determine the temporal and spatial relationship of 
these changes to SNL-induced allodynia. 
2. To determine if the SNL-induced changes in the AFRR and CFRR 
(i.e. spinal hyperexcitability) are spinal PG-dependent, and if so, to 
determine the relevant COX isoform(s). 
3. To determine if SNL triggers the activation of nuclear factor kappa 
B (NFKB) in the affected spinal cord which initiate the delayed 
induction of spinal COX-2. 
4. To determine if the sensitivity to PGE2 is exaggerated during spinal 
PG-dependent allodynia, and if this abnormal state is limited to the 
affected spinal cord three days after SNL. 
5. To determine if PG-dependent spinal hyperexcitability and 
mechanical allodynia are mediated by E-type prostaglandin (EP) 
receptors, and to investigate the changes in the expression of 
spinal EP1-3 receptor subtypes and the glycine-a3 receptor subunit 
(GLY-a3R) three days after SNL. 
6. To determine if disrupting spinal PG synthesis/signaling 
immediately after SNL (i.e. pre-emptive treatment) prevents the 
development of PG-dependent spinal hyperexcitability and 
mechanical allodynia. 
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7. To determine if spinal PG-dependent hyperexcitability is affected by 
the SNL-induced generation of spinal nitric oxide (NO), and if so, to 
investigate relevant NO synthase (NOS) isoform(s). 
8. To determine if, and how, spinal NO-mediated activity affects spinal 
PG-dependent spinal hyperexcitability and mechanical allodynia. 
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2.0 INCREASED EXPRESSION OF CYCLOOXYGENASE AND NITRIC 
OXIDE SYNTHASE ISOFORMS, AND EXAGGERATED SENSITIVITY 
TO PROSTAGLANDIN E2, IN THE RAT LUMBAR SPINAL CORD 
THREE DAYS AFTER L5/L6 SPINAL NERVE LIGATION 
2.1 INTRODUCTION 
There is growing evidence that PG, generated in the spinal cord following 
nerve injury, play a contributory role in the pathogenesis of NP. This was first 
suggested by the robust allodynia induced by i.t. PG in otherwise normal 
(uninjured) conscious mice (Minami et al. , 1992,1 994), an effect blocked by i.t. 
PG receptor antagonists (Minami et al., 1995; Kawahara et al. , 2001 ), and later 
shown to occur in EP1(+/+), EP3(+t+) and EPl'-l, but not EP1(-t-), mice (Minami et al., 
2001 ). Other studies have reported increased EP-receptor-IR in injured nerves 
after partial sciatic nerve ligation (Ma and Eisenach, 2003), and BR-evoked 
increases in the concentration of PGE2 in spinal dialysate two to eight days after 
SNL (Hefferan et al., 2003a). The latter were temporally and spatially linked to 
BR-evoked allodynia, and absent in sham-controls. Experimental allodynia was 
also attenuated by certain COX inhibitors or the EP-receptor antagonist, SC-
51322, when given in the two to eight day window following SNL (Ma et al., 2002; 
Hefferan et al., 2003a). 
SNL triggers early and sustained activation of spinal NMDA receptors 
(Ossipov et al., 2000); a critical trigger for central PG and NO (Sorkin and Moore, 
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1996). This is accompanied by the enhanced expression of COX (Resnick et al. , 
1998; Zhao et al., 2000) and NOS (Choi et al., 1996) in the spinal cord . Nerve 
injury-induced changes in spinal COX-1 and COX-2 expression or 
immunoreactivity have been described (Zhao et al., 2000; Zhu and Eisenach, 
2003; Hefferan et al., 2003b), but little is known about the concurrent expression 
of nNOS and iN OS, or whether any of these changes are confined to the spinal 
segments affected by nerve injury. The expression of both iNOS and nNOS 
increase early after spinal cord injury (Xu et al., 2001; Nakahara et al., 2002). 
Furthermore, the genes coding for inducible NOS and COX have identical 
promoters and response elements to NFKB (Lowenstein et al., 1993), which also 
has increased expression after spinal cord injury (Bethea et al., 1998). In the 
present study, we compared the expression of COX-1 , COX-2, nNOS and iN OS 
in the lumbar, thoracic and cervical spinal cord three days after SNL. 
Anecdotal reports suggest that NSAIDs provide little, if any, clinical benefit 
in relieving NP. However, work in our laboratory has shown that the timing of 
drug administration after nerve injury, and the COX isoforms affected are 
important variables governing the effectiveness of these drugs in experimental 
neuropathy. For example, COX-1 selective inhibitors, given intrathecally two to 
four hours after SNL, prevented the emergence of allodynia in the rat for up to 
twenty-five days (Hefferan et al., 2003b ), but were ineffective in reversing 
established allodynia. These results, and those of previous reports (Zhao et al. , 
2000; Hefferan et al., 2003a), strongly suggest that COX inhibitors need to be 
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given early after nerve injury, and not for the relief of neuropathic pain per se, but 
to prevent the emergence of allodynia. They, in turn, support a pathogenic role 
for spinal PG early after SNL, although the relationship between nerve injury, 
spinal PG activity, and allodynia remains unclear. 
One possibility is that nerve-injured animals develop abnormal sensitivity 
to the pathophysiological effects of endogenous PG in the spinal cord . This could 
trigger, or at least facilitate (i.e. through a pathogenic cascade), further 
adaptations that effect long term disturbances in sensory processing. If correct, 
such a change in sensitivity should be greatest in, and possibly restricted to, 
those spinal segments most affected by nerve injury. It should also be attenuated 
by pharmacological agents that disrupt spinal PG activity. To test this hypothesis, 
we compared the concentration- and dose-response effects of PGE2 in the 
lumbar and thoracic spinal cord of SNL, sham operated and na'ive rats. We also 
investigated the effects of the EP-receptor antagonist, SC-51322, and the S(+)-
and R(-)-enantiomers of IBU in this model. 
2.2 MATERIALS AND METHODS 
All studies were conducted in accordance with the guidelines of the 
Institutional Animal Care Committee of Memorial University of Newfoundland, St. 
John's, NL, Canada. 
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Animals. Male Sprague-Dawley rats (-130 g on the day of 
experimentation) were obtained from the Vivarium of Memorial University of 
Newfoundland and were housed in standard cages with woodchip bedding. 
Animals had free access to food and water and were housed singly after surgery. 
A 12 h light-dark cycle (lights on at 0700 h) was used throughout. 
Intrathecal Catheterization. Intrathecal catheters (6.5 em-length 
terminating near the lumbar enlargement or 4.0 em-length terminating in the mid-
thoracic segments) were implanted as previously described (Hefferan et al., 
2003a). Rats with normal motor, grooming and feeding behavior were housed 
separately and allowed to recover for three days before SNL or sham surgery. 
Neuropathy. Neuropathy was induced using the method of Kim and 
Chung (1994), as previously described (Hefferan et al., 2003a). Rats were 
anesthetized with halothane and the left L4 and L5 spinal nerves were isolated 
and separated. The L5 and L6 spinal nerves were tightly ligated with 6-0 silk 
thread. In sham-controls, the L5 and L6 spinal nerves were isolated but not 
ligated. All animals were allowed to recover for three days before 
experimentation. Allodynia, defined as a PWT of s 4 g, was confirmed using von 
Frey filaments. 
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Western Blotting. The spinal cord was extracted hydraulically (de Sousa 
and Horrocks, 1979), immediately frozen in 2-methylbutane (Sigma Chemical, St. 
Louis, MO, USA), and stored at -80 °C. The spinal cord was separated into 
cervical, thoracic, and lumbar regions (L2 to L6), and further subdivided into the 
left and right, ventral and dorsal quadrants. Spinal cord was homogenized in ice 
cold lysis buffer (1% Nonidet-P40, 10% glycerol in TBS plus a protease inhibitor 
cocktail tablet - Roche Diagnostics, Laval, PQ, CA, 1 mM sodium vanadate, 1 
mM sodium fluoride, and 0.025% SDS) and centrifuged at 10,000 rpm for 5 
minutes (4 °C). Samples, diluted to achieve equal protein concentrations (30 J,Jg), 
were separated by electrophoresis on 8% SDS-polyacrylamide gel. Proteins 
were transferred to a nitrocellulose membrane and incubated for 1.5 h in Tris 
buffer (Tris 25 mM, glycine 192 mM, 200 ml methanol, pH 8). Pre-stained protein 
markers were used for molecular weight determination. The blots were then 
stained with Ponceau Red to assess the equivalency of protein loading, and 
subsequently probed with the following antibodies: polyclonal rabbit anti-COX-1 
(1 :250), polyclonal rabbit anti-COX-2 (1 :1 000), polyclonal rabbit anti-nNOS 
(1:1000), and polyclonal rabbit anti-iNOS (1:1000) primary antibodies (Cayman 
Chemical, Ann Arbor, Ml, USA). Membranes were incubated overnight at 4 °C 
with primary antibodies, and diluted in Tris buffer (containing 3% milk powder and 
0.05% Tween-20). Protein bands were treated with a goat anti-rabbit horseradish 
peroxidase-conjugated secondary antibody (1 :5000; Chemicon International Inc., 
Temecula, CA, USA) for 1 hat room temperature, washed for 30 minutes in Tris 
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buffer, visualized using enhanced chemiluminescence (PerkinEimer Life 
Sciences Boston, MA, USA), and exposed to X-ray film (Cronex MRF Clear 
base, Agfa Corp, Greenville, SC, USA). 
Spinal Glutamate Release. The spinal cord was extracted hydraulically 
(de Sousa and Horrocks, 1979) and the dura and arachnoid membranes carefully 
removed. The lumbar region (L2 to L6) was excised, mounted on cutting blocks 
and immersed in sucrose-modified artificial cerebrospinal fluid (aerated with 95% 
02 and 5% C02). Slices (600 to 8001Jm) were cut with a vibratome and placed in 
aerated artificial cerebrospinal fluid at room temperature. They were immersed in 
HEPES buffer oxygenated with 100% 02 throughout the experiment. Glutamate 
released from the tissue was immediately oxidized to a-ketoglutarate by 
glutamate dehydrogenase, thereby preventing neuronal reuptake of glutamate 
(Nicholls et al., 1987). The reduced form of nicotinamide adenine dinucleotide 
phosphate generated from this reaction was quantitated using spectrofluorometry 
with excitation at 335 nm and emission at 430 nm (Nicholls et al., 1987). Basal 
and PGE2-evoked glutamate release was quantified using standard curves 
constructed with L-glutamate (0 to 360 pmol; Sigma-Aldrich, ON, CA) on each 
day of analysis. Basal glutamate release (i.e. release in the absence of any drug 
stimulus) was determined for 15 minutes before the introduction of drug into the 
cuvette. Drug-evoked release was defined as total release (i.e. after a drug 
stimulus) minus basal release. Protein content in each slice was determined 
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using a modified Lowry protein assay kit (Pierce Biotechnology, Rockford, IL, 
USA). 
Behavioral Testing. Spontaneous (i.e. no brushing) and BR-evoked 
behavior were continuously graded using a modified scoring system (Malmberg 
et al., 1995). Spontaneous behavior (0 - normal behavior, bright, alert and 
exploring; 1 -huddling, burrowing, or hiding; 2- one of the following: piloerection , 
occasional vocalization, or favoring the affected side; 3 - two or more of the 
following: piloerection, occasional vocalization, favoring the affected side; and 4-
any of the following: frequent or persistent vocalization, circling motion, licking or 
biting the affected dermatomes) was graded over a 4-min interval. The hair on 
the back, flanks, limbs, and hind paws was then brushed with a cotton-tipped 
applicator sufficient to deflect the pelage. This was continued for 1 min and the 
behavior graded as follows: 0- normal behavior, curious, alert, and exploring; 1 -
avoidance of stimulus source or protection of the affected dermatomes; 2 - one of 
the following: piloerection, paw withdrawal , or occasional vocalization; 3- two or 
more of the following: piloerection, paw withdrawal, or occasional vocalization; 
and 4 - any of the following: attacking the applicator, frequent or persistent 
vocalization, circling motion, licking or biting the affected dermatomes. This 
sequence was repeated every 5 minutes for the first hour and every 30 minutes 
thereafter up to 6 h or until no responses were detected. The investigator was 
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blinded to the nature of the treatment (i.e. vehicle, drug, concentration) in all 
behavioral experiments. 
Drugs. PGE2, SC-51322, S(+)- and R(-)-IBU were purchased from 
Biomol Research Laboratories, Inc. (Plymouth Meeting, PA, USA). Arachidonic 
acid was purchased from Cayman Chemical (Ann Arbor, Ml, USA). PGE2 
solutions were prepared according to Nishihara et al. (1995). Briefly, PGE2 was 
initially dissolved in ethanol and evaporated under nitrogen gas. It was then re-
dissolved in normal saline and diluted with the same to yield the desired 
concentrations. All other drugs were dissolved in 100% DMSO and diluted with 
normal saline at the time of injection to yield a final DMSO concentration of 50%. 
For the in vitro experiments, drugs were added directly into the cuvette 
containing the slice using a microsyringe. Each concentration of PGE2 was 
tested using a separate slice so that a full PGE2 concentration-response curve 
(CRC) was determined in each animal. All equipment was sterilized with 70% 
alcohol and thoroughly rinsed with 0.9% sterile saline before injection. Intrathecal 
drugs were injected into conscious, unrestrained rats using a hand-held 
microsyringe. Drugs were delivered in a volume of 5 !JI followed by 5 IJI of sterile 
saline. The i.t. catheter was immediately resealed with a stainless steel plug. The 
position of the catheter tip was verified visually after sacrifice in randomly 
selected animals. In three animals, methylene blue (1 0 IJI) was injected i.t. at the 
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mid-thoracic level (i.e. 2 em rostral to the mid-lumbar enlargement) to assess the 
extent of staining below the thoracic cord. 
Data Analysis. Data are reported as the mean ± SEM. Western blots 
were analyzed by optical density using lmageQuant® software (Amersham 
Biosciences Corp., Piscataway, NJ, USA). Expression data are presented as 
nanograms of protein, based on a single cyclooxygenase and NOS standard (50 
ng), run in separate lanes on each gel, and corrected for background optical 
density. Area-under-the-curve (AUC) was calculated using trapezoidal 
integration. Concentration-response analysis was performed using methods from 
Tallarida and Murray (1987). Comparisons within each treatment group were 
performed using one-way, repeated measures ANOVA, followed by the 
Newman-Keuls test. Comparisons across all drug- and vehicle-treated groups at 
each time point were determined using one-way, completely randomized 
ANOVA, followed by the Newman-Keuls test (SigmaStat® 2.0; Systat Software, 
Inc., Point Richmond, CA, USA). 
2.3 RESULTS 
Rats undergoing SNL displayed a significant decrease in PWT from ::2: 15 g 
(baseline) to ~ 4 g (Figure 2.1 ). This change in sensitivity remained stable for at 
least twenty days and confined to the plantar surface of the left hind paw 
(ipsilateral to nerve ligation). By day 20, a modest but significant (p<0.01) 
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decrease in PWT developed on the contralateral side of nerve-ligated animals 
(Figure 2.1 ). Generally, the affected hind paw was kept in an elevated and 
cupped position, thereby minimizing contact with the cage floor. All nerve-ligated 
rats were otherwise healthy, showed normal feeding and grooming behavior, and 
regular weight gain. Neither i.t. catheterization, nor sham-surgery had any effect 
on PWT compared to pre-surgical values (Figure 2.1 ). 
Western analysis revealed a significant increase in the expression of 
COX-2 (45%), nNOS (25%) and iNOS (45%) compared to sham-controls in the 
lumbar cord three days after SNL (Figure 2.2). These changes were localized to 
the left dorsal horn (i.e. ipsilateral to SNL). In contrast, COX-2, nNOS, and iNOS 
expression remained unchanged across the dorso-ventral axis, and between the 
ipsilateral and contralateral sides in the thoracic and cervical segments (Figure 
2.2A, 2.2C, 2.20). Although COX-1 expression increased by 11% in the left L-DH 
of ligated rats, this was not statistically different (p>0.05) from sham-controls 
(Figure 2.28). Neither was there a difference in COX-1 across the dorso-ventral 
axis, or between the ipsilateral and contralateral sides (Figure 2.28). The relative 
expression of COX-1, COX-2, nNOS, and iN OS varied within each spinal region. 
However, there were no significant differences in the rostro-caudal expression of 
each protein (p>0.05) in SNL and sham operated animals, except in the left L-DH 
after SNL. Representative immunoblots of COX-2 and iNOS from the lumbar 
cord of sham operated and SNL animals, and their corresponding protein 
standards are shown in Figure 2.2E. 
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PGE2 resulted in a concentration-dependent release of glutamate (EC5o = 
2.37x10-11 M; Table 2.1) from lumbar slices harvested three days after sham 
surgery (Figure 2.3). PGE2 was equi-effective using slices from na'ive (no 
surgery) and sham operated animals (Figure 2.3A; Table 2.1 ). In contrast, the 
PGE2 CRC using lumbar slices from nerve-ligated rats was significantly shifted to 
left compared to the sham and na'ive groups (Figure 2.3A). The EC50 in the SNL 
group was 8.30 x 1 o-15 M (Table 2.1 ), representing a 2855- and 2807 -fold 
increase in potency relative to sham- and na'ive-controls, respectively. There was 
no significant difference in the peak effect of PGE2 using SNL (3.1 2 ± 0.34 
pmol/min/mg protein), sham operated (3.90 ± 0.62), and naive (3.98 ± 0.58) 
preparations. Neither was there a difference (p>0.05) in the potency of PGE2 
using thoracic slices from sham operated and SNL rats (Figure 2.38; Table 2.1 ). 
Vehicle had no effect on glutamate release from lumbar slices of SNL animals 
(Figure 2.3A). Arachidonic acid evoked glutamate release from lumbar slices of 
na·ive animals but was approximately 250-fold less potent, and 32% more 
efficacious than PGE2 (Figure 2.3A; Table 2.1 ). All results were corrected for 
basal glutamate release, which was significantly greater (p<0.05) in nerve-ligated 
(2.94 ± 0.34 pmol/min/mg protein) as compared to sham-operated (1.50 ± 0.43) 
rats. 
In slices from SNL animals, pretreatment with S(+)-IBU shifted the PGE2 
CRC to the right (p<0.05) relative to R(-)-IBU-treated, vehicle (DMSO)-treated or 
untreated preparations (Figure 2.4; Table 2.1 ). This corresponded to a 24-fold 
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increase in the ECso of PGE2 compared to DMSO pretreatment. R(-)-IBU and 
DMSO had no effect on the EC5o values. Neither S(+)- nor R(-)-IBU had any 
effect (p>0.05) on the potency of PGE2 in sham operated preparations (Figure 
2.4; Table 2.1 ). In separate experiments, pretreatment with the EP-receptor 
antagonist, SC-51322, increased the EC50 of PGE2 in lumbar slices from nerve-
ligated animals (Figure 2.5; Table 2.1 ). It also significantly increased the efficacy 
of PGE2 relative to that in sham ( 41% increase), nerve-ligated (52% increase) 
and nerve-ligated +vehicle treated (42% increase) preparations (Figure 2.5). 
To determine if the enhanced sensitivity to PGE2 has relevance to 
allodynia, the dose-response effect of i.t. PGE2 was compared in SNL and sham 
operated rats. Brushing the hind limbs of sham operated rats treated with i.t. 
PGE2 evoked robust, nociceptive-like behavior (i.e. BR-evoked vocalizations, 
defensive posturing, licking the affected dermatomes, and biting the cotton-tipped 
applicator). Peak allodynia (90% of maximum possible score) was observed 10 
min after injection and declined thereafter (Figure 2.6A). The duration of allodynia 
(0.1 J.Jg) was 210 min. In SNL rats, the same dose of PGE2 elicited peak allodynia 
(100% of maximum possible score) at 10 minutes and remained unchanged for 
90min (Figure 2.6A). The duration of allodynia was >6 h. There were no 
significant differences between sham operated and SNL animals for spontaneous 
behavior (Figure 2.6, panels A and B). Dose-response analysis revealed a 362-
fold decrease in the ED50 of PGE2 in SNL compared to sham operated rats 
(Figure 2.6B; Table 2.2). In the absence of PGE2, identical brushing of SNL + 
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vehicle-treated (302 ± 93 %MPS-min), SNL + untreated (262 ± 82), sham + 
vehicle-treated (154 ± 31) or sham + untreated (116 ± 50) rats had no significant 
effect (p>0.05; Figure 2.68). In addition, there was no dose-response effect of 
PGE2 on spontaneous behavior (p>0.05) in either SNL or sham operated animals 
(Figure 2.68). 
Area-under-the-curve analysis revealed a significant reduction in BR-
evoked allodynia (63% decrease) and spontaneous behavior (53% decrease) in 
SNL animals when PGE2 (0.1 IJg) was injected into the thoracic as compared to 
the lumbar subarachnoid space (Figure 2. 7). A similar trend was observed in 
sham-controls. Both BR-evoked and spontaneous behaviors were significantly 
lower after thoracic as compared to lumbar delivery in all groups. In three 
animals, methylene blue (1 0 !JI) was injected intrathecally at the level of the mid-
thoracic cord. No staining was observed below the thoracic cord. 
In SNL rats, i.t. S(+)-IBU (1 00 !Jg) injected 20 min before PGE2 
significantly decreased BR-evoked behavior by 62% and spontaneous behavior 
by 46% compared to DMSO + PGE2 (Figure 2.8). In sham operated rats, S(+)-
IBU had no significant effect on either BR-evoked or spontaneous behaviors 
(p>0.05). R(-)-IBU was without effect in all treatment groups (Figure 2.8). In SNL 
animals, pretreatment with i.t. SC-51322 (1 OO!Jg), 20 minutes before i.t. PGE2 
(0.01 !Jg), significantly attenuated BR-evoked (39%) and spontaneous behavior 
(28%) compared to DMSO + PGE2 (Figure 2.9). SC-51322 had no effect on BR-
evoked or spontaneous behaviors in sham operated animals (p>0.05). 
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Figure 2.1. Tight ligation of the L5/L6 spinal nerves produced a significant 
reduction in PWT on the plantar surface of the ipsilateral hind paw. Animals were 
implanted with i.t. catheters (CI) three days before SNL or sham surgery (S) and 
all experiments (E) were conducted three days after surgery. Each point 
represents the mean ± SEM of ten animals. Asterisks indicate a significant 
difference from sham-controls or the contralateral side of nerve-ligated animals 
(***p<0.001 ). Daggers indicate a significant difference from sham-controls 
(ttp<0.01 ). All paw withdrawal thresholds on the ipsilateral side of nerve-injured 
animals were significantly different from pre-ligation values. 
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Figure 2.2. The expression of COX-2 (panel A), COX-1 (panel B), nNOS 
(panel C) and iNOS (panel D) in the left (L) and right (R) ventral (V) and dorsal 
(D) horns of the cervical, thoracic and lumbar spinal cord three days after SNL or 
sham surgery. Representative immunoblots (panel E) of COX-2 and iNOS in the 
lumbar spinal cord (lanes 1 &4: sham-operated control; lanes 2&5: corresponding 
protein standard; lanes 3&6: SNL). Asterisks indicate a significant difference 
between sham-operated and SNL animals (*p<0.05, **p<0.01 ), and each bar 
represents the mean ± SEM of five to eight animals. 
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Figure 2.3. The effect of PGE2 on glutamate release from lumbar slices of na·ive, 
sham operated or SNL rats (panel A), and thoracic slices from SNL or lumbar 
slices from sham operated rats (panel B), three days after surgery. Each point 
represents the mean ± SEM of at least five animals (4 to 12 slices/dose) and 
asterisks indicate a significant difference between SNL, sham operated and/or 
na·ive animals (*p<0.05, ***p<0.001) at the corresponding PGE2 concentration. 
Daggers indicate a significant difference between na·ive and sham operated 
animals following treatment with arachidonic acid (tp<0.05, tttp<0.001 ). Double 
daggers indicate a significant difference between the PGE2-treated and vehicle-
treated slices at the corresponding PGE2 concentration (:t:p<0.05, :t::t:p<0.01 , 
:t::t::t:p<0.001 ). 
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Figure 2.4. The effect of pretreatment with S(+)- or R(-)-IBU (1 .0 ~M) on 
PGE2-evoked glutamate release. Spinal (lumbar) slices were harvested three 
days after SNL or sham surgery. Each point represents the mean ± SEM of at 
least six animals (4 to 10 slices/dose). 
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Figure 2.5. The effect of SC-51322 (1 .0 1-1M) on PGE2-evoked glutamate release 
from lumbar slices harvested three days after SNL. Each point represents the 
mean ± SEM of at least five animals (4 to 12 slices/dose). Asterisks indicate a 
significant difference from sham-controls at the corresponding PGE2 
concentration (**p<0.01, ***p<0.001 ). Daggers indicate a significant difference 
from sham-controls at the corresponding PGE2 concentrations (tp<O.OS, 
ttp<0.01, tttp<0.001 ). 
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Figure 2.6. The time-course (panel A) and dose-response (panel B) curves of 
PGE2 on BR-evoked and spontaneous behaviors in SNL or sham operated 
animals. For the time course experiments, rats were injected with i.t. PGE2 (0.1 
!Jg) three days after surgery. The horizontal lines in panel B represent mean BR-
evoked results from vehicle-treated (_ ) and untreated ( ___ ) animals three days 
after SNL, and from vehicle-treated (_ ._)and untreated( ........ ) three days after sham 
surgery. None of these lines were significantly different from each other (p>0.05). 
Each point represents the mean ± SEM of six to fifteen animals. Asterisks 
indicate a significant difference from sham-controls at the individual time points 
(panel A) or doses (panel B) (*p<0.05, **p<0.01, ***p<0.001 ). Daggers indicate a 
significant difference from their respective spontaneous (i.e. non-evoked) control 
(ttp<0.01' tttp<0.001 ). 
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Figure 2.7. BR-evoked and spontaneous behaviors following i.t. PGE2 (0.1 IJg) 
into the lumbar or thoracic subarachnoid space three days after SNL or sham 
surgery. Each bar represents the mean ± SEM of six to fifteen animals. Asterisks 
indicate a significant difference from thoracic delivery within each treatment 
group (**p<0.01, ***p<0.001 ). 
44 
1600 
1400 
Q) 1200 
~ (3 1000 
800 
600 
400 
200 
N 
w 
C) 
Q. 
ur 
C) 
n. ur 
+ C) 
Q. 
BR-evoked Spontaneous 
Figure 2.8. The effect of i.t. S(+)- or R(-)-IBU (100 IJg) on BR-evoked and 
spontaneous behaviors induced by i.t. PGE2 (0.01 IJg). All drugs were injected 
three days after SNL or sham surgery. Each bar represents the mean ± SEM of 
six to twelve animals and asterisks indicate a significant difference (***p<0.001) 
from the both DMSO + PGE2 or R(-)-IBU + PGE2groups. 
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Figure 2.9. The effect of i.t. SC-51322 (100 ~g) on BR-evoked and spontaneous 
behaviors elicited by i.t. PGE2 (0.01 ~g). All drugs were injected three days after 
SNL or sham surgery. Each bar represents the mean ± SEM of six to twelve 
animals and asterisks indicate a significant difference from the corresponding 
SC-51322 + PGE2 treated group (**p<0.01, ***p<0.001 ). 
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2.4 DISCUSSION 
Tight ligation of the left L5/L6 spinal nerves, but not sham surgery, 
induced localized hypersensitivity to both brushing and von Frey filaments. 
Allodynia was accompanied by the increased expression of COX-2, nNOS and 
iNOS, and an exaggerated sensitivity to spinal PGE2 in the lumbar cord , three 
days after SNL. While the extent of change along the spinal cord was more 
difficult to define in vivo compared to the slice experiments, the behavioral data 
are consistent with a lumbar site of exaggerated sensitivity to PGE2. This is 
supported by the absence of detectable pharmacodynamic changes in the 
thoracic cord of nerve-ligated (i.e. allodynic) animals, and the fact that increased 
dermatomal sensitivity to brushing and von Frey filaments remained confined to 
the left hind limb and plantar surface, respectively. The latter is in agreement with 
previous work using the SNL model (Hefferan et al., 2003b; Schafers et al., 
2003). 
The increase in COX-2 expression (45% above baseline three days after 
SNL) was confined to the L-DH ipsilateral to nerve injury. This· effect is similar in 
magnitude to that reported by Zhao et al. (2000) but with a different time-course. 
They described a 45% increase 24 h after SNL which returned to baseline by day 
three. While the cellular localization of increased COX-2 immunoreactivity was 
not investigated in the present study, this isozyme is known to be expressed in 
macrophages and microglia (Durrenberger et al. , 2004). There were also 
differences in COX-1, which is constitutively expressed in cells with glial 
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morphology in the DH and those with motor neuron morphology in the ventral 
horn (Hay et al., 1997a, b; Ebersberger et al. , 1999; Maihofner et al. , 2000; Zhu 
and Eisenach, 2003). Spinal COX-1 was unchanged from baseline in the present 
study, and exceeded that of COX-2, even in spinal segments where COX-2 was 
induced. In contrast, COX-1 expression was undetectable by Zhao et al. (2000). 
Zhu and Eisenach (2003) later reported an increase in the number of COX-1-IR 
cells in the deep and superficial laminae of the ipsilateral lumbar cord four days 
after SNL. This effect persisted in the superficial laminae for up to two weeks. 
The exact reasons for these discrepancies are unclear but could be due to 
differences in the immunoblotting protocol and/or nerve ligation pressure/injury. 
For example, the COX-1 primary antibody was incubated for 24 h at 4 °C in the 
present study compared to 1 h at room temperature by Zhao et al. (2000). 
Differences in nerve ligation pressure would explain the distinct onsets in 
allodynia (i.e. one day versus one week after SNL). Whatever the reasons, the 
results of the present study correlate temporally and spatially with: a) the 
pharmacological changes induced by SNL in this report; b) the preferential 
reversal of allodynia by COX-2 selective inhibitors given two to nine days after 
SNL (Ma et al., 2002; Hefferan et al., 2003a); and c) the prevention of allodynia 
for up to twenty-five days by an i.t. COX-1 , but not a COX-2 selective inhibitor, 
given two to four hours after SNL (Hefferan et al., 2003b). 
A significant increase in the spinal expression of nNOS and iNOS was 
also observed three days after SNL; an effect confined to the ipsilateral L-DH. In 
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a model of traumatic spinal cord injury, cells expressing nNOS increased 
immediately after injury and lasted for 12 h (Nakahara et al., 2002). Those cells 
expressing iNOS were evident from 12 h to three days after injury. A progressive 
increase in iNOS expression, beginning 24 h after spinal trauma and peaking on 
day 7, has also been reported (Xu et al., 2001 ). Neurons exhibiting increased 
NOS-immunoreactivity are located in the superficial laminae of L4 to L6 
seggments ipsilateral to nerve (Lukacova et al. , 2003) or spinal cord injury 
(Gonzalez et al., 2001 ). Collectively, the expression data indicate that COX and 
NOS isozymes are up-regulated in the spinal cord after SNL, but with different 
time-courses. nNOS and possibly COX-1 are affected within hours of injury 
(COX-1 expression is increased in the L-DH 12 h after SNL - unpublished 
results). COX-2 and iNOS exhibit a more delayed effect (i.e. days after injury). 
The genes coding for inducible NOS and COX have identical promoters and 
response elements to NFKB (Lowenstein et al., 1993); a factor known to be 
increased in the spinal cord after injury (Bethea et al., 1998). Experiments were 
subsequently conducted to investigate the connection between increased NFKB, 
NOS, COX, and EP-receptors in the SNL model. 
In vitro, PGE2 yielded a consistent bell-shaped CRC in all slice 
preparations. This was previously described using synaptosomes (Nishihara et 
al., 1995) and astrocytes (Bezzi et al., 1998) from normal animals, and may 
reflect the preferential activation of EP-receptors inhibiting glutamate release 
(e.g. EP3) and/or the desensitization of excitatory EP-receptors (i.e. EP1, EP2 and 
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EP4), at high PGE2 concentrations. The former possibility seems most likely in 
view of the effect of SC-51322 to increase glutamate release at high PGE2 
concentrations. The blockade of EP3 receptors, some of which are coupled to 
inhibitory G-proteins (Sonnenburg et al., 1990) on the central terminals of primary 
afferent fibers, would disinhibit this release. The parallel leftward shift in the PGE2 
CRC (including the descending phase) three days after SNL suggests that all 
EP-receptor subtypes eliciting or inhibiting glutamate release in the affected 
lumbar segments must have undergone comparable increases in sensitivity after 
SNL. Alterations in the spinal expression of EP receptors after SNL are currently 
being investigated in our laboratory. While AA also evoked glutamate release, it 
was significantly less potent than PGE2. AA does not appear to activate inhibitory 
mechanisms at high concentrations as its peak effect was identical to that of 
PGE2 in the presence of SC-51322. 
Prostanoids are known to be active in a variety of nerve injury models. 
PGE2 (1 0 IJM), administered as part of an inflammatory cocktail, increased 
spontaneous activity in dorsal root fibers, and evoked activity in a subpopulation 
of previously 'silent' fibers, two to four weeks after chronic constriction injury 
(Song et al., 2003). In axotomized rats, a mixture containing PGE2 (10 IJM) 
enhanced ectopic mechanical excitability, reduced PWT and increased the 
response magnitude in most (77%) severed mechanosensitive C-fibers and 
some (46%) mechanosensitive A-fibers (Michaelis et al., 1998). Unlike the 
present study however, these reports provided no direct information on the 
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degree to which nerve injury alters the pharamcodynamic response to 
prostanoids. 
The effect of COX inhibitors in NP models vary depending upon the time 
of administration (i.e. pre- or post-treatment). lsoform-selective and non-selective 
COX inhibitors, given systemically or intrathecally near the time of injury (i.e. 
before to one to two days after) attenuated thermal hyperalgesia and/or 
mechanical allodyina in various NP models (Zhao et al., 2000; Hefferan et al. , 
2003a; Ma and Eisenach, 2003; Suyama et al. , 2004). In contrast, their 
effectiveness declined as the time of administration increased after nerve injury 
(i.e. greater than seven days). The results of the present study (i.e. three days 
after SNL) are consistent with this overall time-course profile. 
The mechanisms underlying the marked sensitivity to PGE2 remain to be 
determined but increased EP receptor-effector coupling in the affected spinal 
cord (i.e. receptor supersensitivity), and/or increased spinal EP receptor 
expression are obvious possibilities. Indeed, SNL resulted in a parallel leftward 
shift in the PGE2 concentration-response curve, while pretreatment with SC-
51322 yielded an opposite rightward shift. SC-51322 also inhibited BR-evoked 
and spontaneous behavior in vivo confirming that these effects are mediated by 
spinal EP-receptors. The sheer magnitude of the increase in potency of PGE2 
following SNL also argues strongly for amplification of the pharmacodynamic 
response at the EP-receptor-effector level. SC-51322 had no effect on 
spontaneous or BR-evoked behavioral responses in sham operated animals. 
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This is because an inactive dose of i.t. PGE2 (0.01 IJg) in sham-controls was 
selected for these experiments. Moreover, endogenous spinal PG have no effect 
on behavior in sham operated as compared to SNL rats early (i.e. post three 
days) after nerve injury (Hefferan et al. , 2003a). 
However, additional mechanisms appear to be involved which could also 
have important pathophysiological implications in the nerve-injured state. 
Pretreatment with S(+)-IBU, but not the R(-)-enantiomer, attenuated exogenous 
PGE2-evoked glutamate release from slices of SNL animals, as well as BR-
evoked and, to a lesser degree, spontaneous behavior in vivo. S(+)-IBU had a 
similar effect on electrically-evoked flexor afferent responses recorded from the 
rat biceps femoris three days after SNL (O'Rielly and Loomis, 2007). In every 
experiment, the effect of IBU was stereo-specific indicating that the attenuation of 
exogenous PGE2 was related to COX inhibition. These results strongly suggest 
that spinal PG biosynthesis is activated by exogenous PGE2 in the nerve-injured 
state, and that the resulting products contributed to the observed COX-
dependent effects of spinal PGE2 in this model. The up-regulation of COX and 
NOS, as suggested by the expression data three days after SNL, would provide 
the enhanced biosynthetic capacity in the lumbar spinal cord by which to 
generate such products. The preferential coupling and synergistic interaction 
between the inducible forms of COX-2 and membrane-bound PGE2 synthase 
(Murakami et al. , 2000) also represent a well regulated system by which the 
biosynthesis of PGE2 could be specifically up-regulated after SNL. 
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In fact, the enzymes responsible for PGE2 biosynthesis, and at least one 
of the EP receptor subtypes utilized by PGE2, are strategically co-located within 
the cell. Functional EP1-receptors, like those in the plasma membrane, are co-
located with the inducible forms of COX-2 and membrane-bound PGE2 synthase 
in the nuclear membrane and endoplasmic reticulum (Bhattacharya et al., 1998; 
Murakami et al., 2000). Moreover, COX-1 and COX-2 are also monotopically 
inserted in the endoplasmic reticulum and nuclear membrane with the substrate-
binding pocket precisely orientated to take up AA as it is liberated from the 
membrane by PLA2 or PLC (Ambs et al., 1995; Funk, 2001). PLA2 isoforms are 
up-regulated after sciatic nerve injury (De et al., 2003), and PG rapidly increase 
the cytosolic [Ca2+]tree from internal stores in a concentration-dependent manner 
(Mene et al., 1987). The latter initiates Ca2+-dependent phospholipase activity 
(Phillis and O'Regan, 2004) as evidenced by the effect of prostaglandin F2a on 
PLC activity (Kelefiotis et al., 1995). These biochemical studies confirm the 
presence of the prostanoid catalytic cascade and a requisite receptor subtype 
within the cell by which PGE2 could elicit its own synthesis in an up-regulated 
statet. Whether a similar relationship extends to NO remains to be determined, 
but it is noteworthy that: a) iNOS and nNOS are up-regulated in the ipsilateral L-
DH three days after SNL; b) PG and NO are positively and reciprocally coupled 
t Recent experiments using spinal slices from nerve-ligated animals showed a 1 00-fold or greater 
excess in the bath concentration as compared to the added concentration of PGE2. These 
differences were blunted by pre-incubation with (S+)-IBU (unpublished results). Plotting the 
differences against the [PGE2]added yielded a sigmoidal curve. This concentration-dependent effect 
would explain the parallel shift in the PGE2 concentration-response curve after S(+ )-IBU 
pretreatment in the present study. 
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in many cell types (Goodwin et al., 1999; Perez-Sala and Lamas, 2001); and c) 
PGE2 and NO exhibit additive pro-allodynic effects in the SNL model (Hefferan 
and Loomis, 2004 ). 
In summary, the results of the present study support the hypothesis of 
early and abnormal sensitivity to spinal PGE2 three days after SNL in the rat; 
effects which are mediated by spinal EP-receptors, COX-dependent, and 
localized to spinal segments most likely affected by SNL. They provide further 
evidence for an early pathogenic role of spinal PGE2 in experimental allodynia, 
and indicate that spinal PG, in the nerve-injured state, are capable of triggering 
their own biosynthesis. These results have important pathophysiological 
implications, and are in accordance with previous reports on the functional 
relationship between spinal PG and experimental allodynia in the SNL model (Ma 
et al., 2002; Hefferan et al., 2003a, b). 
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3.0 SPINAL NERVE LIGATION-INDUCED NEURONAL 
HYPEREXCITABILITY MATCHES THE TIME-COURSE OF ALLODYNIA 
AND IS SENSITIVE TO SPINAL CYCLOOXYGENASE INHIBITION 
3.1 INTRODUCTION 
In the rat, L5/L6 SNL elicits stable allodynia, expressed as a marked 
reduction in the PWT and protective posturing of the affected dermatome(s) (Kim 
and Chung, 1994 ). This abnormality is preceded by ectopic discharges in injured 
nerves and sub-threshold oscillations recorded from the corresponding DRG (Liu 
et al., 2000a). These repetitive discharges coincide with the onset of allodynia 
(Liu et al., 2000b). 
Exaggerated afferent input elicits molecular changes in the spinal cord 
giving rise to central sensitization (Attal and Bouhassira, 1999; Zimmermann, 
2001 ). For example, up-regulation of NMDA receptor phosphorylation and 
enhanced expression of the a2o-1 calcium channel subunit occur in the ipsilateral 
DH after SNL (Li et al., 2004; Gao et al. , 2005). This is accompanied by an 
induction of phosphoERK in neurons of the superficial DH (Zhuang et al. , 2005). 
These up-stream effects are coupled to the increased expression of COX-1 and 
COX-2 protein in the ipsilateral L-DH early after SNL (Zhu and Eisenach, 2003; 
O'Rielly and Loomis, 2006); changes temporally correlated with the onset of 
allodynia (Zhu and Eisenach, 2003; Li et al. , 2004; Gao et al. , 2005; O'Rielly and 
Loomis, 2006). 
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Recent studies using SNL have demonstrated: a) an early PG-dependent 
phase of allodynia lasting approximately seven days after nerve injury (Hefferan 
et al., 2003b); b) increased expression of COX-1 and COX-2 in, and release of 
PGE2 and PGI2 from the injured spinal cord (Tonai et al., 1999; Ma and 
Eisenach, 2002, 2003; Hefferan et al. , 2003a; O'Rielly and Loomis, 2006); c) a 
marked increase in the pharmacodynamic sensitivity to PGE2 within the affected 
spinal segments (O'Rielly and Loomis, 2006); and d) the prevention of the 
neurochemical, pharmacological and behavioral features of allodynia by various 
COX inhibitors given intrathecally two to eight hours after nerve injury (Hefferan 
et al., 2003b). These studies support an early pathogenic role of spinal PG in the 
development of allodynia. 
This hypothesis is further supported by the direct excitatory effect of PG 
on wide dynamic range DH neurons, and the ability of PG to sensitize them to 
afferent sensory input (Hingtgen et al., 1995; Ferreira et al. , 1996; Willingale et 
al., 1997; Saba et al., 2001; Ahmadi et al. , 2002). These effects, combined with 
an enhanced sensitivity to PG after SNL, should facilitate central hyperexcitabilty 
in the affected spinal segments. This outcome, which can be measured 
quantitatively using flexion reflexes (e.g. biceps femoris), and the corresponding 
contribution of spinal PG, have not been investigated in a nerve injury model. 
In the present study, changes in the biceps femoris flexor reflex 
(Schouenborg and Sjolund, 1983; Herrero and Cervero, 1996a, b; Willingale et 
al., 1997) were investigated to determine: a) the effect of nerve injury on the 
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AFRR and CFRR, one, three and ten days after SNL; b) the relationship between 
these changes and the onset of allodynia in the SNL model; and c) if spinal PG 
synthesis/release is a necessary feature of SNL-induced hyperexcitability. A 
more detailed study of the effect of spinal PG on SNL-induced allodynia will be 
reported in a subsequent chapter. 
3.2 MATERIALS AND METHODS 
All studies were conducted in accordance with the guidelines of the 
Institutional Animal Care Committee of Memorial University of Newfoundland, St. 
John's, NL, Canada. 
Animals. Male Sprague-Dawley rats (- 130 g on the day of 
experimentation) were obtained from the Vivarium of Memorial University of 
Newfoundland and were housed in standard cages with woodchip bedding. 
Animals had free access to food and water and were housed singly after surgery. 
A 12 h light-dark cycle (lights on at 0700 h) was used throughout. 
Intrathecal Catheterization. Intrathecal catheters (6.5 em-length 
terminating near the lumbar enlargement or 4.0 em-length terminating in the mid-
thoracic segments) were implanted as previously described (Hefferan et al. , 
2003a). Rats with normal motor, grooming and feeding behavior were housed 
separately and allowed to recover for three days before SNL or sham surgery. 
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Neuropathy. Neuropathy was induced using the method of Kim and 
Chung (1994), as previously described (Hefferan et al. , 2003a). Rats were 
anesthetized with halothane and the left L4 and L5 spinal nerves were isolated 
and separated. The L5 and L6 spinal nerves were tightly ligated with 6-0 silk 
thread. In sham-controls, the L5 and L6 spinal nerves were isolated but not 
ligated. All animals were allowed to recover for three days before 
experimentation. Allodynia, defined as a PWT of S4 g, was confirmed using von 
Frey filaments. 
Electrophysiological Recordings. Rats were anesthetized with 
halothane and cannulae were placed in the trachea, left carotid artery and right 
external jugular vein. Halothane anesthesia was then replaced by sodium 
thiobutabarbitone (1 mg·kg-1 i.v.; lnactin, Sigma-Aldrich, ON, CA). The depth of 
anesthesia was assessed by testing for hind limb withdrawal and corneal reflexes 
which had to be absent. Blood pressure was continuously monitored via a left 
carotid artery catheter and the mean arterial pressure maintained between 100 to 
130 mmHg by additional anesthetic as required. Systolic blood pressure did not 
fall below 100 mmHg throughout the experiment. Core temperature was 
maintained close to 37 °C using a homeothermic blanket system. The animal 
preparation was allowed to stabilize for at least 30 minutes prior to recording. 
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Spinal flexor reflexes were evoked by subcutaneous electrical stimulation 
applied to the first toe of the hind paw. Needle location was based on the 
innervation pattern of the sural nerve (Wiesenfeld-Hallin, 1988) and square-wave 
pulses (0.2, 0.6, 1.0 Hz) of 1 ms duration were used. Stimulation at each 
frequency was repeated three times to ensure stability and extracellular 
electromyographic responses were recorded from the biceps femoris muscle 
using a pair of tungsten needle electrodes. Intervals of three to five minutes were 
introduced between successive stimulus trains to prevent a conditioning effect by 
the preceding stimulus. A low intensity supra-threshold stimulus refers to a 
voltage twice the AFRR activation threshold (five pulses at 0.2 Hz). A high 
intensity supra-threshold stimulus refers to a voltage twice the CFRR activation 
threshold (twenty pulses at 1.0 Hz). 
AFRR and CFRR were distinguished on the basis of their response 
latencies. AFRR was classified as those appearing <1 00 ms after the stimulus 
artifact. CFRR was defined as those >1 00 ms up to a maximum of 600 ms. 
These criteria were confirmed by examining the effect of i.t. morphine (1 00 IJg) 
and naloxone (100 1-1g) on the AFRR and CFRR of the biceps femoris reflex in 
naive animals. Based on the measured length of the sural nerve in rats weighing 
130 to 150 g (i.e. 12 em), afferent fibers mediating the late phase (>1 00 to 600 
ms) had an average conduction velocity of 1.2 m·s-1; a value within the accepted 
range for C-fibers (Lynn and Carpenter, 1982). The A- and C-fiber intervals used 
in the present experiments are in agreement with previous reports on the rat 
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biceps femoris reflex (Lynn and Carpenter, 1982; Herrero and Cervera, 1996a, 
b). 
To determine the AFRR activation threshold, stimulus trains of five pulses 
(0.2 to 1.0 Hz) were applied at increasing voltages until a positive response was 
obtained. A positive response was deemed to have occurred when at least three 
of the five stimulus pulses produced a spike (i.e. amplitude >20 IJV). To 
determine the CFRR activation threshold, stimulus trains of twenty pulses (0.2 to 
1.0 Hz) were applied at increasing voltages until a positive response was 
obtained. A positive response was deemed to have occurred when at least ten of 
the twenty stimulus pulses produced a spike (i.e. amplitude >20 IJV). 
Data were collected, stored and analyzed using a Powerlab® data 
acquisition system (ADinstruments, Inc., Colorado Springs, CO, USA). Off-line 
data analysis was initially performed using the data acquisition software provided 
by the manufacturer (Chart 5.0). The data were further analyzed using a 
customized computer program developed in collaboration with the Department of 
Computer Science, Memorial University. 
Data Analysis. Electromyographic recordings in sham operated and SNL 
animals were compared using the mean responses elicited by three stimulus 
trains of 0.2, 0.6 and 1.0 Hz. Data were collected (4000 samples/sec) and high-
pass digital filters (cut-off frequency 70 Hz) were used to remove noise and 
movement artifacts. Spontaneous activity was defined as the average spike 
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count integrated over a 60 s period prior to experimentation. In all cases, the 
magnitude of the AFRR and CFRR was calculated by integrating the spike count 
over the stimulation period (i.e. AUC analysis). Spikes were integrated from 0.5 
to 99.9 ms and 100 to 600 ms for the AFRR and CFRR, respectively. Baseline 
reflex activity was defined as the response to the first stimulus in each impulse 
train. Windup was assessed by comparing the response evoked by the 201h 
stimulus in each train of sham operated and SNL animals. Comparisons within 
and between the treatment groups were performed using one-way ANOVA, 
followed by the Newman-Keuls test. Data are reported as the mean± SEM, and 
p<0.05 indicates a significant difference. 
Drugs. S(+)- and R(-)-IBU were purchased from Biomol Research 
Laboratories, Inc. (Plymouth Meeting, Ml, USA). Drugs were dissolved in 100% 
DMSO and diluted with normal saline at the time of injection to yield a final 
DMSO concentration of 50%. All equipment was sterilized with 70% alcohol and 
thoroughly rinsed with 0.9% sterile saline before injection. Intrathecal drugs were 
injected into conscious, unrestrained rats using a hand-held microsyringe. Drugs 
were delivered in a volume of 5 IJI followed by 5 IJI of sterile saline. The i.t. 
catheter was immediately resealed with a stainless steel plug. The position of the 
catheter tip was verified visually after sacrifice in randomly selected animals. 
61 
3.3 RESULTS 
After SNL, rats displayed a significant decrease in PWT from ~15 g 
(baseline) to S4 g (data not shown; O'Rielly and Loomis, 2006). This change was 
apparent 12 h after SNL, was stable for at least twenty days, and remained 
confined to the plantar surface of the left hind paw (i.e. ipsilateral to SNL). By day 
20, a modest but significant (p<0.01) decrease in PWT developed on the 
contralateral hind limb of SNL animals. Generally, the affected hind paw was kept 
in an elevated and cupped position to minimize contact with the cage floor. All 
SNL rats were otherwise healthy, showed normal feeding and grooming 
behavior, and regular weight gain. Sham surgery had no effect on PWT 
compared to pre-surgical values, as reported previously (O'Rielly and Loomis, 
2006). 
Electromyographic recordings of the AFRR and CFRR of the biceps 
femoris flexor reflex are shown in Figure 3.1A. Intrathecal morphine (100 IJg) had 
no effect on evoked activity in the 0.5 to 99.9 ms range. In contrast, activity 
between 100 and 600 ms range was nearly eliminated (Figure 3.1 B); an effect 
reversed by i.t. naloxone (1 00 1-1g; data not shown). The activation thresholds for 
both the AFRR and CFRR (ipsilateral to SNL) were significantly reduced 
compared to sham-controls (Figure 3.2). Three days after SNL (P-3-D), the 
AFRR exhibited a frequency-independent reduction ranging from 25 to 32% 
(Figure 3.2A). Otherwise, there were no significant differences across the 
stimulation frequencies, or across post-surgical days at a given stimulation 
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frequency. The reduction in the CFRR ranged from 54 to 62% and was also 
frequency-independent (Figure 3.28). This effect was evident at P-1-0 and 
persisted up to P-10-0. After SNL, CFRR was observed at voltages triggering 
AFRR activity in sham-controls. There were no significant differences across 
post-surgical days at a given stimulation frequency. The only difference between 
stimulation frequencies on a given experimental day was 0.2 Hz vs 0.6 Hz and 
0.2 Hz vs 1.0 Hz (Figure 3.28). Neither were there any significant differences 
between the contralateral hind limb of SNL animals and either side of sham-
controls for the AFRR or CFRR (data not shown). 
Compared to sham-controls, the magnitude of both AFRR and CFRR was 
significantly increased after SNL using either AFRR (Figures 3.3 and 3.4A&8; 
Table 3.1) or CFRR threshold stimulation (Figures 3.3 and 3.5A&8; Table 3.2). 
For example, the AFRR increased by 70.6% at AFRR threshold and by 49.4% at 
CFRR threshold at 1.0Hz (Table 3.1 ). Enhanced AFRR and CFRR were evident 
at P-1-0, peaked at P-3-0, and remained elevated at P-10-0, irrespective of 
stimulation frequency and activation threshold (Figures 3.4A&8 and 3.5A&8). 
The only exceptions were the AFRR and CFRR evoked by a twenty pulse 
stimulus at 1.0 Hz (Figures 3.48 and 3.58). Significant differences in AFRR and 
CFRR were observed across experimental days within each stimulation 
paradigm (e.g. 20 pulses, 0.2 Hz) (Figures 3.4A&8 and 3.5A&8). The AFRR and 
CFRR did not vary significantly between respective stimulation paradigms on the 
same experimental day (Figure 3.4A&8). There were also no significant 
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differences in the response magnitude of the AFRR and CFRR (p>0.05) in sham-
controls across the experimental days within each stimulation paradigm (Figures 
3.4A&8 and 3.5A&8), or between stimulation frequencies on a given 
experimental day (e.g. P-1-D at 5 pulses, 0.2 Hz versus P-1-D at 5 pulses, 1.0 
Hz). 
Similar results were observed using supra-threshold stimulation (Table 
3.1 ). At twice the AFRR (Figure 3.7) or CFRR (Figure 3.8) activation threshold, 
the response magnitude of the AFRR was significantly increased in all nerve-
ligated groups compared to their respective sham-controls. For a given stimulus 
paradigm (e.g. 5 pulses, 0.2 Hz), the response magnitude on P-10-D was 
significantly greater than P-3-D and/or P-1-D after SNL, except for the 20 pulse-
1.0 Hz stimulation. There were no significant differences between P-1 -D and P-3-
D after SNL, or across all experimental days in sham-controls (Figure 3.7A&8). 
At twice the CFRR activation threshold, the magnitude of the CFRR was 
significantly increased compared to sham-controls on all experimental days 
(Figure 3.88; Table 3.2). While there was a trend towards increased response 
magnitude over the ten day time-course after SNL, P-10-D was not significantly 
different from P-1-D and/or P-3-D (Figure 3.88). AFRR supra-threshold activation 
had no effect on the CFRR irrespective of stimulus frequency or experimental 
day (Figure 3.8A). 
At threshold activation, the AFRR had a pooled average latency of 12.3 ± 
0.4 ms (AFRR activation threshold) and 9.7 ± 0.3 ms (CFRR activation 
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threshold}. These latencies were unaffected by SNL irrespective of the stimulus 
frequency or experimental day (data not shown). The CFRR had a pooled 
average latency of 173.2 ± 9.9 ms at CFRR activation threshold regardless of the 
stimulation frequency. The latency of the CFRR evoked by a 20-pulse stimulus 
was significantly reduced at P-3-D and P-10-D compared to sham-controls at all 
frequencies tested (data not shown). For example, the CFRR latency decreased 
by 24.3% at 1.0 Hz compared to sham-controls on P-3-D. At supra-threshold 
stimulation, there were no significant differences in either the AFRR or CFRR of 
SNL animals compared to sham-controls (data not shown). In addition, there 
were no significant differences in the latencies of the AFRR or CFRR evoked by 
threshold or supra-threshold stimulation recorded from the contralateral hind limb 
of SNL animals (data not shown). 
At activation threshold, the response duration of both the AFRR and 
CFRR was significantly increased after SNL compared to sham-controls (Figures 
3.4C and 3.5C). This was evident at P-1-D, peaked at P-3-D, and remained 
elevated at P-10-D (Figures 3.4C and 3.5C). The only exception was the duration 
evoked by a 20 pulse stimulus at 0.2 Hz which did not reach statistical 
significance (Figure 3.5C). Supra-threshold stimulation had no effect on the 
duration of either the AFRR (Figure 3. ?C) or CFRR (Figure 3.8C) components in 
SNL compared to sham operated animals. The response duration did not vary 
across experimental days within each treatment group, regardless of the stimulus 
paradigm. 
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Treatment with i.t. S(+)-18U (100 IJg), 30 minutes before supra-threshold 
CFRR activation threshold stimulation, significantly reduced the AFRR (Figure 
3.9A) and CFRR (Figure 3.98) in SNL rats for 2 h compared to three separate 
controls: S(+)-18U+sham; R(-)-18U+sham; and R(-)-18U+SNL (Figures 3.9A and 
3.98). The inhibitory effect of S(+)-18U on the AFRR and CFRR, determined 1 h 
after i.t. injection, was dose-dependent (Figures 3.9C and 3.90). 
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Figure 3.1. Representative tracings of the A- and C-fiber components of the 
biceps femoris flexor reflex in narve animals. An electrical stimulus (S) at 1.5 Hz 
was applied to the hind paw before (A) and after (B) i.t. morphine (100 J,Jg). The 
insert in panel A shows the A- and C-fiber components evoked by the 51h pulse. 
Whereas morphine had no effect on evoked activity in the 0.5 to 99.9 ms range, 
activity between 100 and 600 ms range was nearly eliminated (panel B). A pulse 
stimulus indicator bar is shown under each tracing. 
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Figure 3.2. Threshold stimulation (V) required to activate the A-fiber (panel A) 
and C-fiber (panel B) components of the ipsilateral biceps femoris flexor reflex. 
Data were recorded one (P-1-D), three (P-3-D), and ten (P-10-D) days after SNL 
or sham surgery. Note that after SNL, C-fiber responses occur at voltages 
triggering A-fiber activity in sham-controls. Each bar represents the mean ± SEM 
of five to seven animals. Asterisks indicate a significant difference from the 
corresponding sham-control (**p<0.01 ; ***p<0.001 ). Daggers (tp<0.05; 
ttp<0.01) indicate a significant difference from 0.2 Hz on the same experimental 
day for sham-controls. Double daggers (1:p<0.05; ++p<0.01 ; +++p<0.001) 
indicate a significant difference from 0.2 Hz on the same experimental day for the 
SNL groups. 
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Figure 3.3. Representative tracings of A- and C-fiber components in the biceps 
femoris flexor reflex evoked by electrical stimulation (S) of the ipsilateral hind 
paw at corresponding activation thresholds. Tracings were recorded three days 
after SNL (panels A and B) or sham surgery (panels C and D) at a stimulus 
frequency of 1.0 Hz. A pulse stimulus indicator bar is shown under each tracing. 
Panels A and B, and panels C and D are from the same animal, respectively. 
Note the difference in scale in panel C (50 IJV) compared to panels A, B and D 
(200 IJV). 
69 
A 
... 
. 
~ 2.6 
--
--
12.· ~ __!±Q_ ~ ~ __!±Q_ ~ 
Ju r 
B 
... 
... 
Figure 3.4. The A-fiber 
component of the biceps 
femoris flexor reflex 
evoked by electrical 
stimulation to the ipsilateral 
hind paw one (P-1-D), 
three (P-3-D) and ten (P-
10-D) days after SNL or 
sham surgery. Spike-
integration for A- and C-
fiber activation thresholds 
are shown in panels A and B, respectively. The corresponding response duration 
at a frequency of 1.0 Hz is shown in panel C. Each bar represents the mean ± 
SEM of five to seven animals. Asterisks indicate a significant difference from the 
respective sham-control (*p<0.05; **p<0.01; ***p<0.001 ). Daggers (tp<0.05) 
indicate a significant difference from P-1-D; double daggers (:t:p<0.05; :t::t::t: 
p<0.001) indicate a significant difference from both P-1-D and P-10-D; and pound 
(#p<0.05) indicates a significant difference from both P-3-D and P-10-D. 
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Table 3.1. Change in the A-fiber spike integration (I.IV·s) following SNL 
expressed as the percent of sham-controls. Spinal flexor reflex activity was 
recorded from the ipsilateral biceps femoris on days 1, 3 and 10 after surgery. 
Post- Frequency A-Fiber Activity 
Operative (Hz) Threshold Stimulation Supra-threshold 
Day Stimulation 
A-fiber C-fiber A-fiber C-fiber 
1 0.2 Hz 177.6%** 157.0%* 150.4%** 137.8%* 
1.0 Hz 163.5%* 135.0% 145.9%*** 150.7%** 
3 0.2 Hz 177.7%*** 167.4%*** 135.1%** 137.3%** 
1.0 Hz 170.6%*** 149.4%** 145.5%*** 139.1%*** 
10 0.2 Hz 175.3%*** 148.8%** 146.1 %*** 143.8%*** 
1.0 Hz 161 .6%** 147.5%** 146.5%*** 163.4%*** 
Asterisks indicate a significant difference from sham-controls (*p<0.05 ; **p<0.01 ; 
***p<0.001 ). Threshold stimulation for A-fiber activity represents the voltage 
required to reach the firing threshold for A- and/or C-fiber activation. Supra-
threshold stimulation for A-fiber activity refers to the voltage at twice the firing 
threshold for A- and/or C-fiber activation. 
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Figure 3.5. The C-fiber component of the biceps femoris flexor reflex evoked by 
electrical stimulation to the ipsilateral hind paw one (P-1 -D), three (P-3-D) and 
ten (P-10-0) days after SNL or sham surgery. Spike-integration for A- and C-fiber 
activation thresholds are shown in panels A and 8, respectively. The response 
duration of data in panel 8 are shown in panel C. Each bar represents the mean 
± SEM of five to seven animals. Asterisks indicate a significant difference from 
the corresponding sham-control (*p<0.05; **p<0.01 ; ***p<0.001 ). Daggers 
(ttp<0.05; ttt p<0.001) indicate a significant difference from both P-1-D and P-
10-0 . 
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Table 3.2. Change in the C-fiber spike integration (~.N·s) following SNL 
expressed as the percent of sham-controls. Spinal flexor reflex activity was 
recorded from the ipsilateral biceps femoris on days 1, 3 and 10 after surgery. 
Post- Frequency C-fiber Activity 
Operative Threshold Stimulation Supra-threshold 
Day Stimulation 
A-fiber C-fiber A-fiber C-fiber 
1 0.2 Hz 141 .55%* 128.36%* 115.61% 141.41%* 
1.0 Hz 135.84%* 132.29% 85.12% 141.78%** 
3 0.2 Hz 160.19%*** 153.66%*** 91 .85% 141 .22%* 
1.0 Hz 140.48%*** 152.40%*** 123.47% 156.02%*** 
10 0.2 Hz 137.81%* 130.52%** 115.70% 152.59%*** 
1.0 Hz 130.57%* 129.96%* 118.81% 156.55%*** 
Asterisks indicate a significant difference from sham operated animals (*p<0.05; 
**p<0.01 ; ***p<0.001 ). Threshold stimulation for C-fiber activity represents the 
voltage required to reach the firing threshold for A- and/or C-fiber activation. 
Supra-threshold stimulation for A-fiber activity refers to the voltage at twice the 
firing threshold for A- and/or C-fiber activation. 
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Figure 3.6. Representative tracings of A- and C-fiber components in the spinal 
flexor reflex (biceps femoris) evoked by an electrical stimulus (S) to the ipsilateral 
hind paw at the corresponding supra-threshold stimulation. Tracings were 
recorded three days after SNL (panels A and B) or sham surgery (panels C and 
D) at a stimulus frequency of 1.0 Hz. A pulse stimulus indicator bar is located 
under each tracing. Note the differences in stimulation (V) and scales used 
between SNL (panels A and B) and sham-controls (panels C and D). 
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Figure 3.7. The A-fiber component of the spinal flexor reflex (biceps femoris) 
evoked by supra-threshold stimulation to the ipsilateral hind paw one (P-1-D), 
three (P-3-D) and ten (P-1 0-D) days after SNL or sham surgery. Spike-
integration for A- (5 pulse) and C-fiber (20 pulse) activation thresholds are shown 
in panels A and 8, respectively. The corresponding duration at a frequency of 1.0 
Hz is shown in panel C (5 and 20 pulses). Each bar represents the mean ± SEM 
of five to seven animals. Asterisks indicate a significant difference from the 
respective sham-control (*p<0.05; **p<0.01; ***p<0.001 ). Daggers (tp<0.05; tt 
p<0.01; tttp<0.001) indicate a significant difference from P-1 0-D. 
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Figure 3.8. The C-fiber component of the spinal flexor reflex (biceps femoris) 
evoked by supra-threshold electrical stimulation to the ipsilateral hind paw one 
(P-1-D), three (P-3-D) and ten (P-10-D) days after SNL or sham surgery. Spike-
integration for A- and C-fiber components are shown in panels A and B, 
respectively. The response duration of data in panel B are shown in panel C. 
Each bar represents the mean ± SEM of five to seven animals. Asterisks indicate 
a significant difference from the corresponding sham- control (*p<0.05; **p<0.01; 
***p<0.001). 
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biceps femoris flexor reflex. Electrical responses to supra-threshold C-fiber 
stimulation (1.0 Hz) were recorded from the ipsilateral biceps femoris three days 
after SNL or sham surgery. Each point represents the mean± SEM of four to six 
animals. Treatment with i.t. S(+)-IBU (1 00 ~g) 30 minutes before stimulation 
significantly reduced A-fiber (panel A) and C-fiber (panel B) responses in SNL 
rats compared to S(+)- and R(-)-IBU-treated sham and SNL animals, 
respectively. The inhibitory effect of S(+)-IBU on A-fiber (panel C) and C-fiber 
(panel D) responses, 1 h after injection, was dose-dependent. Asterisks indicate 
a significant difference between the S(+)- and R(-)-enantiomers in SNL animals 
(*p<0.05; **p<0.01; ***p<0.001). Daggers indicate a significant difference from 
the three control groups at individual time points (tp<0.05; tt p<0.01 ; 
tttp<0.001). The adjacent dashed lines in the bottom panel represent the 95% 
confidence interval around the corresponding DRC. 
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3.4 DISCUSSION 
Changes in the excitability of spinal neurons after SNL were investigated 
using the transcutaneous-evoked biceps femoris flexor reflex. The AFRR and 
CFRR were defined using accepted activation and conduction velocity criteria 
(Hartell et al., 1991) and validated by their differential sensitivity to i. t. morphine. 
No attempt was made to further separate the A-fiber components because of the 
confounding effect of demyelination after SNL (Laird and Bennett, 1993). Evoked 
and baseline responses were highly reproducible within the treatment groups and 
across experimental days at each stimulus paradigm. The results indicate that 
neural excitability is significantly increased early after SNL and remains elevated 
for at least ten days. 
The activation threshold of the AFRR and CFRR was significantly reduced 
after SNL; a characteristic feature of peripheral and central sensitization. The 
time course of these changes also matched the onset of allodynia in this model 
(Kim and Chung, 1992). Similar changes in activation threshold were described 
in the partial sciatic nerve ligation (Okamoto et al., 2001 ), sciatic nerve 
transection (Okamoto et al. , 2001), and chronic constriction injury (Meyerson et 
al., 1995; Kohno et al., 2003) models. In contrast, Chapman et al. (1998) 
reported no such change in Af3- or C-fibers seven to seventeen days after SNL. 
The latter may reflect differences in the stimulation/recording protocols, 
electrophysiological end-points (e.g. mean action potentials versus spike 
integration), fiber types investigated, and/or the time points studied after nerve 
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injury. That the experimental time course could be an important factor is 
suggested by evidence showing: a) a transition from spinal PG-dependent to PG-
independent allodynia seven to ten days after SNL (Hefferan et al. , 2003b); and 
b) the modulatory effect of endogenous spinal PG on the biceps femoris reflex. 
The magnitude of evoked AFRR and CFRR was significantly increased 
after SNL, consistent with spinal sensitization and the onset of allodynia. In the 
SNT model, A-fiber EPSCs were significantly increased two to four weeks after 
injury (Okamoto et al., 2001 ). Likewise, AJ3- and C-fibers exhibited increased 
activity two to fifty-two weeks after spinal transection (Bennett et al. , 2004 ). No 
such changes were reported seven to seventeen days after SNL (Chapman et 
al., 1998; see comments above) or nine to eleven days after chronic constriction 
injury (Laird and Bennett, 1993). The lack of effect in the latter model may reflect 
the preferential loss of large fibres. 
Baseline activity in both the AFRR and CFRR was also enhanced in a 
stimulus-dependent manner. Previous studies reported increased compound 
potentials on the surface of the spinal cord (Colvin et al. , 1996), and ectopic 
discharges in the injured DRG after SNL (Liu et al., 2000a, b). These ectopic 
discharges corresponded with the onset of allodynia. The results of the present 
study indicate that both baseline (i.e. before stimulus-evoked spatial and 
temporal summation are apparent) and evoked activity are significantly affected 
by SNL. 
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Exaggerated responses to repeated AFRR and CFRR stimulation also 
exhibited a windup-like effect in SNL animals. This feature was more prominent 
in the AFRR as compared to the CFRR. The latter was stimulus-dependent and 
only observed under activation threshold conditions. In an earlier study using 
spinal compression, windup of an electrically evoked spinal reflex was reported 
two weeks after injury (Bennett et al., 2004) but no attempt was made to 
distinguish between the A- and C-fiber components. Kimura et al. (2005) 
reported enhanced windup of a C-fiber mediated nociceptive flexor reflex in a 
mouse model of painful diabetic neuropathy. Others have reported no evidence 
of windup after experimental nerve injury (Laird and Bennett, 1993; Chapman et 
al., 1998). That A-fiber activity is exaggerated after SNL is consistent with the 
onset of mechanical allodynia in this model. 
Unlike the AFRR, there was an apparent reduction in CFRR latency at 
threshold stimulation. This decrease was unexpected given the demyelination 
and degeneration reported one to two weeks after SNL (Senapati et al. , 2005). 
Neurons exhibiting monosynaptic Ao-fiber EPSCs decreased after CCI or SNT 
while those exhibiting polysynaptic Ao-fiber EPSCs increased (Kohno et al. , 
2003). The apparent decrease in CFRR latency could reflect delayed and/or 
prolonged activation of injured Ao-fibers as reported one week after chronic 
constriction injury (Bai et al. , 1999). These early changes are unlikely to involve 
synaptic reorganization which normally occur weeks to months after nerve injury 
(Okamoto et al., 2001 ; Kohno et al., 2003). 
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To date, most electrophysiological studies of nerve injury models have 
focused on after-discharge activity making it impossible to analyze changes in 
the duration of the A- and C-fiber components. In the present study, the duration 
of both AFRR and CFRR activity was significantly increased by SNL. A similar 
effect was reported in rat pups irradiated with UV-Iight on the hind foot-pad 
(Thompson et al., 1994). The increase in duration, combined with the concurrent 
decrease in firing threshold, enhanced activity, and elevated baseline reflex 
clearly indicate an overall increase in spinal excitability early after SNL. This is 
likely to optimize the conditions necessary for the onset of allodynia in advance 
of the long term genotypic and phenotypic changes that sustain a neuropathic 
state. 
Tactile allodynia arising from peripheral nerve injury is elicited by impulses 
carried along surviving Al3-afferents (Kim and Chung, 1992). In the present study, 
both the AFRR and CFRR of the biceps femoris reflex exhibited a decrease in 
firing threshold and a corresponding increase in activity early after SNL. These 
changes coincide with the onset of behavioral allodynia (Kim and Chung, 1992). 
Indeed, enhanced electrophysiological activity was evident as early as one day 
after SNL. While A-fiber mediated windup has been described following 
peripheral inflammation (Ma and Woolf, 1996; Thompson et al, 1994), this is the 
first report of such an effect early after nerve injury. The release of brain-derived 
nerve growth factor (BDNF), especially from injured A-fibers (Zhou et al. , 2000), 
and nerve growth factor (NGF) are likely to be involved. Antibodies to each of 
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these neurotrophins, injected into the L5 DRG at the time of L5 SNL, significantly 
attenuated mechanical allodynia (Zhou et al. , 2000). Conversely, BDNF and NGF 
injected into uninjured DRG increased mechanical sensitivity within 4h (Zhou et 
al., 2000). Enhanced C-fiber activity may also reflect the early pathogenic effect 
of substance P (sP) via NK-1 receptors (Pitcher and Henry, 2004). In this regard, 
NK-1 knockout mice did not display the increased mechanical sensitivity of wild 
type animals 24 h after SNL (Mansikka et al., 2000). BDNF, NGF and sP induce 
central sensitization through modulation of NMDA receptors. Functional 
reorganization and/or phenotypic changes within the spinal cord (Woolf et al., 
1992; Kohno et al., 2003) are unlikely to contribute to allodynia so soon after 
SNL. 
SNL-induced allodynia also features a PG-dependent phase beginning 
immediately after injury and lasting for seven to ten days (Hefferan et al. , 2003b). 
The present study indicates that spinal PG modulation is reflected 
electrophysiologically in the biceps femoris reflex. Thus, i.t. S(+)-, but not R(-)-
IBU, given three days after SNL, dose-dependently inhibited the nerve injury-
induced exaggerated of the AFRR and CFRR. This stereo-selective effect mirrors 
the time-course of COX-1 and COX-2 expression in the ipsilateral lumbar cord 
(Zhu and Eisenach, 2003; O'Rielly and Loomis, 2005), the BR-evoked release of 
PGE2 in spinal CSF (Hefferan et al., 2003a), and the marked increase in 
pharmacodynamic sensitivity to PGE2 (O'Rielly and Loomis, 2006) in the lumbar 
cord after SNL. This is the first report of such an effect in a NP model and 
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corroborates, electrophysiologically, the early contribution of spinal PG in the 
development of allodynia. A detailed investigation of spinal PG on SNL-induced 
central hyperexcitability will be reported in a subsequent chapter. 
This prostanoid modulation probably reflects the inhibition of glycine-
mediated IPSCs in DH neurons; an effect mediated by spinal EP2-receptors 
(Ahmadi et al., 2001). The resulting disinhibitory state would be especially 
relevant under conditions of exaggerated production (Ahmadi et al. , 2001), 
release (Hefferan et al. 2003a) and sensitivity (O'Rielly and Loomis, 2006) to 
PGE2; abnormalities present after SNL. Recent experiments in our laboratory 
indicate that EP2-receptors are also up-regulated in the ipsilateral L-DH three 
days after SNL (unpublished results). This mechanism of SNL-induced allodynia 
also accords with the robust and highly selective allodynia induced by low dose 
i.t. strychnine in conscious, uninjured rats (Yaksh, 1989). A related SNL effect on 
motor neurons in the biceps femoris reflex cannot be completely excluded at this 
time. However, spasticity and/or seizure-like effects are unusual features of this 
model and were uniformly absent in the present study. Thus, afferent sensory 
input appears to be preferentially affected after SNL. 
Electromyographic analysis of the biceps femoris flexor reflex revealed a 
significant increase in spinal excitability (i.e. decreased activation threshold, 
increased firing activity and response duration, increased baseline activity and 
windup) from one to ten days after SNL. The AFRR and CFRR were both 
affected but to varying degrees. The time course of these spinal changes 
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parallels the development of mechanical allodynia in the SNL model. 
Electrophysiological changes were stereo-selectively attenuated by i.t. IBU given 
three days after SNL providing further evidence for the early role of spinal PG in 
central sensitization and allodynia in this model. 
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4.0 SPINAL PROSTAGLANDINS EXAGGERATE A- AND C-FIBER 
EXCITABILITY AND ARE CRITICAL TO THE DEVELOPMENT OF 
MECHANICAL ALLODYNIA EARLY AFTER L5/L6 SPINAL NERVE 
LIGATION 
4.1 INTRODUCTION 
The mechanisms underlying NP (including allodynia) are known to be 
complex, multi-factorial, and subject to plasticity (Beydoun and Backonja, 2003; 
Dworkin et al., 2003; Takeda et al., 2005). Understanding the time-course and 
pharmacology of the mechanisms comprising the cascade leading to allodynia 
can enable the identification of interceptive measures that prevent acute nerve 
injury from becoming a chronic neuropathic state. In view of the complex and 
time-dependent changes triggered by nerve injury, targeting vital signaling events 
early after injury would be an obvious strategy. The early contribution of spinal 
PG in the development of experimental allodynia (Tonai et al., 1999; Ma and 
Eisenach, 2002, 2003; Zhu and Eisenach, 2003; O'Rielly and Loomis, 2006; 
Hefferan et al., 2003a, b), and the clinical availability of drugs with which to 
disrupt their effects, make prostanoids an interesting, potential target. 
A role for spinal PG in allodynia is consistent with their direct excitatory 
effects on DH neurons, as well as their ability to exaggerate cellular responses to 
afferent sensory input (Hingtgen et al. , 1995; Ferreira and Lorenzetti, 1996; 
Willingale et al., 1997; Saba et al. , 2001; Ahmadi et al., 2002), and the early 
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induction of molecular changes, such as increases in NMDA receptor 
phosphorylation (Gao et al., 2005), a26-1 calcium channel subunit expression (Li 
et al., 2004), and the induction of phosphoERK (Zhuang et al., 2005), coupled to 
spinal COX-1 and COX-2 expression (Zhu and Eisenach, 2003; O'Rielly and 
Loomis, 2006). These changes are temporally correlated with the onset of 
allodynia (Zhu and Eisenach, 2003; Li et al., 2004; Gao et al. , 2005; Zhuang et 
al., 2005; O'Rielly and Loomis, 2006), and support the hypothesis of an early 
pathogenic role of spinal PG. 
Previous pharmacological studies with the L5/L6 SNL model of allodynia 
revealed a preferential sensitivity to COX-1 inhibitors given two to eight hours 
after injury (Hefferan et al., 2003b). Thus, i.t. SC-560 completely prevented the 
neurochemical, pharmacological and behavioral features of SNL-induced 
allodynia for at least twenty days. This result was comparable to that observed 
with i.t. S(+)-IBU (Hefferan et al. , 2003b). In contrast, R(-)-IBU and SC-236 were 
without effect (Hefferan et al. , 2003b). These data suggested that COX-1 is 
primarily responsible for the generation of spinal PG up to twenty-four hours after 
SNL which contribute to the development of allodynia in this model. However, the 
expression profile and time-course of the COX isoforms affecting allodynia, and 
their relevance (or not) to changes in central sensitivity early after SNL have not 
been characterized. 
Treatment with i.t. SC-51322 starting two days after SNL significantly 
reversed tactile allodynia (Hefferan et al. , 2003a) indicating that spinal EP 
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receptors mediate the pro-allodynic effects of PG in the spinal cord. EP receptor 
subtypes are known to be coupled to discrete signaling pathways, each of which 
could contribute to central sensitivity and allodynia. Increased EP1, EP2, EP3 and 
EP4 receptor-IR has been reported in the DRG following partial sciatic nerve 
ligation (Ma and Eisenach, 2003). However, the effect of experimental nerve 
injury, including SNL, on the expression of EP receptors in the spinal cord has 
not been investigated. 
To further study the early contribution of spinal PG in experimental 
allodynia, we investigated: a) the effect of SNL on the expression of COX-1, 
COX-2, and EP1, EP2 and EP3 receptors in the rat L-DH; and b) the temporal and 
pharmacological relationship of these changes to AFRR and CFRR and 
allodynia, twenty-four hours after SNL or sham surgery. 
4.2 MATERIALS AND METHODS 
All studies were conducted in accordance with the guidelines of the 
Institutional Animal Care Committee of Memorial University of Newfoundland, St. 
John's, NL, Canada. 
Animals. Male Sprague-Dawley rats (-130 g on the day of 
experimentation) were obtained from the Vivarium of Memorial University of 
Newfoundland and were housed in standard cages with woodchip bedding. 
87 
Animals had free access to food and water and were housed singly after surgery. 
A 12 h light-dark cycle (lights on at 0700 h) was used throughout. 
Intrathecal Catheterization. Intrathecal catheters (6.5 em-length 
terminating near the lumbar enlargement or 4.0 em-length terminating in the mid-
thoracic segments) were implanted as previously described (Hefferan et al. , 
2003a). Rats with normal motor, grooming and feeding behavior were housed 
separately and allowed to recover for three days before SNL or sham surgery. 
Neuropathy. Neuropathy was induced using the method of Kim and 
Chung (1994), as previously described (Hefferan et al. , 2003a). Rats were 
anesthetized with halothane and the left L4 and L5 spinal nerves were isolated 
and separated. The L5 and L6 spinal nerves were tightly ligated with 6-0 silk 
thread. In sham-controls, the L5 and L6 spinal nerves were isolated but not 
ligated. All animals were allowed to recover for three days before 
experimentation. Allodynia, defined as a PWT of s 4 g, was confirmed using von 
Frey filaments. 
Electrophysiological Recordings. Rats were anesthetized with 
halothane and cannulae were placed in the trachea, left carotid artery and right 
external jugular vein. Halothane anesthesia was then replaced by sodium 
thiobutabarbitone (1 mg·kg-1 i.v.; lnactin, Sigma-Aldrich, ON, CA). The depth of 
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anesthesia was assessed by testing for hind limb withdrawal and corneal reflexes 
which had to be absent. Blood pressure was continuously monitored via a left 
carotid artery catheter and the mean arterial pressure maintained between 100 to 
130 mmHg by additional anesthetic as required. Systolic blood pressure did not 
fall below 100 mmHg throughout the experiment. Core temperature was 
maintained close to 37 °C using a homeothermic blanket system. The animal 
preparation was allowed to stabilize for at least 30 minutes prior to recording. 
Spinal flexor reflexes were evoked by subcutaneous electrical stimulation 
applied to the first toe of the hind paw. Needle location was based on the 
innervation pattern of the sural nerve (Wiesenfeld-Hallin, 1988) and square-wave 
pulses (0.2, 0.6, 1.0 Hz) of 1 ms duration were used. Stimulation at each 
frequency was repeated three times to ensure stability and extracellular 
electromyographic responses were recorded from the biceps femoris muscle 
using a pair of tungsten needle electrodes. Intervals of three to five minutes were 
introduced between successive stimulus trains to prevent a conditioning effect by 
the preceding stimulus. 
AFRR and CFRR were distinguished on the basis of their response 
latencies. AFRR was classified as those appearing <1 00 ms after the stimulus 
artifact. CFRR was defined as those >1 00 ms up to a maximum of 600 ms. 
These criteria were confirmed by examining the effect of intrathecal morphine 
(100 j.Jg) and naloxone (100 j.Jg) on the AFRR and CFRR of the biceps femoris 
reflex in naive animals. Based on the measured length of the sural nerve in rats 
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weighing 130 to 150 g (i.e. 12 em), afferent fibers mediating the late phase 
(>100-600 ms) had an average conduction velocity of 1.2 m·s-1 ; a value within 
the accepted range for C-fibers (Lynn and Carpenter, 1982). The A- and C-fiber 
intervals used in the present experiments are in agreement with previous reports 
on the rat biceps femoris reflex (Lynn and Carpenter, 1982; Herrero and Cervero, 
1996a, b). 
To determine the AFRR activation threshold, stimulus trains of five pulses 
(0.2 to 1.0 Hz) were applied at increasing voltages until a positive response was 
obtained. A positive response was deemed to have occurred when at least three 
of the five stimulus pulses produced a spike (i.e. amplitude >20 !JV). To 
determine the CFRR activation threshold, stimulus trains of twenty pulses (0.2 to 
1.0 Hz) were applied at increasing voltages until a positive response was 
obtained. A positive response was deemed to have occurred when at least ten of 
the twenty stimulus pulses produced a spike (i.e. amplitude >20 !JV). 
Data were collected, stored and analyzed using a PowerLab® data 
acquisition system (ADinstruments, Inc. , Colorado Springs, CO, USA). Off-line 
data analysis was initially performed using the data acquisition software provided 
by the manufacturer (Chart 5.0) . The data were further analyzed using a 
customized computer program developed in collaboration with the Department of 
Computer Science, Memorial University. 
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Immunohistochemistry. Animals were deeply anesthetized with 
urethane (1.2 mg/ kg i.p.) and perfused intracardially with 0.1 M phosphate buffer 
(PBS) followed by 4% paraformaldehyde in ice cold 0.1 M PBS buffer. The 
lumbar region (L2 to L6) was subsequently removed, post-fixed for 18 to 24 h 
and cryoprotected in 50% sucrose overnight at 4 °C. Sections (20 ~m) were cut 
on a cryostat and stored in 0.1 M PBS at 4 °C. Cryostat sections were blocked in 
normal goat serum (5% in 0.1 M PBS) for 1 h at room temperature, and sections 
were washed extensively in 0.3 M PBS between each of the following steps. 
Sections were incubated overnight with the COX-1 primary antibody (1 :5000). 
Binding sites were visualized with Alexa Fluor secondary antibodies diluted in 0.1 
M PBS. Specifically, anti-COX-1 was detected with goat anti-rabbit antibody 
(1: 1 000; Molecular Probes, Burlington, ONT, CA). To determine the specificity of 
antibody staining, the COX-1 antibody was preabsorbed with 1 ~g/ml of a 
blocking peptide (Cayman Chemical, Ann Arbor, Ml, USA). A monoclonal 
antibody to vertebrate neuron-specific nuclear protein was used to identify most 
neuronal cell types throughout the spinal cord (NeuN; 1:1000; Upstate Cell 
Signaling, Charlotteville, VA, USA). Anti-lntegrin alphaM, clone OX-42 was used 
to identifiy glial cells and macrophages (1: 1 000; Upstate Cell Signaling, 
Charlotteville, VA, USA). Anti-Macrophages/Monocytes, clone ED-1 was used to 
identify infiltrating macrophages and monocytes (ED-1; 1:1 000; Upstate Cell 
Signaling, Charlotteville, VA, USA). Binding sites were visualized with a goat anti-
rabbit antibody (1: 1 000; Molecular Probes, Burlington, ON, CA). Sections were 
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then mounted on slides, coverslipped, and assessed by confocal laser scanning 
microscopy (Leica Microsystems Inc., Richmond Hill, ON, CA). Double labeled 
sections were imaged using filter combinations appropriate for the specific 
visualization of Alexa Fluor secondary antibodies (488 and 594 nm; Molecular 
Probes, Burlington, ON, CA). 
Western Blotting. Animals were deeply anesthetized with urethane (1 .2 
mg/kg i.p.) and perfused intracardially with ice cold saline (0.9% NaCI). The 
spinal cord was extracted hydraulically (de Sousa and Horrocks, 1979), 
immediately frozen in 2-methylbutane (Sigma Chemical, St. Louis, MO, USA), 
and stored at -80 °C. The lumbar region (L2 to L6) of the spinal cord was 
isolated, removed and subsequently divided into the left and right, ventral and 
dorsal quadrants. Spinal cord was homogenized in ice cold lysis buffer (1% 
Nonidet-P40, 10% glycerol in TBS plus a protease inhibitor cocktail tablet -
Roche Diagnostics, Laval, PQ, CA, 1 mM sodium vanadate, 1 mM sodium 
fluoride, and 0.025% SDS); and centrifuged at 10,000 rpm for 5 min (4 °C). 
Samples, diluted to achieve equal protein concentrations (30J.Jg), were separated 
by electrophoresis on 8% SDS-polyacrylamide gel. Proteins were transferred to a 
nitrocellulose membrane and incubated for 1.5 h in Tris buffer (Tris 25 mM, 
glycine 192 mM, 200 ml methanol, pH 8). Pre-stained protein markers were used 
for molecular weight determination. Blots were initially stained with Ponceau Red, 
and later probed with an antibody directed against the cytosolic protein, actin 
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(1:1000; Sigma, Oakville, ONT, CA) to assess the equivalency of protein loading. 
Blots were subsequently probed with the following primary antibodies: polyclonal 
rabbit COX-1 antibody (1:250); polyclonal rabbit COX-2 antibody (1 :1000); 
polyclonal rabbit EP1 receptor antibody (1 :1 000); polyclonal rabbit EP2 receptor 
antibody (1 :2000); and a polyclonal EP3 receptor antibody (1 : 1 000). These 
primary antibodies were purchased from Cayman Chemical (Ann Arbor, Ml , 
USA). Protein standards for COX-1, COX-2 and EP receptors were probed with 
antibodies that were preabsorbed with their corresponding blocking peptide 
(Cayman Chemical, Ann Arbor, Ml, USA) to determine the antibody specificity. 
Western blots were corrected for non-specific binding by subtracting the optical 
density in the presence of the corresponding blocking peptide from that of each 
test sample. The membranes were incubated overnight at 4 °C with the primary 
antibodies, and diluted in Tris buffer (containing 3% milk powder and 0.05% 
Tween-20). Protein bands were treated with a goat anti-rabbit horseradish 
peroxidase-conjugated secondary antibody (1 :5000; Chemicon International Inc., 
Temecula, CA, USA) for 1 h at room temperature, washed for 30 minutes in Tris 
buffer, visualized using enhanced chemiluminescence (PerkinEimer Life 
Sciences Boston, MA, USA), and exposed to X-ray film (Cronex MRF Clear 
base, Agfa Corp, Greenville, SC, USA). 
Drugs. SC-236 and SC-560 were generous gifts from Searle (Skokie, IL, 
USA). SC-51322 was purchased from Biomol Research Laboratories, Inc. 
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(Plymouth Meeting, Ml, USA). Drugs were dissolved in 100% DMSO and diluted 
with normal saline at the time of injection to yield a final DMSO concentration of 
50%. All equipment was sterilized with 70% alcohol and thoroughly rinsed with 
0.9% sterile saline before injection. Intrathecal drugs were injected into 
anesthetized rats using a hand-held microsyringe. Drugs were delivered in a 
volume of 5 !JI followed by 5 !JI of sterile saline. The i.t. catheter was immediately 
resealed with a stainless steel plug. The position of the catheter tip was verified 
visually after sacrifice in randomly selected animals. 
Data Analysis. Electromyographic recordings in sham operated and SNL 
animals were compared using the mean responses elicited by three stimulus 
trains of 0.2, 0.6 and 1.0 Hz. Data were collected (4000 samples/sec) and high-
pass digital filters (cut-off frequency 60 Hz) were used to remove noise and 
movement artifacts. Spontaneous activity was defined as the average spike 
count integrated over a 60 s period prior to experimentation. In all cases, the 
magnitude of AFRR and CFRR was calculated by integrating the spike count 
over the stimulation period (i.e. area-under-the-curve analysis). Spikes were 
integrated from 0.5 to 99.9 ms and 100 to 600 ms for the AFRR and CFRR, 
respectively. Windup was assessed by comparing the response evoked by the 
last stimulus in each train of sham operated and SNL animals. Area-under-the-
curve was calculated using trapezoidal integration. Western blots were analyzed 
by optical density using lmageQuant® software (Amersham Biosciences Corp., 
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Piscataway, NJ, USA). Expression data are presented as nanograms of protein 
relative to COX (50 ng) or EP receptor (25 ng) standards which were corrected 
for background optical density and normalized using the cytosolic protein, actin. 
Dose-response analysis was performed using methods from Tallarida and 
Murray (1988). Comparisons within each treatment group were performed using 
one-way, repeated measures ANOVA, followed by the Newman-Keuls test. 
Comparisons across all drug- and vehicle-treated groups at each time point were 
determined using one-way, completely randomized ANOVA, followed by the 
Newman-Keuls test (SigmaStat® 2.0). 
4.3 RESULTS 
After SNL, rats displayed a significant decrease in PWT from ~ 15 g 
(baseline) to s 4 g (data not shown). This change was apparent 24 h after SNL, 
was stable for at least twenty days, and remained confined to the plantar surface 
of the left hind paw (i.e. ipsilateral to nerve ligation). Generally, the affected hind 
paw was kept in an elevated and cupped position to minimize contact with the 
cage floor. All SNL rats were otherwise healthy, showed normal feeding and 
grooming behavior, and regular weight gain. Sham-surgery had no effect on 
PWT compared to pre-surgical values, as reported previously. 
Western analysis revealed a 4.2-fold increase (p<0.05) in the expression 
of COX-1 in the ipsilateral L-DH of SNL rats compared to sham-controls 24 h 
after surgery (Figure 4.1A). In contrast, COX-2 was unchanged from sham-
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controls (p>0.05; Figure 4.1C). In addition, the expression of COX-1 or COX-2 in 
the contralateral lumbar cord was unchanged from their respective ipsilateral or 
contralateral sham-controls (p>0.05; Figure 4.1A&C). At this time point, COX-1-
immunoreactivity was clearly evident in the cytoplasm of neurons (Figure 4.2A-
C), glial cells (Figure 4.20-F) and macrophages (resident and infiltrating) of SNL 
rats (Figure 4.2G-I). 
Electromyographic recordings of the AFRR and CFRR of the biceps 
femoris flexor reflex in narve animals are shown in Figure 4.3A. Intrathecal 
morphine (100J.Jg) had no significant effect on evoked activity in the AFRR. In 
contrast, activity in the CFRR was nearly eliminated (Figure 4.3). There was no 
change in the activation threshold for the AFRR. However, the activation 
threshold for the CFRR (ipsilateral to SNL) was significantly reduced compared 
to sham-controls (Figure 4.48). The reduction in the CFRR ranged from 56 to 
60% evoked at voltages triggering AFRR activity in sham-controls (Figure 
4.4A&B). Neither were there any significant differences between the contralateral 
hind limb of SNL animals and either side of sham-controls for AFRR or CFRR 
activity (data not shown). 
The magnitude of both AFRR and CFRR evoked by supra-threshold 
stimulation was significantly increased 24 h after SNL compared to sham-
controls (Figure 4.5A-C). This increase in evoked activity was greater in A-fibers 
(51.9%) compared to C-fibers (41.8%). Repeated low- and high-intensity supra-
threshold stimulation yielded significant amplification (i.e. a windup-like effect) of 
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the AFRR in SNL as compared to sham operated animals (Table 4.1). A 
comparable effect was observed with CFRR activity (Table 4.1 ). The AFRR and 
CFRR activity to the first evoked stimulus was significantly increased in nerve-
ligated compared to sham operated animals using supra-threshold stimulation 
(Table 4.1). Spontaneous activity was also increased in SNL rats compared to 
sham-controls but failed to reach statistical significance (p>0.05). There was no 
increase in spontaneous activity on the contralateral hind limb (data not shown). 
At supra-threshold activation, the AFRR had a pooled average latency of 12.3 ± 
0.4 ms, whereas the CFRR had a pooled average latency of 173.2 ± 9.9 ms. 
These latencies were unaffected by SNL irrespective of the stimulus intensity 
(data not shown). In addition, there were no significant differences in the 
latencies of the AFRR or CFRR evoked by supra-threshold stimulation recorded 
from the contralateral hind limb of SNL animals (data not shown). 
Treatment with SC-560 (1 00 IJg), 30 minutes before low- or high-intensity 
stimulation significantly reduced AFRR activity in nerve-ligated rats, 24 h after 
SNL (Figure 4.6A). Whereas SC-560 also significantly inhibited CFRR activity 
evoked by high-intensity stimulation, no such effect was observed using low-
intensity stimulation (Figure 4.68). SC-236 had no effect on AFRR or CFRR 
activity using either paradigm (Figure 4.6A&B). The duration of action of SC-560 
was 2 h (Figure 4.6C&D). SC-560, but not SC-236 significantly reduced A- and 
C-fibre windup for up to 2 h (Table 4.2). The AFRR to the first evoked stimulus 
was inhibited for 1 h by SC-560, but not SC-236 (Table 4.2). There was no 
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significant effect {p>0.05) on the C-fiber response to the first evoked stimulus by 
either SC-560 or SC-236. Both SC-560 and SC-236 had no significant effect on 
spontaneous activity, response latency or duration after SNL or sham surgery 
(data not shown). DMSO had no significant effect (p>0.05) on any evoked 
responses except for the exaggeration of AFRR activity at high-intensity 
stimulation (Figure 4.6A&B). The inhibitory effect of SC-560 on AFRR and CFRR 
activity, determined 30 minutes after i.t. injection, was dose-dependent (Figure 
4. 7 A& B). SC-560 had no effect in sham-controls {p>0.05; data not shown). There 
is a lack of a dose-response effect of SC-236 on the AFRR and CFRR, 
determined after i.t. injection, respectively (data not shown). SC-560 and SC-236 
had no effect in sham-controls {p>0.05). 
Treatment with i.t. SC-51322 (100 IJg), 30 minutes before low- and high-
intensity stimulation significantly reduced AFRR activity in nerve-ligated rats, 24 h 
after SNL (Figure 4.8A). Whereas SC-51322 also significantly inhibited CFRR 
activity evoked by high-intensity stimulation, no such effect was observed using 
low-intensity stimulation (Figure 4.88). While, the duration of action of SC-51322 
on AFRR activity was 2 h, the inhibitory effect on CFRR activity was 1 h (Figure 
4.8C&D). The inhibitory effect of SC-51322 on A- and C-fiber windup produced a 
similar time-course (data not shown). SC-51322 had no effect on AFRR or CFRR 
activity in sham-controls (p>0.05; data not shown). Furthermore, SC-51322 had 
no effect on AFRR and CFRR latencies, duration and response to the first 
evoked stimulus in either nerve-ligated animals or sham-controls (data not 
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shown). Spontaneous activity was unaffected with i.t. SC-51322. DMSO had no 
significant effect (p>0.05) on any evoked responses except for the exaggeration 
of AFRR activity at high-intensity stimulation (Figure 4.8A&B). 
Western analysis revealed a significant increase in the expression of EP1 
(2.0-fold), EP2 (2.2-fold) and EP3 (2.5-fold) in nerve ligated animals compared to 
sham-controls in the ipsilateral L-DH 24 h after SNL (Figure 4.9). In addition, the 
expression of all EP receptor subtypes in the contralateral lumbar cord was 
unchanged from their respective ipsilateral or contralateral sham-controls 
(p>0.05; Figure 4.9A-C). 
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Figure 4.1. The expression of COX-1 (panels A&B) and COX-2 (panel C) in the 
dorsal or ventral horns of the lumbar spinal cord 24 h after SNL or sham surgery. 
Data were normalized using total protein content, corrected for non-specific 
immunoreactivity, and expressed as ng of protein (see Methods). Asterisks 
indicate a significant difference from sham-operated animals (*p<0.05). Each bar 
represents the mean ± SEM of three to five animals. 
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Figure 4.2. COX-1-IR was co-localized in neurons (panels A-C; green=neurons; 
red=COX-1), microglia (panels 0-F; green=microglia; red=COX-1) and 
macrophages (panels G-1; green=macrophages; red=COX-1) 24h after SNL. 
Sections were probed with anti-COX-1 and subsequently doubled-labeled using 
neuN, anti-OX-42 and anti-ED-1. The last column (panels C, F & I) represents a 
merge of confocal images from each row, respectively (scale bar of 20~m) . 
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Figure 4.3. Representative electromyographic tracings of the AFRR and CFRR 
from na'ive animals. An indicator bar (S) illustrating individual stimuli (1.5 Hz; 24 
V) is included below each tracing. Stimuli were applied to the hind paw before 
(panel A) and after (panel B) i.t. morphine (1 00 ~g). Inserts represent the AFRR 
(0.5 to 99.9 ms) and CFRR (100 to 600 ms) evoked by a single stimulus. Note 
the virtual absence of evoked activity between 100 and 600 ms after i.t. 
morphine; the 0.5 to 99.9 ms interval remained unchained (panel B). 
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Figure 4.4. Activation threshold (V) eliciting the AFRR (Panel A) and CFRR 
(panel B) in the ipsilateral biceps femoris 24 h after SNL or sham surgery. Each 
bar represents the mean ± SEM of five to seven animals and asterisks indicate a 
significant difference from the respective sham-control (***p<0.001 ). Note the 
differences in activation threshold (V) for the AFRR and CFRR. Representative 
electromyographic tracings of the AFRR and CFRR after sham surgery (panel C) 
and SNL (panel D). Note the differences in both the stimulus (S) and response 
voltages between SNL and sham-controls, and the presence of the CFRR 
evoked by threshold stimulation of the AFRR after SNL 
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Figure 4.5. Individual electromyographic tracings (panels A), spike integration 
of the AFRR and CFRR in the ipsilateral biceps femoris (panel B) and 
representative wind-up versus stimulus number curves for the AFRR (panel C) 
and CFRR (panel 0). EMG responses were evoked by high intensity supra-
threshold stimulation (1 .0 Hz) 24 h after SNL or sham surgery. Data are 
presented as the mean ± SEM of four to six animals and asterisks indicate a 
significant difference from sham-controls (*p<0 .05; **p<0.01 ). Note the 
differences in the stimulation (S) and response voltages between SNL (24 V & 
400 !JV) and sham-controls (48V & 200 !JV) in panel A Also note the differences 
in spike integration scale for AFRR (panel C) and CFRR (panel D). 
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Table 4.1. Spike integration of reflex responses recorded from the ipsilateral 
biceps femoris 24 h after SNL or sham surgery. 
Pulse Stimulus A-Fiber Mediated Reflex C-Fiber Mediated Reflex 
Number Intensity Response h.IV·s) Response h.IV·s) 
Sham SNL Sham SNL 
1St Low 1.01 ± 0.25 2.70 ± 0.60* 5.30 ± 0.25 5.45 ± 0.41 
High 1.45 ± 0.29 2.96 ± 0.56* 6.60 ± 0.79 6.14 ± 0.74 
20m Low 1.07 ± 0.15 2.02 ± 0.22*** 5.21 ± 0.14 7.44 ± 0.58** 
High 1.60 ± 0.12 3.23 ± 0.26* 8.62 ± 0.48 13.62 ± 2.07* 
Asterisks indicate a significant difference from sham operated animals (*p<0.05; 
**p<0.01 ***p<0.001). Reflex responses were evoked by supra-threshold 
stimulation (see Methods). 
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Figure 4.6. The effect of i.t. SC-560 and SC-236 on SNL-induced exaggeration 
of the AFRR (panels A&C) and CFRR (panels 8&0). Electromyographic 
responses were recorded ipsilateral biceps femoris, 24 h after SNL. All data are 
presented as the mean ± SEM of four to six animals. Panels A and B represent 
the peak effect (i.e. 30 minutes after injection) of SC-560 and SC-236, 
respectively. Asterisks indicate a significant difference from before injection 
(*p<0.05; ***p<0.001). Note the differences in scale in panels A and B. The time-
course of drug effects on the AFRR and CFRR evoked by high intensity supra-
threshold stimulation are shown in panels C and D, respectively. Asterisks 
indicate a significant difference from sham-controls (*p<0.05; **p<0.01 ). 
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Figure 4.7. The dose-response effect of i.t SC-560 on the AFRR (panel A) and 
CFRR (panel B) in the biceps femoris. Electromyographic responses to high 
intensity supra-threshold stimulation were recorded ipsilaterally, 24 h after SNL. 
Data are expressed as the mean ± SEM of four to six animals and represent the 
peak effect of SC-560 (30 minutes after injection). The linear regressions (r2 
values) for AFRR and CFRR were 0.25 and 0.15, respectively. Dashed lines 
indicate the 95% confidence intervals around the regression (dotted) line. 
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Table 4.2. Effect of i.t. SC-560 (100 j..Jg) on reflex responses recorded 
ipsilaterally 24 h after SNL or sham surgery. 
Pulse Hours After A-Fiber Mediated C-Fiber Mediated Reflex 
Number Injection Reflex Response (% Response(% baseline) 
baseline) 
Sham SNL Sham SNL 
0.5 120.15% 60.48%* 128.94% 59.85%* 
1st 1.0 116.52% 62.53%* 123.43% 59.58%* 
2.0 126.23% 80.91%* 131.18% 59.19%* 
3.0 115.77% 93.47% 110.40% 68.30% 
0.5 109.29% 42.72%* 118.81% 85.68% 
20th 1.0 110.29% 46.68%* 106.77% 82.25% 
2.0 110.80% 64.06% 110.69% 93.00% 
3.0 111 .73% 70.57% 102.33% 101 .30% 
Asterisks indicate a significant difference (*p<0.05; **p<0.01; ***p<0.001) from 
before i.t. drug injection (i.e. baseline). Reflex responses were evoked by supra-
threshold stimulation (see Methods). 
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Figure 4.8. The effect of i.t. SC-51322 on the AFRR (panels A&C) and CFRR 
(panels 8&0) of the biceps femoris. Electromyographic responses to supra-
threshold stimulation were recorded ipsilaterally, 24 h after SNL. All data are 
presented as the mean ± SEM of four to six animals. In Panels A and 8, 
asterisks indicate a significant difference from before injection (*p<0.05 ; 
**p<0.01 ). Note the differences in scale in panels A and B. The time-courses of 
SC-51322 on the AFRR and CFRR evoked by high-intensity supra-threshold 
stimulation are shown in panels C and D, respectively. Asterisks indicate a 
significant difference from sham-controls (*p<0.05; **p<0.01 ; ***p<0.001 ). 
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Figure 4.9. The expression of EP1- (panel A), EP2- (panel B) and EP3- (panel C) 
receptors in the ipsilateral and contralateral L-DH 24 h after SNL or sham 
surgery. Each bar represents the mean ± SEM of three to five animals and 
asterisks indicate a significant difference from the corresponding sham-control 
(**p<0.01 ; ***p<0.001 ). 
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4.4 DISCUSSION 
Changes in the excitability of spinal neurons were investigated 24 h after 
SNL using the biceps femoris flexor reflex. EMG analysis revealed a significant 
increase in excitability as evidenced by the decrease in activation threshold, 
increase in evoked activity to single (i.e. activity before spatial and temporal 
summation) and repetitive stimulation, and the presence of windup; sustained 
input known to trigger the neural generation of spinal prostanoids (Millan, 1999; 
Vanegas and Schaible, 2001 ). These changes, characteristic of peripheral and 
central sensitization, paralleled the development of mechanical allodynia. The 
effect on AFRR activity is especially interesting given that SNL-induced 
mechanical allodynia is elicited by impulses carried along surviving AJ3-afferents 
(Kim and Chung, 1992). To our knowledge, this is the first report of A-fibre 
mediated windup after SNL. While an effect on motor neurons cannot be 
completely excluded at this time, spasticity and/or seizure-like effects are highly 
unusual in the SNL model and were uniformly absent in these experiments. 
Thus, afferent sensory input appears to be preferentially affected by SNL. 
The AFRR and CFRR were investigated using accepted activation and 
conduction criteria (Lynn and Carpenter, 1982; Herrero and Cervera, 1996a, b), 
and further validated by their differential sensitivity to the inhibitory effects of i.t. 
morphine. Responses were highly reproducible within the treatment groups at 
low- and high-intensity stimulation. No attempt was made to separate the A-fiber 
subtypes primarily because of altered conductivity to injured and uninjured A-
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fibers (Laird and Bennett, 1993). The absence of detectable changes in AFRR or 
CFRR latencies was not surprising since synaptic reorganization in the spinal 
cord is delayed, normally taking weeks to months after nerve injury (Okamoto et 
al., 2001; Kohno et al., 2003). The results of the present study illustrate the 
influence of SNL on the excitability of spinal neurons to both single and repetitive 
stimulation 24 h after nerve injury. 
Comparable increases in spinal excitability have been described in other 
nerve injury models including chronic constriction injury (Meyerson et al., 1995; 
Colvin et al., 1996; Kohno et al., 2003), complete sciatic nerve transection 
(Okamoto et al., 2001; Kohno et al., 2003), partial sciatic nerve ligation 
(Meyerson et al., 1995), spared nerve injury (Kohno et al. , 2003) and spinal cord 
transection (Bennett et al., 2004). In contrast, Chapman et al. (1998) reported no 
change in the excitability of Al3- and C-fibers, seven to seventeen days after SNL. 
While this result may be due, in part, to methodological differences from the 
present study (e.g. degree of constriction injury), there is evidence that the time 
points investigated after SNL are important. For example, previous work 
(Hefferan et al., 2003b) demonstrated a transition from spinal PG-dependent to 
PG-independent allodynia seven to ten days after SNL t . Moreover, the central 
sensitization described in the present study was significantly attenuated by i. t. 
SC-51322 or SC-560, but not SC-236. Thus, the hyperexcitability recorded 24 h 
after SNL was not only spinal PG-dependent and EP receptor-mediated, but also 
t Early results in our laboratory indicate that central sensitization also exhibits a transition to PG-
independence seven to ten days after SNL (unpublished results). 
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consistent with the preferential increase in spinal COX-1 protein at the same time 
point. COX-1 expression was evident in neurons and glia as well as 
macrophages of the ipsilateral L-DH, indicating that this was not an inflammatory 
response. This finding is in agreement with others which reported increased 
expression of COX-1 following experimental nerve injury (Garrison et al. , 1991 ; 
Zhu and Eisenach, 2003; Abbadie, 2005). That spinal COX-2 was not up-
regulated at 24 h does not mean it is unaffected by SNL. A significant increase in 
COX-2 expression is evident three days after SNL (O'Rielly and Loomis, 2006), 
suggesting that the dominant isoform undergoes a time-dependent shift from 
COX-1 (24 h) to COX-2 (72 h) in affected spinal segments. 
Western analysis revealed a significant increase in the expression of EP1, 
EP2 and EP3 receptors in the ipsilateral L-DH 24 h after SNL. Unfortunately, 
reliable and selective staining of EP 4 receptors could not be achieved with the 
commercially available antibodies precluding further investigation in this study. 
EP1 receptors, located on primary afferent terminals, facilitate neurotransmitter 
release (Vanegas and Schaible, 2001) and likely mediate, at least in part, the 
central sensitizing effect of spinal PG. Post-synaptic EP2 receptors in the DH 
(Saba et al., 2001) attenuate glycine-mediated IPSCs (Ahmadi et al. , 2002). That 
the resulting disinhibition is conducive to allodynia is indicated by the robust and 
selective allodynia following low dose i.t. strychnine in conscious rats (Yaksh, 
1989). The EP2-mediated disinhibitory state would also be exaggerated by the 
enhanced production/release of and sensitivity to PGE2; abnormalities known to 
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occur in the affected spinal cord early after SNL (Hefferan et al., 2003a,b; 
O'Rielly and Loomis, 2006). The contribution of the EP3 receptor subtype to 
central sensitization is more complex, reflecting its multiple variants and signaling 
pathways. Some EP3 receptors in the DH are positively coupled to NOS with the 
resulting NO (Matsumura et al., 2005) amplifying PG synthesis and PG-
dependent allodynia (Bredt and Snyder, 1992; Mollace et al., 1995; Hefferan MP 
and Loomis, 2004). The up-regulation of EP3 variants which are negatively 
coupled to adenylyl cyclase explains the previously reported increase in 
glutamate release from slices of SNL rats pretreated with SC-51322 and evoked 
by high concentrations of PGE2 (O'Rielly and Loomis, 2006). 
In summary, SNL triggered a significant increase in A- and C-fiber input as 
well as COX-1, EP1, EP2 and EP3 expression in the spinal cord 24 h after injury. 
These SNL-induced effects: a) paralleled the development of allodynia; b) were 
only evident in animals exhibiting this abnormality; and c) were significantly 
attenuated by i.t. SC-560 or SC-51322 (but not SC-236) given 24 h after nerve 
injury. The results demonstrate for the first time the significant influence of spinal 
PG on exaggerated A- and C-fiber excitability after SNL, and identify COX-1 as 
the dominant isoform in the affected spinal cord 24 h after nerve injury. They also 
corroborate earlier evidence for the contribution of spinal PG in the development 
of SNL-induced allodynia including: a) the increased expression of COX-1 and 
COX-2 in, and the release of PGE2 and PGb from the injured spinal cord (Tonai 
et al., 1999; Ma and Eisenach, 2002, 2003; Hefferan et al., 2003a; Zhu and 
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Eisenach, 2003; O'Rielly and Loomis, 2006); b) the brush-evoked release of 
PGE2 in spinal CSF from SNL rats but not sham-controls (Hefferan et al. , 2003a); 
c) the ability of i.t. COX inhibitors, given two to eight hours after SNL, to prevent 
the development of allodynia for at least twenty days (Hefferan et al. , 2003b); d) 
the marked increase (2855-fold in vitro and 362-fold in vivo) in pharmacodynamic 
sensitivity to PGE2 in SNL (i.e. allodynic) rats (O'Rielly and Loomis, 2006); e) the 
increase in EP receptor immunoreactivity in the injured nerve following partial 
sciatic nerve ligation (Ma and Eisenach, 2003), and f) the reversal of tactile 
allodynia (i.e. -2 h duration) by SC-51322 starting two days after SNL (Hefferan 
et al. , 2003a). 
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5.0 SPINAL NERVE LIGATION-INDUCED ACTIVATION OF NUCLEAR 
FACTOR KAPPAS IS FACILITATED BY PROSTAGLANDINS IN THE 
AFFECTED SPINAL CORD AND IS A CRITICAL STEP IN THE 
DEVELOPMENT OF MECHANICAL ALLODYNIA 
5.1 INTRODUCTION 
NFKB is constitutively expressed in glia and neurons (Lu et al. , 2003; Lee 
et al., 2004; Yan et al. , 2004; Tsatsanis et al. , 2006) where it is stored in the 
cytoplasm as an inactive complex with the inhibitory factor, IKB (Egan & Toruner, 
2006). Following cell activation, IKB is phosphorylated by protein kinases such as 
IKB kinase alpha, releasing NFKB from the complex. NFKB is then free to 
translocate into the nucleus where it is activated and binds to specific response 
elements of the DNA initiating gene transcription. 
Experimental nerve injuries such as partial ligation, complete transection 
or chronic constriction of the sciatic nerve, or spinal cord compression trigger the 
activation of NFKB (Sakaue et al. , 2001 ; Pollock et al. , 2005; Bethea et al. , 1998). 
As a modulator of gene transcription (Lu et al. , 2003; Lee et al. , 2004; Yan et al. , 
2004; Tsatsanis et al. , 2006), NFKB plays a critical role in cell survival, apoptosis, 
and synaptic plasticity (Shishodia & Aggarwal, 2002; Piva et al. , 2006; Bubici et 
al. , 2006; Albensi & Mattson, 2000). Thus, it is well positioned to affect the 
functional outcomes induced by nerve injury. Consistent with this hypothesis are 
reports that blocking the transcriptional effects of NFKB with PDTC or its decoy 
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significantly attenuated the mechanical allodynia normally elicited by chronic 
constriction of the sciatic nerve (Ebersberger et al. , 2006), spinal cord injury (La 
Rosa et al. , 2004; Jimenez-Garza et al. , 2005), or treatment with i.t. dynorphin 
(Laughlin et al., 2000). Understanding the pharmacology of these acute signaling 
events provides a scientific basis for safe and effective interventions to mitigate 
the chronic and often debilitating outcomes of nerve injury. 
L5/L6 spinal nerve ligation is a widely used nerve injury model inducing 
mechanical allodynia in experimental animals (Kim and Chung, 1992; Hefferan et 
al., 2003a, b). This model is characterized by early changes in and dependence 
on spinal PG signaling seven to ten days after SNL (Hefferan et al. , 2003b; 
O'Reilly and Loomis, 2006; 2007). These changes include the up-regulation of 
COX-2 and EP1_3 receptors in the affected DH, a marked increase in 
pharmacodynamic sensitivity to PGE2 in the lumbar cord (O'Rielly and Loomis, 
2006; 2007), and the onset of BR-evoked (i.e. non-noxious) release of PGE2 into 
spinal CSF (Hefferan et al. , 2003b). Transcription of the COX-2 gene, which 
reaches maximum protein expression three days after SNL (O'Rielly and Loomis, 
2006), is known to be modulated by NFKB (Tsatsanis et al., 2006), and COX-2-
derived spinal PG play a critical role in the development of SNL-induced 
allodynia (O'Rielly and Loomis, 2006, 2007; Hefferan et al. , 2003a, b). Thus, SNL 
represents a logical NP model in which to determine if the activation of NFKB in 
the affected spinal cord is an immediate and necessary step in the development 
of allodynia. 
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To test this hypothesis, NFKB was determined in nuclear extracts from the 
ipsilateral and contralateral L-DH twelve hours, one day and three days after SNL 
or sham surgery. To assess the transcriptional effect of NFKB, the expression of 
COX-2 protein was determined using Western analysis. PDTC, an inhibitor of 
NFKB, was used to probe the functional relationship between NFKB in the 
affected spinal cord, the induction of spinal COX-2, and the development of 
mechanical allodynia and spinal hyperexcitability three days after SNL. The latter 
was investigated using AFRR, CFRR, and PWT was used to confirm mechanical 
allodynia. The possibility that spinal PG, generated immediately after SNL, might 
facilitate the initial activation of NFKB and, in turn, its downstream transcriptional 
effect on COX-2 was also investigated. 
5.2 MATERIALS AND METHODS 
All studies were conducted in accordance with the guidelines of the 
Institutional Animal Care Committee of Memorial University of Newfoundland, St. 
John's, NL, Canada. 
Animals. Male Sprague-Dawley rats (130 to 150 g) were obtained from 
the Vivarium of Memorial University of Newfoundland (St. John's, NL, CA) and 
housed in standard cages with woodchip bedding. Animals had free access to 
food and water. A 12 h light-dark cycle (lights on at 0700 h) was used throughout. 
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Intrathecal Catheterization. Intrathecal catheters (6.5 em-length 
terminating near the lumbar enlargement) were implanted according to method of 
Yaksh and Rudy (1976) as modified by Hefferan et al. (2003a). Catheters were 
sterilized with 70% alcohol and filled with sterile saline. Under halothane 
anesthesia, the catheter was inserted through an incision in the atlanta-occipital 
membrane of the cisterna magna. The catheter was externalized behind the 
head and sealed with a piece of stainless steel wire. Intrathecal catheters (inner 
diameter, i.d. 240 IJm, outer diameter, o.d. 290 IJm) were constructed from triple 
lumen PE-5 tubing (Spectranetics, Colorado Springs, CO, USA) using the 
modified method of Marsala et al. (1995). Rats with normal motor, grooming and 
feeding behavior were housed separately and allowed to recover for two days 
before SNL or sham surgery. 
Neuropathy. Neuropathy was induced using the method of Kim and 
Chung (1992) as previously described (Hefferan et al. , 2003a). Briefly, rats were 
anesthetized with halothane, the left L4 and L5 spinal nerves were isolated and 
separated, and the L5 and L6 spinal nerves were tightly ligated with 6-0 silk 
thread. In sham-controls, the L5 and L6 spinal nerves were isolated but not 
ligated. Except for NFKB Western analysis, which was determined 12 and 24 h 
after surgery, all animals were allowed to recover for three days before 
experimentation. 
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Paw Withdrawal Threshold. Mechanical allodynia was quantified by 
determining the PWT using von Frey filaments (Chaplan et al., 1994). Briefly, rats 
were placed in a plastic cage with a wire-mesh bottom allowing access to the 
plantar surface of the left hindpaw. Following a 20-min acclimatization period, a 
control threshold was determined. Allodynia was defined as a PWT of s 4 g 
(Chaplan et al. 1994; Hefferan et al., 2003a,b). 
Electrophysiological Recordings. Rats were anesthetized with 
halothane and cannulae were placed in the trachea, left carotid artery and right 
external jugular vein. Halothane anesthesia was then replaced by sodium 
thiobutabarbitone (1 mg•kg-1 i.v. ; lnactin, Sigma-Aldrich, Oakville, ON, CA). 
Adequate depth of anesthesia was assessed by testing for hind limb withdrawal 
and corneal reflexes which had to be absent. Blood pressure was continuously 
monitored via a left carotid artery catheter and the mean arterial pressure 
maintained between 100 to 130 mmHg by additional anesthetic as required. 
Systolic blood pressure did not fall below 1 00 mmHg throughout the experiment. 
In the event that the blood pressure dropped and consistently remained below 
100 mmHg, the experiment was stopped and the animal euthenized. Core 
temperature was maintained close to 37 °C using a homeothermic blanket 
system. The animal preparation was allowed to stabilize for at least 30 minutes 
prior to data collection. 
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Spinal flexor reflexes were evoked by subcutaneous electrical stimulation 
applied to the first toe of the hind paw. Needle location was based on the 
innervation pattern of the sural nerve (Wiesenfeld-Hallin, 1988) and square-wave 
pulses (0.2, 0.6, 1.0 Hz) of 1 ms duration were used. Stimulation at each 
frequency was repeated three times to ensure stability and extracellular 
electromyographic responses were recorded from the biceps femoris muscle 
using a pair of tungsten needle electrodes. Intervals of three to five minutes were 
introduced between successive stimulus trains to prevent a conditioning effect by 
the preceding stimulus. A low intensity supra-threshold stimulus refers to a 
voltage twice the AFRR activation threshold (five pulses at 0.2 Hz). A high 
intensity supra-threshold stimulus refers to a voltage twice the CFRR activation 
threshold (twenty pulses at 1.0 Hz). 
The AFRR and CFRR were distinguished on the basis of activation 
threshold and response latency. Electrical stimulation sufficient to activate the 
CFRR resulted in two distinct components; an early and late phase separated by 
a quiescent period of variable duration. The AFRR and CFRR were classified as 
those appearing <100 ms after the stimulus artifact, and >100 ms up to a 
maximum of 600 ms, respectively. These criteria were confirmed by examining 
the effect of i.t. morphine (1 00 !Jg) and naloxone (1 00 !Jg) on the AFRR and 
CFRR of the biceps femoris reflex in naive animals (O'Rielly and Loomis, 2007). 
Assuming a motor neuron conduction distance of 11 em, a conduction velocity of 
60 m·s-1 (Chamberlain and Lewis, 1989), a synaptic delay of 0.5 ms at the 
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neuromuscular junction, a minimum central synaptic delay of 0.5 ms, and an 
afferent conduction distance of 12 em, the fastest afferent fibers mediating the 
late component of the reflex response had conduction velocities of approximately 
1.2 m·s-1 (lynn and Carpenter, 1982). The AFRR and CFRR intervals used in the 
present experiments are in agreement with previous reports on the rat biceps 
femoris reflex (lynn and Carpenter, 1982; Herrero and Cervera, 1996a, b). No 
attempt was made to separate the A-fiber subtypes primarily because of altered 
conductivity to injured and uninjured A-fibers (Laird and Bennett, 1993). 
To determine the AFRR activation threshold, stimulus trains of five pulses 
(0.2 to 1.0 Hz) were applied at increasing voltages until a positive response was 
obtained. A positive response was deemed to have occurred when at least three 
of the five stimulus pulses produced a spike (i.e. amplitude >20 !JV). To 
determine the CFRR activation threshold, stimulus trains of twenty pulses (0.2 to 
1.0 Hz) were applied at increasing voltages until a positive response was 
obtained. A positive response was deemed to have occurred when at least ten of 
the twenty stimulus pulses produced a spike (i.e. amplitude >20 !JV). For the 
purposes of this study, spinal hyperexcitability is defined as a significant 
decrease (p<0.05) in the activation threshold and an increase in the response 
magnitude of the AFRR and/or CFRR following SNL. 
Data were collected, stored and analyzed using a Powerlab data 
acquisition system (ADinstruments, Inc., Colorado Springs, CO, USA). Off-line 
data analysis was initially performed using the data acquisition software provided 
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by the manufacturer (Chart 5.0). The data were further analyzed using a 
customized computer program developed in collaboration with the Department of 
Computer Science, Memorial University of Newfoundland (St. John's, NL, CA). 
Western Blotting. Animals were deeply anesthetized with urethane (1 .2 
mg•kg-1 i.p.) and perfused intracardially with ice cold saline (0.9% NaCI). The 
spinal cord was extracted hydraulically (de Sousa and Horrocks, 1979), 
immediately frozen in 2-methylbutane (Sigma Chemical, Oakville, ON, CA), and 
stored at -80 °C. The lumbar region (L2 to L6) of the spinal cord was isolated, 
removed and subsequently divided into the left and right ventral and dorsal 
quadrants. The quadrants were homogenized in ice cold lysis buffer (1% 
Nonidet-P40, 10% glycerol in TBS plus a protease inhibitor cocktail tablet -
Roche Diagnostics, Laval, PQ, CA, 1 mM sodium vanadate, 1 mM sodium 
fluoride, and 0.025% SDS) and centrifuged at 10,000 rpm for 5 minutes (4 °C). 
Preparation of nuclear extracts was performed using special homogenization 
buffers and additional centrifugation as previously described (Bethea et al. , 
1998). The Coomassie Plus Protein Assay kit (Pierce Biotechnology, Rockford, 
IL, USA) was used to determine the protein quantity of all samples. Samples, 
diluted to achieve equal protein concentrations (30 j.Jg), were separated by 
electrophoresis on 8% SDS-polyacrylamide gel. Proteins were transferred to a 
nitrocellulose membrane and incubated for 1.5 h in Tris buffer (Tris 25 mM, 
glycine 192 mM, 200 ml methanol, pH 8). Pre-stained protein markers were used 
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for molecular weight determination. Blots were initially stained with Ponceau Red, 
and later probed with an antibody directed against the cytosolic protein, actin 
(1 :1000; Sigma, Oakville, ON, CA) to assess the equivalency of protein loading. 
Blots were subsequently probed with the following primary antibodies: polyclonal 
rabbit COX-1 antibody (1 :250); polyclonal rabbit COX-2 antibody (1 :1 000); and 
polyclonal rabbit anti-NFKB-p65 (1 :2000). The latter antibody is selective for 
NFKB-p65 when used in combination with a control (blocking) peptide provided 
by the supplier. All primary antibodies were purchased from Cayman Chemical 
(Ann Arbor, Ml, USA) except the NFKB-p65 antibody which was purchased from 
Chemicon International, Inc. (Temecula, CA, USA). Protein standards for COX-1 , 
COX-2, and NFKB (non-stimulated A431 cell lysate; Upstate Cell Signaling 
Solutions, Charlottesville, VA, USA) were pre-absorbed with their corresponding 
blocking peptide to determine the antibody specificity. Since most antibodies 
have some degree of cross-reactivity, western blots were corrected for non-
specific binding by subtracting the optical density in the presence of the 
corresponding blocking peptide from that of each test sample. The membranes 
were incubated overnight at 4 °C with the primary antibodies, and diluted in Tris 
buffer (containing 3% milk powder and 0.05% Tween-20). Protein bands were 
treated with a goat anti-rabbit horseradish peroxidase-conjugated secondary 
antibody (1 :5000; Chemicon International Inc., Temecula, CA, USA) for 1 h at 
room temperature, washed for 30 minutes in Tris buffer, visualized using 
enhanced chemiluminescence (PerkinEimer Life Sciences Boston, MA, USA), 
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and exposed to X-ray film (Cronex MRF Clear base, Agfa Corp, Greenville, SC, 
USA). 
Drugs. S(+)-IBU and R(-)-IBU were purchased from Sigma-Aldrich 
(Oakville, ON, CA). PDTC was purchased from Sigma-Aldrich (Oakville, ON, 
CA). All drugs were dissolved in 100% DMSO and diluted with normal saline at 
the time of injection to yield a final DMSO concentration of 50%. All equipment 
was sterilized with 70% alcohol and thoroughly rinsed with 0.9% sterile saline 
before injection. Intrathecal drugs were injected into anesthetized rats using a 
hand-held microsyringe. Drugs were delivered in a volume of 5 J,JI followed by 5 
J,JI of sterile saline. The i.t. catheter was immediately resealed with a stainless 
steel plug. The position of the catheter tip was verified visually after sacrifice in 
randomly selected animals. 
Data Analysis. Electromyographic recordings in sham operated and SNL 
animals were compared using the mean responses elicited by three stimulus 
trains of 0.2, 0.6 and 1.0 Hz. Data were collected (4000 samples/sec) and high-
pass digital filters (cut-off frequency 60 Hz) were used to remove noise and 
movement artifacts. Spontaneous activity was defined as the average spike 
count integrated over a 60 s period prior to experimentation. In all cases, the 
magnitude of the AFRR and CFRR was calculated by integrating the spike count 
over the stimulation period (i.e. area-under-the-curve analysis). Spikes were 
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integrated from 0.5 to 99.9 ms and 100 to 600 ms for the AFRR and CFRR, 
respectively. Western blots were analyzed by optical density using lmageQuant 
software (Amersham Biosciences Corp., Piscataway, NJ, USA). Expression data 
are presented as micrograms of protein relative to an NFKB protein standard (1 0 
j.Jg), and as nanograms of protein relative to COX-1 or COX-2 (50 ng). 
Expression data were corrected for background optical density and normalized 
using the cytosolic protein, actin. Dose-response analysis was performed using 
methods from Tallarida and Murray (1987). Comparisons within each treatment 
group were performed using one-way, repeated measures ANOVA, followed by 
the Newman-Keuls test. Comparisons across all drug- and vehicle-treated 
groups at each time point were determined using one-way, completely 
randomized ANOVA, followed by the Newman-Keuls test (SigmaStat 2.0; Systat 
Software Inc., San Jose, CA, USA). 
5.3 RESULTS 
There was a progressive and significant increase in the amount of NFKB in 
the ipsilateral L-DH, twelve hours (35%), one day (55%) and three days (59%) 
after SNL compared to their respective sham-controls (Figure 5.1 ). NFKB in the 
contralateral DH (Figure 5.1) or in either ventral horn (data not shown) was 
unchanged from sham-controls. There was a corresponding increase in the 
expression of COX-2 protein (p<0.05) in the ipsilateral L-DH of SNL animals 
compared to sham-controls three days after surgery (Figure 5.2). The PWT was 
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significantly reduced (<4 g) in all SNL rats (Figure 5.3A); an effect confined to the 
plantar surface of the ipsilateral hind paw. Generally, the affected paw was kept 
in an elevated and cupped position to minimize contact with the cage floor. 
Allodynic animals were otherwise healthy, and exhibited normal grooming 
behavior except for the left hind paw. Sham-surgery had no effect on PWT 
compared to pre-surgical values (Figure 5.3A). 
To further investigate the enhanced sensitivity to mechanical stimulation 
and its possible connection to the SNL-induced changes in spinal NFK8, A- and 
C-fiber mediated responses were recorded from the biceps femoris flexor reflex 
three days after SNL or sham surgery. The threshold voltages eliciting the AFRR 
(Figure 5.38) and CFRR (Figure 5.3C) were significantly reduced compared to 
sham-controls. This effect was independent of the stimulation frequency (0.2 to 
1.0 Hz) and still evident ten days after nerve injury (Figure 5.38&C). In contrast, 
the threshold voltages eliciting the AFRR and CFRR in the contralateral hind limb 
were unchanged (p>0.05) from sham-controls three or ten days after surgery 
(data not shown). Consistent with reduction in firing thresholds of the AFRR and 
CFRR were the exaggerated responses to high intensity supra-threshold 
stimulation (Figure 5.48) compared to sham-controls (Figure 5.4A). As shown in 
Figure 5.4C, the mean response magnitudes of the AFRR and CFRR in SNL rats 
were increased (p<0.05) by 110% and 30%, respectively at their respective 
supra-threshold stimulation voltages (see Methods). In addition, spontaneous 
(i.e. non-evoked) activity increased by 104% (p<0.05) compared to sham-
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controls (Figure 5.4C) or the contralateral hind limb of SNL animals (data not 
shown). Response latencies were unaffected by SNL at all stimulus intensities 
(data not shown). 
To determine if the development of mechanical allodynia (i.e. changes in 
PWT, firing threshold and response magnitude of the AFRR and CFRR) is 
related to the SNL-induced activation of spinal NFKB, rats were given PDTC 
(1 OO!Jg i.t.), vehicle (50% DMSO) or no drug immediately after SNL or sham 
surgery. Three days later, the PWT in the left hind paw of SNL +PDTC treated 
animals was not significantly different from sham-controls (~15 g; Figure 5.5A). In 
contrast, the PWT was <4 g in all SNL rats receiving either vehicle or no drug 
treatment (Figure 5.5A). Likewise, PDTC completely prevented the SNL-induced 
decrease in the firing threshold of the AFRR (Figure 5.58) and partially prevented 
the decrease in the CFRR (Figure 5.5C) compared to sham-controls. The 
average firing thresholds were 88% and 65% of control for the AFRR and CFRR, 
respectively (Figure 5.5B&C). Neither of the control groups (i.e. vehicle or no 
drug treatment) had any effect on the SNL-induced decreases in activation 
threshold (Figure 5.5B&C). PDTC also prevented the SNL-induced increase in 
spike integration of the AFRR and CFRR compared to the SNL + vehicle or 
SNL + no drug groups (Figure 5.50). The effect of i.t. PDTC on spinal 
hyperexcitability was dose-dependent (e.g. 1Cso=25.4 !Jg for the response 
magnitude of AFRR; IC50=41 .5 1-1g for the CFRR). The response magnitudes of 
128 
the AFRR and CFRR in the SNL + POTC group were unchanged (p>0.05) from 
sham-controls (Figure 5.50). 
If the SNL-induced expression of spinal COX-2 (Figure 5.2) is also 
initiated by NFKB activation, then animals treated with POTC (1 00 j.Jg i.t.) 
immediately after SNL should exhibit little or no change in COX-2 protein three 
days later (i.e. the time of maximum COX-2 expression in this nerve injury 
model). POTC, which blocked the activation of NFKB in these animals (Figure 
5.6A), not only prevented the increase in spinal COX-2 (Figure 5.6C), but 
decreased it below that of sham-controls. While this was more prominent in the 
ipsilateral cord, a bilateral effect was apparent (Figure 5.6B&C). Neither POTC 
nor vehicle had any effect in sham controls (Figure 5.6A-C). 
To investigate the possibility that spinal PG, generated immediately after 
SNL, might promote the activation of NFKB and, in turn, the induction of spinal 
COX-2, spinal hyperexcitability and allodynia, S(+)-IBU, R(-)-IBU or OMSO were 
given immediately after SNL or sham surgery. S(+)-IBU (1 00 j.Jg i.t.) not only 
blocked the SNL-induced increase in NFKB activation (Figure 5. 7 A) and COX-2 
protein (Figure 5.7C) three days later, but reduced COX-1 and COX-2 expression 
{p<0.05) below that in sham-controls (Figure 5.7B&C). Likewise, S(+)-IBU 
prevented the concurrent SNL-induced changes in PWT (Figure 5.8A), firing 
threshold (Figure 5.8B&C) and response magnitude (Figure 5.80) of the AFRR 
and CFRR. R(-)-IBU and OMSO had no effect on the SNL-induced expression of 
NFKB (Figure 7 A) and COX-2 (Figure 5. 78) or the development of spinal 
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hyperexcitability and allodynia (Figure 5.8A-D). The effect of i.t. S(+)-IBU on 
spinal hyperexcitability was dose-dependent (e.g. IC50=36.3 1..1g for the response 
magnitude of AFRR; 1Cso=50.8 1..1g for the CFRR). S(+)-IBU, R(-)-IBU and DMSO 
were without effect in sham controls or the contralateral DH of SNL rats (Figure 
5.7&5.8). 
130 
A 
20 
-
-- Figure 5.1. The amount of activated NFKB 
in the ipsilateral and contralateral L-DH 
twelve hours (panel A), one day (panel B) 
and three days (panel C) after SNL or sham 
B 
surgery. Data were normalized using total 
protein content, corrected for non-specific 
immunoreactivity and expressed as IJg of 
protein (see Methods). Each bar represents 
the mean ± SEM of three to five animals and 
asterisks indicate a significant difference 
from sham-operated animals (*p<0.05; 
c 
**p<0.01; ***p<0.001). Representative 
immunoblots of activated NFKB and ~-actin 
in the ipsilateral (ipsi) or contralteral (contra) 
L-DH are shown in the inserts above each 
panel. Lane 1: sham (ipsi); Lane 2: SNL 
(ipsi); Lane 3: sham (contra); Lane 4: SNL (contra). 
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The amount of COX-1 (panel A) and COX-2 (panel B) in the 
ipsilateral and contralateral L-DH three days after SNL or sham surgery. Data 
were normalized using total protein content, corrected for non-specific 
immunoreactivity and expressed as ng of protein (see Methods). Each bar 
represents the mean ± SEM of three to five animals and asterisks indicate a 
significant difference from sham-controls (*p<0.05). Representative immunoblots 
of COX-1 and COX-2 in the ipsilateral (ipsi) or contralteral (contra) L-DH are 
shown in the inserts above each panel. Lane 1: sham (ipsi); Lane 2: SNL (ipsi); 
Lane 3: sham (contra); Lane 4: SNL (contra). 
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Figure 5.3. The effect of SNL on PWT (panel A) and activation threshold (V) of 
the AFRR (panel B) and CFRR (panel C). While PWT was assessed three days 
after surgery, evoked responses in the ipsilateral biceps femoris flexor reflex 
were recorded three and ten days after surgery. Each bar represents the mean ± 
SEM of five to seven animals and asterisks indicate a significant difference from 
the corresponding sham-control (*p<0.05; **p<0.01 ; ***p<0.001). Note the 
differences in pulse amplitude (V) between panels B and C. 
133 
A B 
Sham SNL 
~ l ' tJ .l .. L 
I J' I I I 
2 
Il l· ···· · IC44V) 
••t•l l I I III IC2oiV) 
c 
-
--
Figure 5.4. Electromyographic (EMG) recordings and spike integration of the 
ipsilateral biceps femoris flexor reflex three days after sham surgery or SNL. 
EMG responses were evoked by high intensity, supra-threshold stimulation (1 .0 
Hz). A pulse stimulus indicator bar is shown under each tracing (panels A&B). 
Note the differences in the stimulation (S) and response voltages between SNL 
(24 V & 400 IJV) and sham-controls (44 V & 400 1-JV). Spike integration analysis 
of the AFRR and CFRR and spontaneous (i.e. non-evoked) activity three days 
after SNL or sham surgery is summarized in panel C. Each bar represents the 
mean ± SEM of five to seven animals and asterisks indicate a significant 
difference from the corresponding sham-control (*p<0.05; ***p<0.001). 
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Figure 5.5. The effect of PDTC, vehicle (50% DMSO) or no drug treatment on 
PWT {panel A), the activation threshold of the AFRR (panel B) and CFRR (panel 
C), and spike integration (panel D) three days after SNL or sham surgery. Note 
the scale difference in panel C. PDTC (100 IJg) or DMSO was injected i.t. 
immediately after surgery. Data are presented as the mean ± SEM of five to 
seven animals and asterisks in all panels indicate a significant difference from 
corresponding sham-controls (*p<0.05 ; ***p<0.001 ). Daggers in panels C 
indicate a significant difference from the SNL + PDTC group (ttp<0.01) and 
those in panel D indicate a significant difference from the SNL + no drug and 
SNL + DMSO groups (tp<0.05; ttp<0.01 ; tttp<0.001 ). 
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Figure 5.6. The effect of PDTC, vehicle (50% 
DMSO), or no drug treatment on the amount of 
activated NFKB (panel A), COX-1 (panel B), and 
COX-2 (panel C) in the ipsilateral and 
contralateral L-DH, three days after SNL or 
sham surgery. PDTC (1 00 ~g) or DMSO was 
injected i.t. immediately after surgery. Data 
were normalized using total protein content, 
corrected for non-specific immunoreactivity and 
expressed as the amount of protein (see 
= ::::- Methods). Note the scale difference in panel A. 
Each bar represents the mean ± SEM of three 
to five animals. Asterisks indicate a significant 
difference from the corresponding sham-control (*p<0.05; **p<0.01 ; ***p<0.001) 
and daggers indicate a significant difference from SNL animals receiving either 
no drug or DMSO (tp<0.05; ttp<0.01 ; tttp<0.001 ). Representative 
immunoblots of activated NFKB, COX-1, COX-2, and ~-actin in the ipsilateral 
(ipsi) or contralteral (contra) L-DH are shown in the inserts above each panel. 
Lane 1: sham + no drug (ipsi); Lane 2: sham + PDTC (ipsi); Lane 3: SNL + 
DMSO (ipsi); Lane 4: SNL + PDTC (ipsi); Lane 5: SNL + DMSO (contra); Lane 6: 
SNL + PDTC (contra). 
136 
A 
8 
.. 
c 
---
-.... ..., r • .:. ll!• t-*o' 
·--=
--
lLA II•...., 
Figure 5.7. The effect of i.t. S(+)-IBU (1 00 
IJg), R(-)-IBU (1 001-Jg), DMSO or no drug 
treatment on the amount of activated NFKB 
(panel A), COX-1 (panel B) and COX-2 
(panel C) in the ipsilateral and contralateral 
L-DH three days after SNL or sham surgery . 
All drugs were given immediately after 
surgery. Data were normalized using total 
protein content, corrected for non-specific 
immunoreactivity and expressed as the 
amount of protein (see Methods). Note the 
scale difference in panel A. Each bar 
: =: represents the mean ± SEM of three to five 
::::::J ........ 
animals and asterisks indicate a significant 
difference from all other treatment groups 
(**p<0.01). Representative immunoblots of activated NFKB, COX-1, COX-2 and 
~-actin in the ipsilateral (ipsi) or contralteral (contra) L-DH are shown in the 
inserts above each panel. Lane 1: sham + no drug (ipsi); Lane 2: sham + R(-)-
IBU (ipsi); Lane 3: sham + S(+)-IBU (ispi); Lane 4: SNL + DMSO (ipsi); Lane 5: 
SNL + R(-)-IBU (ipsi); Lane 6: SNL + S(+)-IBU (ipsi); Lane 7: SNL + DMSO 
(contra); Lane 8: SNL + R(-)-IBU (contra); Lane 9: SNL + S(+)-IBU (contra). 
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Figure 5.8. The effect of Lt. S(+)-IBU, R(-)-IBU, DMSO or no drug treatment on 
PWT (panel A), the activation threshold of the AFRR (panel B) and CFRR (panel 
C), and spike integration (panel D), three days after SNL or sham surgery_ Note 
the scale difference in panel C. S(+)-IBU (100 IJg), R(-)-IBU (100 IJg) or DMSO 
was injected i.t. immediately after surgery. Data are presented as the mean ± 
SEM of five to seven animals and asterisks in all panels indicate a significant 
difference from the corresponding sham-controls (*p<0.05; ***p<0.001 ). Daggers 
in panel D indicate significant differences from the SNL + R(-)-ibuprofen and the 
SNL + DMSO groups (tttp<0.001 ). 
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5.4 DISCUSSION 
NFKB, measured in nuclear extracts from the left and right dorsal and 
ventral quadrants was significantly up-regulated in the ipsilateral, but not 
contralateral L-DH twelve hours after SNL. This effect preceded the induction of 
spinal COX-2, the development of spinal hyperexcitability, and the reduction in 
PWT in the affected hind paw. This time-course of NFKB activation is comparable 
to that reported in the peripheral nervous system following partial (Ma and Bisby, 
1998) or complete sciatic nerve transection (Pollock et al. , 2005), or in the spinal 
cord of animals with spinal contusion injury (Bethea et al., 1998). In a recent 
study using SNL, the overall amount and nuclear localization of NFKB in the 
ipsilateral DRG were shown to exceed that in the contralateral DRG (Wu et al., 
2006). However, changes in the spinal cord were not investigated. The present 
study is the first report of nerve injury-induced changes in NFKB activation in the 
affected spinal cord. 
All SNL animals displayed significant decreases in PWT (<4 g), increased 
spontaneous activity in the ipsilateral biceps femoris reflex, and reduced 
activation thresholds and corresponding increases in the response magnitudes of 
the AFRR and CFRR to transcutaneous electrical nerve stimulation. These 
changes, indicative of spinal hyperexcitability, are comparable to those reported 
in other nerve (Meyerson et al. , 1995; Colvin et al., 1996; Okamoto et al. , 2001 ; 
Kohno et al., 2003) or spinal cord (Bennett et al., 2004) injury models one or 
more weeks after nerve injury. A comparison of the present results to those 
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determined one day after SNL (O'Rielly and Loomis, 2007) revealed an 
exaggeration of the AFRR and CFRR on day three. For example, the response 
magnitude of the AFRR was increased nearly two-fold compared to day one 
(O'Rielly and Loomis, 2007), matching the near two-fold increase in COX-2 
expression in the affected DH (O'Rielly and Loomis, 2006). These results 
indicate an early progression of the mechanisms underlying spinal 
hyperexcitability in the SNL model; mechanisms preceded by the activation of 
spinal NFKB and previously shown to involve spinal PG derived primarily from 
spinal COX-2 (O'Rielly and Loomis, 2007; Hefferan et al., 2003a, b). 
To determine if the activation of NFKB is critical to the development of 
spinal hyperexcitability and mechanical allodynia, and not just a coincidental 
event, i.t. PDTC was given immediately after SNL. PDTC is a highly effective 
inhibitor of NFKB, disrupting its translocation from the cytoplasm into the nucleus, 
the binding of NFKB to specific response elements on the DNA, and the 
subsequent transcription of relevant effector genes (Karin & Ben-Neriah, 2000; 
Tergaonkar, 2006). In the present study, PDTC not only blocked the activation of 
NFKB, but prevented the induction of spinal COX-2, the increase in spinal 
hyperexcitability (i.e. AFRR and CFRR), and the reduction in PWT in the 
ipsilateral hind paw. The effect of PDTC on COX-2 protein was evident in both 
the ipsilateral and contralateral lumbar cord, resembling its effect on COX-2 
mRNA (Lee et al. , 2004), and corroborating, in vivo, the modulatory role of NFKB 
activation on the COX-2 gene in the nerve-injured state. The effect of PDTC on 
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A- and C-fiber mediated responses in the present study extends the results with 
PDTC in other nerve injury models in which only changes in PWT were 
determined (Laughlin et al., 2000; Tegeder et al., 2004). The present results 
demonstrate an important functional relationship between the early activation of 
spinal NFKB and the subsequent exaggeration of A- and to a lesser extent C-
fiber mediated responses in the affected hind limb. The changes in the AFRR 
and their sensitivity to PDTC are especially relevant given the predominant role 
of A-fibers in mechanical allodynia (Zimmerman, 2001 ). 
PG promote neuronal depolarization by modulating the kinetics of Na + and 
K+ channels, and by increasing intracellular Ca2+ levels (Vasko, 1995; Saba et 
al., 2001; Chen & Bazan, 2005; Sugimoto & Narumiya, 2007). Their synthesis by 
constitutive and inducible COX at the onset of nerve injury could promote the 
initial activation of NFKB and its downstream transcriptional effects. S(+)-IBU, 
given i.t. immediately after SNL, blocked the activation of NFKB, the induction of 
spinal COX-2 and the development of spinal hyperexcitability and allodynia three 
days later, mimicking the effect of PDTC. In contrast, identical treatment with the 
inactive R(-)-enantiomer was without effect. These results are consistent with a 
locus of action of i.t. IBU on spinal COX (Hefferan et al, 2003a, b), and indicate 
that spinal PG synthesis begins at the onset of nerve injury. In turn, PG facilitate 
the activation and transcriptional effect of NFKB in the affected spinal cord. This 
is the first report of COX inhibitors attenuating NFKB activation in a nerve-injury 
model and could explain how i.t. S(+)-IBU, given up to 2 h after SNL, prevented 
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the development of mechanical allodynia for as long as twenty-one days 
(Hefferan et al., 2003a, b). A similar effect on NFKB activation has been reported 
in vitro with flurbiprofen (Tegeder et al., 2001) and rofecoxib (Niederberger et al., 
2003) in cultured macrophages. The observed decrease in COX-2 protein below 
sham-controls is not due to a decrease in binding of COX-2 to the antibody in the 
presence of ibuprofen. Rather, it likely reflects increased enzyme catabolism (i.e. 
turnover) in nerve-injured and/or drug-treated animals. The COX inhibitor, 
paracoxib accelerated the degradation of COX-2 by the ubiquitin proteosome 
system in cultured Hela cells (Neuss et al., 2007). 
Notwithstanding the clear evidence for an early role of spinal PG in this 
and other nerve injury models, the activation of NFKB following nerve injury is 
bound to be multi-factorial. For example, NO promotes cellular excitability by 
soluble guanylate cyclase (sGC)-dependent and sGC-independent mechanisms, 
including the enhanced release of calcitonin gene-related peptide and PGE2 
(Holzer et al., 1995). These mediators (especially PGE2) exert a positive 
feedback effect on NOS to drive further NO production (Salvemini et al., 1993; 
Tsai et al., 1994; Aley et al., 1998; Sakai et al. , 1998; Matsumura et al. , 2005; 
Dudhgaonkar et al., 2006). In addition, NFKB is known to modulate the 
transcription of iNOS (Lowenstein et al., 1993; Mabuchi et al., 2003). Preliminary 
work in our laboratory has shown a PDTC-sensitive up-regulation of iNOS in the 
spinal cord three days after SNL (unpublished results) . The concurrent up-
regulation of NOS and COX following nerve injury, and a corresponding increase 
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in NO- and PG-signaling could have an additive or even synergistic effect on the 
activation of NFKB and, based on the results of the present study, the 
development of spinal hyperexcitability and allodynia. This is the focus of a later 
chapter. 
In summary, blocking the activation of spinal NFKB, either directly with 
PDTC or indirectly with S(+)-IBU, prevented the SNL-induced expression of 
spinal COX-2 and the development of spinal hyperexcitability and allodynia three 
days later. These results demonstrate that NFKB is not only activated by SNL, 
but facilitated by PG (and undoubtedly other mediators) generated in the affected 
spinal cord from the onset of nerve injury. Interrupting critical signaling events 
early after nerve injury could reduce the chronic and debilitating features of NP, 
and would be more effective than intervening weeks to months after nerve injury. 
While the potential of this strategy has been demonstrated in preliminary studies 
of experimental nerve injury (Araujo et al., 2003; Takahashi et al. , 2005; 
Marabese et al., 2007; O'Rielly and Loomis, 2007), the results of the present 
study provide a scientific basis for the early disruption of spinal PG signaling and 
its relationship to NFKB. 
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6.0 THE SPINAL INTERACTION BETWEEN NFKB AND NITRIC OXIDE IN 
THE DEVELOPMENT OF HYPEREXCITABILITY AND TACTILE 
ALLODYNIA FOLLOWING L5/L6 SPINAL NERVE LIGATION 
6.1 INTRODUCTION 
Tight ligation of the L5/L6 spinal roots triggers the activation of NFKB and 
the up-regulation of iNOS and nNOS, respectively in the affected spinal cord 
(Mabuchi et al., 2003; O'Rielly and Loomis, 2006, 2008). This is consistent with 
the known increase in NFKB in the peripheral and central nervous system 
following experimental nerve injury (Bethea et al. , 1998; Sakaue et al., 2001 ; 
Pollock et al., 2005; O'Rielly and Loomis, 2008), the direct modulation of iNOS 
transcription by NFKB (Lowenstein et al. , 1993; Mabuchi et al., 2003), and the 
positive correlation between the NFKB activation and nNOS expression (Miscusi 
et al. , 2006). 
The early activation of NFKB, the up-regulation of NOS protein and activity 
(Choi et al., 1996; Gordh et al. , 1998; Mabuchi et al. , 2003), and the 
enhancement of NO signaling in the affected spinal cord may be critical steps in 
the development of allodynia following SNL. This is further supported by reports 
that blockers of NFKB significantly attenuated mechanical allodynia and thermal 
hyperalgesia in several nerve injury models (Laughlin et al. , 2000; La Rosa et al. , 
2004; Jimenez-Garza et al. , 2005; Ebersberger et al. , 2006). In this chapter, we 
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tested this hypothesis by investigating the relationship between these molecular, 
cellular and functional changes using a range of experimental techniques. 
Unlike other neuromodulators, NO is a diffusible messenger whose 
excitatory activity is neither mediated by membrane-bound cell surface receptors 
nor limited by their cellular distribution (Millan, 1999; Petersen-Zeitz & Basbaum, 
1999). Given the marked effect of NO on cellular excitability and the fact that NO 
is not stored but must be synthesized de novo, it is possible that spinal NO, 
generated by constitutive NOS isozymes at the onset of SNL, promotes the 
activation of NFKB. The subsequent up-regulation of NOS isozymes and 
corresponding increase in NO signaling could sustain, at least in part, the 
activation of NFKB through a positive feedback effect (i.e. vicious cycle). The 
hypothesis that spinal NO affects the expression of enzymes responsible for its 
synthesis/signaling in the acute nerve-injured state was therefore investigated. 
To test these hypotheses, we investigated the effect of i.t. PDTC, a 
selective inhibitor of NFKB, on the expression of nNOS and iNOS protein in the 
lumbar dorsal horn three days after SNL. The contribution of NO signaling to the 
development of spinal hyperexcitability and allodynia was investigated using 
molecular (i.e. cGMP and PKG protein) and pharmacological approaches (i.e. L-
NAME). The electrophysiological properties of the AFRR and CFRR in the biceps 
femoris flexor reflex were used as measures of spinal hyperexcitability elicited by 
A- and C-fiber input, respectively. Allodynia was confirmed and quantified using 
von Frey filaments. 
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6.2 MATERIALS AND METHODS 
Studies were approved by, and experiments conducted in accordance with 
the guidelines of the Institutional Animal Care Committee of Memorial University 
of Newfoundland (St. John's, NL, CA). 
Animals. Male Sprague-Dawley rats (130 to 150 g) were obtained from 
the Vivarium of Memorial University of Newfoundland (St. John's, NL, CA) and 
housed in standard cages with woodchip bedding. Animals had free access to 
food and water. A 12 h light-dark cycle (lights on at 0700 h) was used throughout. 
Intrathecal Catheterization. Intrathecal catheters (6.5 em-length 
terminating near the lumbar enlargement) were implanted according to the 
method of Yaksh and Rudy (1976) as previously modified (Hefferan et al. , 2003a, 
b). Catheters were sterilized with 70% alcohol and filled with sterile saline. Under 
halothane anesthesia, the catheter was inserted through an incision in the 
atlanto-occipital membrane of the cisterna magna. The catheter was externalized 
behind the head and sealed with a piece of stainless steel wire. Intrathecal 
catheters (inner diameter, i.d. 240 !Jm, outer diameter, o.d. 290 J.Jm) were 
constructed from triple lumen PE-5 tubing (Spectranetics, Colorado Springs, CO, 
USA) using the modified method of Marsala et al (1995). Rats with normal motor, 
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grooming and feeding behavior were housed separately and allowed to recover 
for two days before SNL or sham surgery. 
Neuropathy. Neuropathy was induced using the method of Kim and 
Chung (1992) as previously described (Hefferan et al., 2003a, b; O'Rielly and 
Loomis, 2006-2008). Briefly, rats were anesthetized with halothane and the left 
L4 and L5 spinal nerves were isolated and separated. The L5 and L6 spinal 
nerves were tightly ligated with 6-0 silk thread. In sham controls, the L5 and L6 
spinal nerves were isolated, but not ligated. Animals were allowed to recover for 
three days before experimentation except for the NOS expression experiments 
which were investigated one and three days after surgery. 
Paw Withdrawal Threshold. Mechanical allodynia was quantified by 
determining the PWT using von Frey filaments (Chaplan et al., 1994). Briefly, rats 
were placed in a plastic cage with a wire-mesh bottom allowing access to the 
plantar surface of the left hindpaw. Following a 20-min acclimatization period, a 
control threshold was determined. Allodynia was defined as a PWT of S4 g 
(Chaplan et al. 1994; Hefferan et al., 2003a, b). 
Electrophysiological Recordings. Rats were anesthetized with 
halothane and cannulae were placed in the trachea, left carotid artery and right 
external jugular vein. Halothane anesthesia was then replaced by sodium 
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thiobutabarbitone (1 mg•kg·1 i.v.; lnactin, Sigma-Aldrich, Oakville, ON, CA). The 
depth of anesthesia was assessed by testing for hind limb withdrawal and 
corneal reflexes which had to be absent. Blood pressure was continuously 
monitored via a left carotid artery catheter and the mean arterial pressure 
maintained between 100 to 120 mmHg by additional anesthetic as required. 
Systolic blood pressure did not fall below 100 mmHg throughout the experiment. 
In the event that the blood pressure dropped and consistently remained below 
1 OOmmHg, the experiment was stopped and the animal euthanized. Core 
temperature was maintained close to 37 °C using a homeothermic blanket 
system. The animal preparation was allowed to stabilize for at least 30 minutes 
prior to data collection. 
Spinal flexor reflexes were evoked by subcutaneous electrical stimulation 
applied to the first toe of the hind paw. Needle location was based on the 
innervation pattern of the sural nerve (Wiesenfeld-Hallin, 1988) and square-wave 
pulses (0.2, 0.6, 1.0 Hz) of 1 ms duration were used. Stimulation at each 
frequency was repeated three times to ensure stability and extracellular 
electromyographic responses were recorded from the biceps femoris muscle 
using a pair of tungsten needle electrodes. Intervals of three to five minutes were 
introduced between successive stimulus trains to prevent a conditioning effect by 
the preceding stimulus. A low intensity supra-threshold stimulus refers to a 
voltage twice the A-fiber mediated reflex response (AFRR) activation threshold 
(five pulses at 0.2 Hz). A high intensity supra-threshold stimulus refers to a 
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voltage twice the C-fiber mediated reflex response (CFRR) activation threshold 
(twenty pulses at 1.0 Hz). 
The AFRR and CFRR were distinguished on the basis of activation 
threshold and response latency. Electrical stimulation sufficient to activate the 
CFRR resulted in two distinct components; an early and late phase separated by 
a quiescent period of variable duration. The AFRR and CFRR were classified as 
those appearing < 1 00 ms after the stimulus artifact, and > 100 ms up to a 
maximum of 600 ms, respectively. These criteria were confirmed by examining 
the effect of i. t. morphine ( 100 J..lg) and naloxone ( 1 00 1-1g) on the AFRR and 
CFRR of the biceps femoris reflex in naive animals (O'Rielly and Loomis, 2007). 
Based on the measured length of the sural nerve in rats weighing 130 to 150 g 
(i.e. 12 em), afferent fibers mediating the late phase (>100 to 600 ms) had an 
average conduction velocity of 1.2 m·s·1; a value within the accepted range for C-
fibers (Lynn and Carpenter, 1982). The AFRR and CFRR intervals used in the 
present experiments are in agreement with previous reports on the rat biceps 
femoris reflex (Lynn and Carpenter, 1982; Herrero and Cervero, 1996a, b). No 
attempt was made to separate the A-fiber subtypes primarily because of altered 
conductivity of injured and uninjured A-fibers (Laird and Bennett, 1993). 
The threshold voltages eliciting the AFRR and CFRR were investigated 
using accepted criteria for A- and C-fibers and validated by their differential 
sensitivity to the inhibitory effects of i.t. morphine (O'Rielly and Loomis, 2007). To 
determine the AFRR activation threshold , stimulus trains of five pulses (0.2 to 1.0 
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Hz) were applied at increasing voltages until a positive response was obtained. A 
positive response was deemed to have occurred when at least three of the five 
stimulus pulses produced a spike (i.e. amplitude >20 ~V). To determine the 
CFRR activation threshold, stimulus trains of twenty pulses (0.2 to 1.0 Hz) were 
applied at increasing voltages until a positive response was obtained. A positive 
response was deemed to have occurred when at least ten of the twenty stimulus 
pulses produced a spike (i.e. amplitude >20 ~V). For the purposes of this study, 
spinal hyperexcitability is defined as a significant decrease {p<0.05) in the 
activation threshold and an increase in the response magnitude of the AFRR 
and/or CFRR following SNL. 
Data were collected, stored and analyzed using a Powerlab data 
acquisition system (ADinstruments, Inc., Colorado Springs, CO, USA). Off-line 
data analysis was initially performed using the data acquisition software provided 
by the manufacturer (Chart 5.0). The data were further analyzed using a 
customized computer program developed in collaboration with the Department of 
Computer Science, Memorial University of Newfoundland (St. John's, NL, CA). 
Western Blotting. Animals were deeply anesthetized with urethane (1.2 
mg/kg i.p.) and perfused intracardially with ice cold saline (0.9% NaCI). The 
spinal cord was extracted hydraulically (de Sousa and Horrocks, 1979), 
immediately frozen in 2-methylbutane (Sigma-Aldrich, Oakville, ON, CA), and 
stored at -80 °C. The lumbar region (L2 to L6) of the spinal cord was isolated, 
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removed and subsequently divided into the left and right, ventral and dorsal 
quadrants. Spinal cord was homogenized in ice cold lysis buffer (1% Nonidet-
P40, 10% glycerol in TBS plus a protease inhibitor cocktail tablet - Roche 
Diagnostics, Laval, PQ, CA, 1 mM sodium vanadate, 1 mM sodium fluoride, and 
0.025% SDS), and centrifuged at 10,000 rpm for 5 minutes (4 °C). Preparation of 
nuclear extracts was performed using special homogenization buffers and 
additional centrifugation as previously described (Bethea et al., 1998). The 
Coomassie Plus Protein Assay kit (Pierce Biotechnology, Rockford, IL, USA) was 
used to determine the protein quantity of all samples. Samples, diluted to achieve 
equal protein concentrations (30 IJg), were separated by electrophoresis on 8% 
SDS-polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane 
and incubated for 1.5 h in Tris buffer (Tris 25 mM, glycine 192 mM, 200 ml 
methanol, pH 8). Pre-stained protein markers were used for molecular weight 
determination. Blots were initially stained with Ponceau Red, and later probed 
with an antibody directed against the cytosolic protein, actin (1 :1 000; Sigma-
Aldrich, Oakville, ONT, CA) to assess the equivalency of protein loading. Blots 
were subsequently probed with the following primary antibodies: polyclonal rabbit 
anti-nNOS (1 :1000), polyclonal rabbit anti-iNOS (1 :1000), polyclonal anti-cGMP 
(1 :2000), and polyclonal anti-PKG (1 :500), and polyclonal rabbit anti-NFKB-p65 
(1 :2000). Anti-nNOS and polyclonal rabbit anti-iNOS were purchased from 
Cayman Chemical (Ann Arbor, Ml, USA). Anti-NFKB-p65 was purchased from 
Chemicon International, Inc. (Temecula, CA, USA) and anti-cGMP and anti-PKG 
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were purchased from Upstate Cell Signaling Solutions (Temecula, CA, USA) and 
Stressgen Bioreagents (Ann Arbor, Ml, USA), respectively. Standards for nNOS, 
iNOS and NFKB (non-stimulated A431 cell lysate; Upstate Cell Signaling 
Solutions, Charlottesville, VA, USA) were preabsorbed with their corresponding 
blocking peptide to determine the antibody specificity. With the exception of anti-
cGMP or anti-PKG, all western blots were corrected for non-specific binding by 
subtracting the optical density in the presence of the corresponding blocking 
peptide from that of each test sample. In the case of anti-cGMP or anti-PKG 
where commercially available blocking peptides were unavailable, non-specific 
binding was assessed using samples incubated without the primary antibody. 
The membranes were incubated overnight at 4 °C with the primary antibodies, 
and diluted in Tris buffer (containing 3% milk powder and 0.05% Tween-20). 
Protein bands were treated with a goat anti-rabbit horseradish peroxidase-
conjugated secondary antibody (1 :5000; Chemicon International Inc., Temecula, 
CA, USA) for 1 h at room temperature, washed for 30 minutes in Tris buffer, 
visualized using enhanced chemiluminescence (PerkinEimer Life Sciences 
Boston, MA, USA), and exposed to X-ray film (Cronex MRF Clear base, Agfa 
Corp, Greenville, SC, USA). 
Drugs. L-NAME, and 0-NAME were purchased from Biomol Research 
Laboratories, Inc. (Plymouth Meeting, PA, USA). These were appropriate choices 
given L-NAME's comparable and stereo-specific inhibition of nNOS and iNOS; 
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isozymes, and the value of the inactive D-isomer as a pharmacological control. 
PDTC was purchased from Sigma-Aldrich (Oakville, ON, CA). PDTC was 
dissolved in 100% DMSO and diluted with normal saline at the time of injection to 
yield a final DMSO concentration of 50%, whereas L-NAME and D-NAME were 
dissolved in saline (0.9% NaCI). All equipment was sterilized with 70% alcohol 
and thoroughly rinsed with 0.9% sterile saline before injection. Intrathecal drugs 
were injected into anesthetized rats using a hand-held microsyringe. Drugs were 
delivered in a volume of 5 1-11 followed by 5 1-11 of sterile saline. The i.t. catheter 
was immediately resealed with a stainless steel plug. The position of the catheter 
tip was verified visually after sacrifice in randomly selected animals. 
Data Analysis. Electromyographic recordings in sham operated and SNL 
animals were compared using the mean responses elicited by three stimulus 
trains of 0.2, 0.6 and 1.0 Hz. Data were collected (4000 samples/sec) and high-
pass digital filters (cut-off frequency 60 Hz) were used to remove noise and 
movement artifacts. Spontaneous activity was defined as the average spike 
count integrated over a 60 s period prior to experimentation. In all cases, the 
magnitude of the AFRR and CFRR was calculated by integrating the spike count 
over the stimulation period (i.e. area-under-the-curve analysis). Spikes were 
integrated from 0.5 to 99.9 ms and 100 to 600 ms for the AFRR and CFRR, 
respectively. Area-under-the-curve was calculated using trapezoidal integration. 
Western blots were analyzed by optical density using lmageQuant software 
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(Amersham Biosciences Corp., Piscataway, NJ, USA). Expression data are 
presented as micrograms of protein relative to an NFKB protein standard (10 j.Jg), 
and as nanograms of protein relative to nNOS/iNOS (50 ng) standards. 
Expression data were corrected for background optical density except for cGMP 
and PKG (see Western Blotting above), and all expression data were normalized 
using the cytosolic protein, ~-actin. The absence of available standards for cGMP 
and PKG meant that optical density could not be converted to the amount of 
protein and therefore are presented as % of sham-control. Dose-response 
analysis was performed using methods from Tallarida and Murray (1987). 
Comparisons within each treatment group were performed using one-way, 
repeated measures ANOVA, followed by the Newman-Keuls test. Comparisons 
across all drug- and vehicle-treated groups at each time point were determined 
using one-way, completely randomized ANOVA, followed by the Newman-Keuls 
test (SigmaStat 2.0; Systat Software Inc., San Jose, CA, USA). 
6.3 RESULTS 
Expression of nNOS and iNOS protein was significantly increased in the 
ipsilateral L-DH compared to sham-controls or the contralateral DH of SNL 
animals, one and three days after surgery (Figure 6.1 ). The amount of nNOS 
protein (Figure 6.1A) exceeded that of iNOS (Figure 6.1 B) by 39 ± 9% in the 
ipsilateral L-DH one day after SNL. By day three, th is pattern had changed with 
the amount of iNOS protein (Figure 6.1 D) nearly matching that of nNOS (Figure 
154 
6.1 C). This reflected a 41 ± 7% increase {p<0.05) in the amount of iN OS protein 
(Figure 6.1 D) compared to day 1 (Figure 6.1 B), and the absence of any 
significant increase in nNOS protein (Figure 6.1C vs 6.1A). There was a 
corresponding increase {p<0.05) in the expression of cGMP and PKG protein in 
the ipsilateral L-DH of SNL animals compared to sham-controls (Figure 6.1 E). 
SNL had no effect {p>0.05) on cGMP and PKG in the contralateral L-DH (Figure 
6.1E). 
Three days after SNL, there was also a significant increase in the amount 
of activated NFKB in the ipsilateral L-DH compared to sham-controls or the 
contralateral DH of SNL animals (Figure 6.2A). PDTC (1 00 IJg i.t.), given 
immediately after SNL, prevented the increase in activated NFKB (Figure 6.2A), 
nNOS (Figure 6.28) and iNOS (Figure 6.2C). These amounts were unchanged 
from their respective sham-control or the contralateral side of SNL animals 
(Figure 6.2). In contrast, vehicle had no effect on the SNL-induced increase in 
activated NFKB, nNOS or iNOS protein three days after injury similar to that 
observed in ligated animals receiving no drug treatment (Figure 6.2). For ease of 
comparison, the quantitative data shown in Figure 6.1 C&D (i.e. SNL without drug 
treatment) are replicated in Figure 6.2B&C, respectively. 
In the absence of drug treatment, all SNL animals were clearly allodynic 
as indicated by the decrease in PWT from a baseline of 15 g to ~4 g (Figure 
6.3A), and the corresponding reduction in firing threshold of the AFRR (Figure 
6.38) and CFRR (Figure 6.3C), ipsilateral to SNL. Moreover, the affected hind 
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paw was kept in an elevated and cupped position to minimize contact with the 
cage floor. To determine if the SNL-induced increases in NOS protein are 
relevant to allodynia at three days, i.t. L-NAME (1 00 j.Jg), 0-NAME (1 00 j.Jg) or 
vehicle were injected three days after SNL (i.e. at the onset of maximum 
allodynia). L-NAME significantly attenuated the SNL-induced decrease in PWT 
such that there were no significant differences from either pre-surgical values or 
the contralateral hind-limb (Figure 6.3A). In contrast, neither 0-NAME (1 00 j.Jg 
i.t.) nor vehicle had any effect on PWT in SNL animals. Both groups were 
unchanged from nerve ligated-untreated animals (Figure 6.3A). 
In view of the marked effect of SNL on PWT and its sensitivity to i.t. L-
NAME, the possible contribution of spinal NO signaling to changes in the 
excitability of A- and C-fibers three days after SNL was investigated using the 
biceps femoris flexor reflex. The threshold voltages eliciting the AFRR (Figure 
6.38) and CFRR (Figure 6.3C) were significantly reduced in the ipsilateral hind-
limb compared to sham-controls. As illustrated in Figure 6.4, CFRR activity was 
evoked by a threshold stimulus triggering AFRR activity in SNL animals. 
Consistent with the results on PWT, treatment with L-NAME (1 00 j.Jg i.t.) three 
days after nerve injury (i.e. 30minutes before electrical stimulation) significantly 
prevented the SNL-induced decrease in activation threshold of the AFRR (Figure 
6.38) and CFRR (Figure 6.3C). 0-NAME (1 OOj.Jg i.t.) and vehicle were without 
effect (Figure 6.3). 
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There was also a significant increase in the response magnitude (i.e. 
spike integration) of the AFRR (panel A) and CFRR (panel B) three days after 
SNL, irrespective of stimulus intensity (Figure 6.4). L-NAME (100 J.Jg i.t.) given 30 
minutes before electrical stimulation on day 3, significantly attenuated the SNL-
induced increase in spike integration of the AFRR (Figure 6.5A) and CFRR 
(Figure 6.58) compared to control, vehicle or treatment with 0-NAME (Figure 
6.5A&B). The inhibitory effect of i.t. L-NAME peaked 30min after injection, lasted 
for 2 h (Figure 6.5C&O) and was dose-dependent over the range 10 to 100 J.Jg 
(1050=58.4 IJg AFRR; 10s0=49.8 J.Jg CFRR). These results indicate that spinal NO 
is not only an important contributor to the functional changes in A- and C-fiber 
mediated responses characteristic of allodynia three days after SNL, but that 
these events are triggered by the SNL-induced activation of spinal NFKB. 
To determine if spinal NO, generated at the onset of SNL, also facilitates 
the initial activation of spinal NFKB, L-NAME, 0-NAME or vehicle were injected 
immediately after SNL or sham surgery. In the absence of treatment (i.e. no 
drug), the amount of activated NFKB, nNOS, and iNOS protein were significantly 
increased in the ipsliateral L-OH three days after SNL (Figure 6.6). Treatment 
with either vehicle or 0-NAME (100 IJg i.t.) had no effect compared to SNL 
animals without drug treatment (Figure 6.6). However, L-NAME (100 IJg i. t.) 
significantly prevented the SNL-induced increase in NFKBa, nNOS, and iNOS 
protein in the ipsilateral L-OH three days later (Figure 6.6). These values were 
unchanged from those of the contralateral side (Figure 6.6). Similarly, L-NAME 
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prevented the reduction in PWT (Figure 6.7A) and the corresponding increase in 
response magnitude of the AFRR and CFRR (Figure 6. 78) three days after SNL. 
0-NAME (1 00 J,Jg i.t.) and vehicle were without effect (Figure 6.7 A&B). These 
results indicate the additional role of NO-signaling at the onset of SNL, including 
the activation of spinal NFKB and subsequent downstream effects leading to 
allodynia. 
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Figure 6.1. The effect of SNL 
or sham surgery on the 
expression of enzymes 
involved in NO synthesis and 
signaling in the L-DH. Panels 
A&B illustrate the expression 
of nNOS and iNOS protein 
one day after surgery, and 
panels C&D illustrate the 
expression of nNOS and iNOS 
protein three days after 
surgery. Each bar represents the mean ± SEM of three to five animals and 
asterisks indicate a significant difference from sham-controls or the contralateral 
DH of SNL animals (*p<0.05; **p<0.01). The expression of cGMP and PKG 
protein is illustrated in panel E. Data are expressed as % of sham-control, based 
on units of optical density and normalized using total protein content (see 
Methods). Asterisks indicate a significant difference between the ipsilateral and 
contralateral lumbar dorsal horns of SNL animals (**p<0.01 ; ***p<0.001). 
Representative immunoblots of nNOS, iNOS, and f3-actin in the ipsilateral (ipsi) 
or contralteral (contra) L-DH are shown in the inserts above each panel. Lane 1: 
sham (ipsi); Lane 2: SNL (ipsi); Lane 3: Sham (contra); Lane 4: SNL (contra). 
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Figure 6.2. The effect of PDTC, vehicle (50% 
DMSO) or no drug treatment on the amount of 
activated NFKB (panel A), nNOS (panel B) and 
iNOS (panel C) in the ipsilateral and 
contralateral L-DH, three days after SNL or 
sham surgery. PDTC (1 OOj.Jg) or DMSO was 
injected i.t. immediately after surgery. Data 
were normalized using total protein content, 
corrected for non-specific immunoreactivity 
and expressed as the amount of protein (see 
= .. -
-= Methods). Note the scale difference in panel A. 
Each bar represents the mean ± SEM of three 
to five animals and asterisks indicate a 
significant difference from sham animals receiving no drug, DMSO or PDTC 
(*p<0.05; **p<0.01; ***p<0.001 ). Daggers indicate a significant difference from 
SNL animals receiving no drug or DMSO (tp<0.05; ttp<0.01 ). Representative 
immunoblots of activated NFKB, nNOS, iNOS and J3-actin in the ipsilateral (ipsi) 
or contralteral (contra) L-DH are shown in the inserts above each panel. Lane 1: 
sham + no drug (ipsi); Lane 2: sham + PDTC (ipsi); Lane 3: SNL + DMSO (ispi); 
Lane 4: SNL + PDTC (ipsi); Lane 5: SNL + DMSO (contra); Lane 6: SNL + PDTC 
(contra). 
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Figure 6.3. The effect of L-
NAME (100 ~g) , 0-NAME (100 
~g) or vehicle (i.e. saline) on 
PWT (Panel A) and activation 
threshold of the AFRR (panel B) 
and CFRR (panel C) three days 
after surgery. All drugs were 
injected three days after SNL or 
sham surgery and responses 
recorded as described in the 
Methods. Data are presented as 
the mean ± SEM of five to seven 
animals. Asterisks in Panel A 
indicate a significant difference 
from the corresponding 
contralateral control after SNL 
(**p<0.01; ***p<0.001 ). Asterisks in Panels 8 and C indicate a difference from 
sham-controls or SNL animals treated with L-NAME (**p<0.01 ; ***p<0.001 ). 
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Figure 6.4. Representative electromyographic tracings evoked at AFRR 
threshold three days after SNL (Panel A) or sham surgery (Panel 8). Each panel 
contains a magnification of the activity evoked by a single (i.e. 41h) stimulus at 
AFRR threshold. A stimulus indicator bar is shown below each tracing. Note the 
presence of CFRR activity evoked at AFRR threshold after SNL (Panel A). See 
methods for the selection and activation criteria of the AFRR and CFRR. 
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Figure 6.5. The effect of L-NAME (100 IJg), D-NAME (100 IJg) or vehicle (i.e. 
saline) on the magnitude of the AFRR (Panel A) and CFRR (Panel B) three days 
after SNL. All drugs were injected three days after surgery and responses were 
evoked by low or high-intensity stimulation (see methods). Each bar represents 
the mean ± SEM of five to seven animals. In panels A&B, asterisks indicate a 
significant difference from sham animals (**p<0.01; ***p<0.001) and daggers 
indicate a significant difference from SNL animals with or without vehicle or D-
NAME (tp<0.05; ttp<0.01). The time-course of L-NAME (100 IJg), 0-NAME (100 
IJg) or vehicle on the response magnitude of the AFRR and CFRR are shown in 
Panels C and D. Asterisks indicate a significant difference from sham animals, 
and SNL animals with or without vehicle or D-NAME (*p<0.05; **p<0.01 ; 
***p<0.001). 
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Figure 6.6. The effect of L-NAME (1 00 JJg), 
D-NAME (100 JJg), or vehicle (i.e. saline) on 
the amount of activated NFKB (panel A), 
nNOS (panel B) and iNOS (panel C) in the 
e ipsilateral and contralateral L-DH, three days 
• 
---
after SNL or sham surgery. All drugs were 
injected i.t. immediately after surgery. Data 
were normalized using total protein content, 
corrected for non-specific immunoreactivity 
and expressed as ng of protein (see 
Methods). Note the scale difference in panel 
A. Each bar represents the mean ± SEM of 
three to five animals. Asterisks indicate a 
significant difference from sham animals receiving no drug, saline, 0-NAME, or 
L-NAME (*p<0.05; **p<0.01; ***p<0.001) and daggers indicate a significant 
difference from SNL animals receiving no drug, saline or D-NAME (t<0.05; 
ttp<0.01). Representative immunoblots of activated NFKB, nNOS, iNOS and 13-
actin in the ipsilateral (ipsi) or contralteral (contra) L-DH are shown in the inserts 
above each panel. Lane 1: sham + no drug (ipsi); Lane 2: sham + D-NAME (ipsi); 
Lane 3: sham + L-NAME (ispi); Lane 4: SNL + Saline (ipsi); Lane 5: SNL + D-
NAME (ipsi); Lane 6: SNL + L-NAME (ipsi); Lane 7: SNL + Saline (contra); Lane 
8: SNL + 0-NAME (contra); Lane 9: SNL + L-NAME (contra). 
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Figure 6.7. The effect of L-NAME 
(1 00 !Jg), D-NAME (1 00 !Jg) or 
vehicle (i.e. saline) on PWT (Panel 
A) and response magnitude of the 
AFRR and CFRR (Panel B) three 
days after SNL or sham surgery. 
All drugs were injected 
t-- SNL ----i 
immediately after surgery. The 
response magnitude of the AFRR 
and CFRR were evoked using 
high-intensity stimulation (see 
Methods). Each bar represents the 
CFRR 
mean ± SEM of five to seven 
animals and asterisks. Asterisks in Panel A indicate a significant difference from 
the corresponding contralateral control after SNL (***p<0.001 ). Asterisks in Panel 
B indicate a significant difference from sham animals (***p<0.001) and daggers 
indicate a significant difference from SNL animals receiving vehicle or D-NAME 
(ttp<0.01 ). 
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6.4 DISCUSSION 
Molecular, electrophysiological and behavioural outcomes reflecting 
changes to spinal NO-synthesis/signaling were observed three days after SNL. 
These changes were completely absent in sham-controls (with or without i. t. 
catheters), unaffected by i.t. catheterization in SNL animals (O'Rielly and Loomis, 
unpublished observations), and only evident ipsilateral to nerve injury. 
Consequently, the molecular and functional effects reported in this study are 
directly attributable to nerve ligation and not surgery per se. As such, they appear 
to be critical steps in the development of allodynia early after SNL. 
Expression of nNOS and iNOS protein was significantly increased in the 
lumbar dorsal horn ipsilateral to nerve ligation. nNOS, the more constitutive and 
predominant isoform in neurons (Szabo, 1996), exceeded that of iNOS in both 
absolute and relative terms one day after SNL. By three days, this pattern had 
changed reflecting the time-dependent induction of iNOS in cells of the affected 
dorsal horn. Significant increases in NFKB protein were also found in the nuclear 
fraction prepared from the same DH segments. SNL had no effect on NFKB in 
the ipsilateral or contralateral ventral horns of the lumbar cord (O'Rielly and 
Loomis, 2008). The increase in NFKB was completely prevented by i.t. PDTC 
given immediately after SNL. PDTC, a selective inhibitor of NFKB, blocks the 
translocation of NFKB from the cytoplasm into the nucleus, its binding to 
corresponding promoter regions of the DNA, and the promotion of genes coding 
for NOS and other proteins (Karin & Ben-Neriah, 2000; Tergaonak, 2006). The 
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parallel increases in NFKB and NOS protein in the affected DH, and their mutual 
attenuation by i.t. PDTC indicate that the activation of NFKB triggered by SNL is a 
critical antecedent to the up-regulation of nNOS and iNOS protein in the early 
nerve-injured state. These results are consistent with the direct modulation of 
iNOS transcription by NFKB (Lowenstein et al., 1993; Mabuchi et al., 2003), and 
the positive correlation between the activation of NFKB and nNOS expression 
following spinal cord injury (Miscusi et al., 2006). 
Surprisingly, i.t. L-NAME given immediately after SNL mirrored the effect 
of PDTC on NFKB, nNOS and iNOS protein. In contrast, i.t. L-NAME given three 
days after SNL had no significant effect on NFKB or NOS expression (O'Rielly 
and Loomis, unpublished observations), but did normalize the SNL-induced 
changes in A- and C-fiber mediated reflex and PWT responses for 2 h (discussed 
below). The results with L-NAME given immediately after SNL suggest that spinal 
NO, generated by constitutive NOS at the onset of nerve injury, promotes the 
injury-induced activation of NFKB. It also explains how L-NAME, a stereo-specific 
inhibitor of NOS activity, affects the downstream expression of NOS isoforms. 
The latter was not an artifact of the immunoblotting technique as the binding of 
NOS to either antibody was unaffected by the presence of L-NAME, and 
indistinguishable from that with D-NAME (data not shown). This is the first 
evidence that NO affects the activation of NFKB and the downstream expression 
of enzymes responsible for NO synthesis/signaling in the acute nerve-injured 
state. Whether this is a direct or indirect effect remains to be determined. Either 
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way, it enables rapid amplification of spinal NO-synthesis/signaling in the 
affected dorsal horn and the exaggeration of effects facilitated by spinal NO early 
after nerve injury. 
To further assess whether the up-regulation of NOS isozymes translated 
into increased NO-signaling, two important elements in the NO-signaling cascade 
were investigated. Western analysis provided a convenient method for probing 
SNL-induced changes in cGMP and PKG protein in the same spinal cord 
segments described above. The concurrent up-regulation of cGMP, PKG, nNOS 
and iNOS in the ipsilateral L-DH three days after SNL suggests an increase in 
both NO synthesis and signaling in the affected lumbar cord. This is consistent 
with effects of i.t. L-NAME on spinal hyperexcitability and allodynia (described 
below), and previous reports implicating the NO-cGMP-PKG pathway in the 
development of nerve injury-induced tactile allodynia (Hua et al., 1999; Sung et 
al., 2004, 2006). Whereas others have reported changes in cGMP and PKG in 
the DRG or in the spinal cord weeks after nerve injury (Siegan et al., 1996; Shi et 
al., 1998), this is the first study describing changes in spinal cGMP and PKG 
protein early after experimental nerve injury, and the first using the SNL model. 
The molecular changes induced by SNL in this and a previous report 
(O'Rielly and Loomis, 2008) were accompanied by spinal hyperexcitability and 
mechanical allodynia ipsilateral to nerve injury. All SNL animals featured 
exaggerated reflex responses (AFRR and CFRR) in the biceps femoris flexor 
reflex of the affected hind-limb, and hypersensitivity to von Frey filaments on the 
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plantar surface of the same hind-paw. The threshold voltages eliciting the AFRR 
and CFRR were significantly reduced in the ipsilateral hind limb. Indeed, CFRR 
activity was evoked by threshold stimuli normally triggering AFRR activity. The 
more pronounced effect of SNL on the firing threshold of the CFRR compared to 
the AFRR probably reflects the greater sensitivity of small diameter, 
unmyelinated fibers to nerve constriction. There was also a corresponding 
increase in the response magnitude (i.e. spike integration) of the AFRR and 
CFRR. It is unlikely that the spinal hyperexcitability observed after SNL is 
explained by supersensitivity of the denervated portion of the biceps femoris. 
Since the SNL model utilizes tight ligation of the L5/L6 spinal roots leaving many 
afferent and efferent fibres intact (i.e. uninjured and functional), evident by the 
significant decrease activation thresholds of the AFRR and CFRR (and PWT). 
These electrophysiological changes, which are evident one day after SNL 
(O'Rielly and Loomis, 2007), were exacerbated at three days (i.e. an 
approximate 2-fold increase compared to day one) and detectable for at least ten 
days (O'Rielly and Loomis, 2007, 2008). They were also highly reproducible 
within treatment groups, and qualitatively similar to those reported in other 
experimental nerve (Meyerson et al., 1995; Colvin et al. , 1996; Okamoto et al. , 
2001; Kohno et al., 2003), and spinal cord (Bennett et al. , 2004) injury models. 
The latter suggests broader applicability of the present results to the early nerve-
injured state. 
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In a recent study, PDTC given i.t. immediately after SNL consistently 
prevented the development of spinal hyperexcitability and mechanical allodynia 
three days later (O'Rielly and Loomis, 2008). There is no evidence that PDTC 
affects electrophysiological activity or PWT directly in either nerve-injured 
animals or sham-controls, indicating that the molecular and functional effects 
induced by SNL begin with the activation of spinal NFKB. In the present study, L-
NAME given i.t. immediately after SNL also prevented the up-regulation of NFKB, 
nNOS and iNOS protein (see above), and the development of spinal 
hyperexcitability and allodynia. Together, these results underscore the 
importance of the up-regulation of nNOS and iNOS in the spinal cord , and the 
corresponding increase in spinal NO-synthesis/signaling to the development of 
SNL-induced spinal hyperexcitability and allodynia. That these outcomes 
continue to depend on NO-synthesis/signaling is indicated by the temporary, 
dose-dependent normalization of the AFRR, CFRR and PWT by i.t. L-NAME 
given three days after SNL. Overall, the results highlight the role of spinal NO in 
the onset, development and early maintenance of spinal hyperexcitability and 
allodynia. 
The molecular, electrophysiological and behavioural changes described in 
this study appear to represent an important set of coordinated responses 
contributing to spinal hyperexcitability and mechanical allodynia early after SNL. 
That these outcomes reflect increased NO-synthesis/signaling in the affected DH 
is in agreement with previous studies reporting the normalization of PWT by i.t. L-
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NAME after nerve injury (Hefferan and Loomis, 2004), the facilitatory effect of NO 
on neuronal excitability (Wilson, 2000; Ahern et al., 2002; Gonzalez-Forero et al. , 
2007), and the recognized role of low-threshold A-fibers in mechanical allodynia 
(Bulka et al., 2002). Considering the degree of hyperexcitability that develops 
rapidly in the acute nerve-injured state, including the range of neuromodulators 
that are unleashed (Millan, 1999), the outcomes attributed to spinal NO-signaling 
in the present study are unlikely to be mediated by NO alone. One obvious family 
is the prostanoids, especially PGE2. There is an extensive literature 
documenting: a) the role of spinal PG in acute nerve-injured states (Zhao et al. , 
2000; Kawahara et al., 2001; Ma et al. , 2002; Hefferan et al. , 2003a, b; Ma and 
Eisenach, 2003; Zhu and Eisenach 2003; O'Rielly and Loomis, 2006-2008); b) 
interactions between PG and NO (Salvemini et al. , 1993, 1995; Tsai et al. , 1994; 
Salvemini et al. , 1995; Landino et al., 1996; Mollace et al. , 1998; Kim et al. , 2005; 
Matsumura et al. , 2005; Dudhgaonkar et al., 2007); c) the modulation of COX-2 
and iNOS gene transcription by NFKB (Lowenstein et al., 1993; Mabuchi et al. , 
2003); and d) the parallel changes in COX and NOS activity following nerve 
injury (Dolan and Nolan, 1999; Milne et al., 2001 ). The nature of the interaction 
between spinal NO and PG early after SNL is the subject of the next chapter. 
In summary, the present study describes the differential up-regulation of 
nNOS and iNOS protein in the ipsilateral L-DH one and three days after SNL; 
effects occurring secondary to the activation of NFKB. The activation of NFKB 
appears to be facilitated by spinal NO at the onset of ligation and persists for at 
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least three days. Functionally, the results demonstrate the relevance of increased 
NO synthesis and signaling on A- and C-fiber mediated reflex responses and 
PWT in the SNL model. Pharmacological disruption of NO-synthesis/signaling 
immediately after SNL prevented the electrophysiological and behavioural 
features of allodynia. Overall, the results support the hypothesis that spinal NO is 
a critical early signal in the complex events underlying allodynia, and the 
rationale for early interventions to mitigate the chronic and often debilitating 
outcomes of nerve injury. 
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7.0 NITRIC OXIDE MEDIATES PROSTAGLANDIN SIGNALING IN THE 
DEVELOPMENT OF ALLODYNIA FOLLOWING L5/L6 SPINAL NERVE 
LIGATION 
7.1 INTRODUCTION 
Nerve ligation of the L5/L6 spinal roots triggers the immediate activation of 
NFKB in the L-DH ipsilateral to nerve injury (O'Rielly and Loomis, 2008). This 
initiates a cascade of events amplifying PG signaling in the spinal cord including 
the up-regulation of COX isoforms, the increased expression of PGE-type 
receptors (EPR1_3) and a marked increase in pharmacodynamic sensitivity to 
PGE2 (O'Rielly and Loomis, 2006-2008). These molecular and physiological 
changes are evident 24h after SNL, are temporally and spatially correlated with 
the onset of spinal PG-dependent hyperexcitability and mechanical allodynia, 
and persist for approximately ten days (Kim and Chung, 1992; O'Rielly and 
Loomis, 2006, 2007). Importantly, they are also prerequisite steps in the 
development of long term, PG-independent allodynia in the SNL model (Hefferan 
et al., 2003a, b; O'Rielly and Loomis, 2006-2008). 
The SNL-induced activation of NFKB also affects the expression of nNOS 
and iNOS in the same affected segments (O'Rielly and Loomis, 2006-2008; 
Mabuchi et al., 2003). This observation is consistent with the direct modulation of 
COX-2 and iNOS gene transcription by NFKB (Lowenstein et al., 1993; Mabuchi 
et al., 2003), and the positive correlation between the activation of NFKB and the 
173 
expression of nNOS (Miscusi et al., 2006). It is also in accord with the concurrent 
up-regulation of COX and NOS protein in the central and/or peripheral nervous 
system (Dolan and Nolan, 1999; Milne et al., 2001 ; O'Rielly and Loomis, 2006, 
2007, 2008) and the corresponding increase in NOS activity after nerve injury 
(Choi et al. , 1996; Gordh et al., 1998; Mabuchi et al., 2003). Like spinal PG, NO 
signaling is critical in the development and early maintenance of SNL-induced 
spinal hyperexcitability and allodynia (O'Rielly and Loomis, 2008). This includes 
the facilitation of NFKB activation in the affected dorsal horn beginning at the 
onset of nerve injury (O'Rielly and Loomis, 2007, 2008). The parallel changes in 
spinal PG- and NO-signaling, and their comparable effects on spinal 
hyperexcitability and allodynia (Dolan and Nolan, 1999; Milne et al., 2001; 
O'Rielly and Loomis, 2006-2008) indicate that both signaling pathways are 
triggered at the onset of nerve injury. These pathways may operate dependently 
or independently in the acute nerve injured state. 
In a previous study using selective COX and NOS inhibitors, fixed-molar 
isobolographic analysis revealed an additive anti-allodynic interaction in the SNL 
model (Hefferan and Loomis, 2004). This result points to a convergence of spinal 
PG- and NO-pathways in the development of allodynia, and thus a dependency 
in their modulation of sensory processing. NO is a readily diffusible, excitatory 
neuromodulator which is known to release arachidonic acid from the plasma 
membrane, to increase COX activity through a variety of mechanisms, and to 
evoke the release of neurotransmitters and other neuromodulators, including PG 
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(Davidge et al., 1995; Landino et al., 1996; Chalimoniuk et al., 2006; Egan et al. , 
1976; Salvemini et al., 1995; Salvemini et al., 1993; Tsai et al. , 1994; 
Dudhgaonkar et al., 2006; Sakai et al., 1998; Matsumura et al. , 2005). Therefore, 
we tested the hypothesis that spinal NO-signaling is critical to the development of 
enhanced sensitization to spinal PG and thus the PG-dependent phase of SNL-
induced allodynia. In turn, we investigated the effect of NO-signaling on COX-1 
and COX-2, the glycine-a3 receptor (GL Y-a3R), and EP1_3 receptors in the 
affected dorsal horn; molecular targets governing PG synthesis, signaling and 
spinal sensitization. 
7.2 MATERIALS AND METHODS 
Studies were approved by, and experiments conducted in accordance with 
the guidelines of the Institutional Animal Care Committee of Memorial University 
of Newfoundland (St. John's, NL, Canada). 
Animals. Male Sprague-Dawley rats (130 to 150 g) were obtained from 
the Vivarium of Memorial University of Newfoundland (St. John's, NL, CA) and 
housed in standard cages with woodchip bedding. Animals had free access to 
food and water. A 12 h light-dark cycle (lights on at 0700 h) was used throughout. 
Intrathecal Catheterization. Intrathecal catheters (6.5 em-length 
terminating near the lumbar enlargement) were implanted according to method of 
175 
Yaksh and Rudy (1976) as previously modified (Hefferan et al., 2003a). 
Catheters were sterilized with 70% alcohol and filled with sterile saline. Under 
halothane anesthesia, the catheter was inserted through an incision in the 
atlanto-occipital membrane of the cisterna magna. The catheter was externalized 
behind the head and sealed with a piece of stainless steel wire. Intrathecal 
catheters (inner diameter, i.d. 240 IJm, outer diameter, o.d. 290 !Jm) were 
constructed from triple lumen PE-5 tubing (Spectranetics, Colorado Springs, CO, 
USA) using the modified method of Marsala et al. (1995). Rats with normal 
motor, grooming and feeding behavior were housed separately and allowed to 
recover for two days before SNL or sham surgery. 
Neuropathy. Neuropathy was induced using the method of Kim and 
Chung (1992) as previously described (Hefferan et al. , 2003a, b; O'Rielly and 
Loomis, 2006, 2007a, b). Briefly, rats were anesthetized with halothane and the 
left L4 and L5 spinal nerves were isolated and separated. The L5 and L6 spinal 
nerves were tightly ligated with 6-0 silk thread. In sham-controls, the L5 and L6 
spinal nerves were isolated, but not ligated. All animals were allowed to recover 
for 3 days before experimentation. Allodynia, defined as a paw withdrawal 
threshold (PWT) of $4 g, was confirmed using von Frey filaments prior to 
experimentation. 
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Western Blotting. Animals were deeply anesthetized with urethane (1 .2 
mg/kg i.p.) and perfused intracardially with ice cold saline (0.9% NaCI). The 
spinal cord was extracted hydraulically (de Sousa and Horrocks, 1979), 
immediately frozen in 2-methylbutane (Sigma-Aldrich, Oakville, ON, CA), and 
stored at -80 °C. The lumbar region (L2-L6) of the spinal cord was isolated, 
removed and subsequently divided into the left and right, ventral and dorsal 
quadrants. Spinal cord was homogenized in ice cold lysis buffer (1% Nonidet-
P40, 10% glycerol in TBS plus a protease inhibitor cocktail tablet - Roche 
Diagnostics, Laval, PQ, CA, 1 mM sodium vanadate, 1 mM sodium fluoride, and 
0.025% SDS), and centrifuged at 1 O,OOOrpm for 5 min (4 °C). Samples, diluted to 
achieve equal protein concentrations (30 IJg), were separated by electrophoresis 
on 8% 80S-polyacrylamide gel. Proteins were transferred to a nitrocellulose 
membrane and incubated for 1.5 h in Tris buffer (Tris 25mM, glycine 192mM, 
200ml methanol, pH 8). Pre-stained protein markers were used for molecular 
weight determination. Blots were initially stained with Ponceau Red, and later 
probed with an antibody directed against the cytosolic protein, actin (1 : 1 000; 
Sigma-Aldrich, Oakville, ONT, CA) to assess the equivalency of protein loading. 
Blots were subsequently probed with the following primary antibodies: 
polyclonal rabbit COX-1 antibody (1 :250); polyclonal rabbit COX-2 antibody 
(1 : 1 000); polyclonal rabbit EP1 receptor antibody (1 : 1 000); polyclonal rabbit EP2 
receptor antibody (1 :2000); and a polyclonal EP3 receptor antibody (1 : 1 000), and 
polyclonal rabbit Glya3 (GLY-a3R) receptor antibody (1 :1000). All primary 
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antibodies were purchased from Cayman Chemical (Ann Arbor, Ml , USA) except 
for the GL Y-a3R receptor antibody (Invitrogen, Carlsbad, California, USA). 
Standards for COX-1, COX-2, and EP receptors were preabsorbed with their 
corresponding blocking peptide to determine the antibody specificity with the 
exception of a cGMP standard (Sigma-Aldrich, Oakville, ONT, CA). Antibody 
specificity was not preformed using anti-Giya3R due to a lack of a commercially 
available blocking peptide. Where appropriate, the western blots were corrected 
for non-specific binding by subtracting the optical density in the presence of the 
corresponding blocking peptide from that of each test sample. The membranes 
were incubated overnight at 4°C with the primary antibodies, and diluted in Tris 
buffer (containing 3% milk powder and 0.05% Tween-20). Protein bands were 
treated with a goat anti-rabbit horseradish peroxidase-conjugated secondary 
antibody (1 :5000; Chemicon International Inc., Temecula, CA, USA) for 1 h at 
room temperature, washed for 30min in Tris buffer, visualized using enhanced 
chemiluminescence (PerkinEimer Life Sciences Boston, MA, USA), and exposed 
to X-ray film (Cronex MRF Clear base, Agfa Corp, Greenville, SC, USA). 
Spinal Glutamate Release. The spinal cord was extracted hydraulically 
(de Sousa and Horrocks, 1979) and the dura and arachnoid membranes carefully 
removed. The lumbar region (L2 to L6) was excised, mounted on cutting blocks 
and immersed in sucrose-modified artificial cerebrospinal fluid (aerated with 95% 
0 2 and 5% C02). Slices (600 to BOO IJm) were cut with a vibratome and placed in 
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aerated artificial cerebrospinal fluid at room temperature. They were immersed in 
HEPES buffer oxygenated with 100% 0 2 throughout the experiment. Glutamate 
released from the tissue was immediately oxidized to a-ketoglutarate by 
glutamate dehydrogenase, thereby preventing neuronal reuptake of glutamate 
(Nicholls et al., 1987). The reduced form of nicotinamide adenine dinucleotide 
phosphate generated from this reaction was quantitated using spectrofluorometry 
(excitation: 335 nm; emission: 430 nm; Nicholls et al., 1987). Basal and PGE2-
evoked glutamate release was quantified using standard curves constructed with 
L-glutamate (0 to 360 pmol; Sigma-Aldrich, Oakville, ON, CA) on each day of 
analysis. Basal glutamate release (i.e. release in the absence of any drug 
stimulus) was determined for 15 minutes before the introduction of drug into the 
cuvette. Drug-evoked release was defined as total release (i.e. after a drug 
stimulus) minus basal release. Protein content in each slice was determined 
using a modified Lowry protein assay kit (Pierce Biotechnology, Rockford, IL, 
USA). 
Behavorial Testing. Spontaneous (no brushing) and BR-evoked 
behavior were continuously graded using a modified scoring system (Malmberg 
et al., 1995), as previously described (O'Rielly and Loomis, 2006). Spontaneous 
behavior (0- normal behavior, bright, alert and exploring; 1 -huddling, burrowing, 
or hiding; 2 - one of the following: piloerection, occasional vocalization, or 
favoring the affected side; 3 - two or more of the following: piloerection, 
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occasional vocalization, favoring the affected side; and 4 - any of the following: 
frequent or persistent vocalization, circling motion, licking or biting the affected 
dermatomes) was graded over a 4-min interval. The hair on the back, flanks, 
limbs, and hind paws was then brushed with a cotton-tipped applicator sufficient 
to deflect the pelage. This was continued for 1 min and the behavior graded as 
follows: 0 - normal behavior, curious, alert, and exploring; 1 - avoidance of 
stimulus source or protection of the affected dermatomes; 2 - one of the 
following: piloerection, paw withdrawal, or occasional vocalization; 3 - two or 
more of the following: piloerection, paw withdrawal, or occasional vocalization; 
and 4 - any of the following: attacking the applicator, frequent or persistent 
vocalization, circling motion, licking or biting the affected dermatomes. This 
sequence was repeated every 5 minutes for the first hour and every 30min 
thereafter up to 6 h or until no responses were detected. The investigator was 
blinded to the nature of the treatment (i.e. vehicle, drug, concentration) in all 
behavioral experiments. 
Drugs. Prostaglandin E2 (PGE2), N-nitro-L-arginine methylester (L-
NAME), and N-nitro-0-arginine methylester (0-NAME) were purchased from 
Biomol Research Laboratories, Inc. (Plymouth Meeting, PA, USA). PGE2 
solutions were prepared according to Nishihara et al (1995). Briefly, PGE2 was 
initially dissolved in ethanol and evaporated under nitrogen gas. It was then re-
dissolved in normal saline and diluted with the same to yield the desired 
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concentrations. PDTC was dissolved in 100% DMSO and diluted with normal 
saline at the time of injection to yield a final DMSO concentration of 50%, 
whereas L-NAME and D-NAME were dissolved in saline (0.9% NaCI). For the in 
vitro glutamate release experiments, exogenous PGE2 was added directly into 
the cuvette containing the slice using a microsyringe. Each concentration of 
PGE2 was tested using a separate slice so that a full PGE2 concentration-
response curve was determined in each animal. All equipment was sterilized with 
70% alcohol and thoroughly rinsed with 0.9% sterile saline before injection. 
Intrathecal drugs were injected into anesthetized rats using a hand-held 
microsyringe. Drugs were delivered in a volume of 5 ~I followed by 5 ~I of sterile 
saline. The i.t. catheter was immediately resealed with a stainless steel plug. The 
position of the catheter tip was verified visually after sacrifice in randomly 
selected animals. 
Data Analysis. All data are displayed as mean ± SEM. Western blots 
were analyzed by optical density using lmageQuant software (Amersham 
Biosciences Corp., Piscataway, NJ, USA). Expression data are presented as 
nanograms of protein relative to COX-1/COX-2 (50 ng), or EP receptor (25 ng) 
standards. Expression data was corrected for background optical density and 
normalized using the cytosolic protein, actin. The absence of available standards 
for GL Y-a3R meant that optical density could not be converted to the amount of 
protein and therefore are presented as % of sham-control. Dose-response 
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analysis was performed using methods from Tallarida and Murray (1987). 
Comparisons within each treatment group were performed using one-way, 
repeated measures ANOVA, followed by the Newman-Keuls test. Comparisons 
across all drug- and vehicle-treated groups at each time point were determined 
using one-way, completely randomized ANOVA, followed by the Newman-Keuls 
test (SigmaStat 2.0; Systat Software Inc., San Jose, CA, USA). 
7.3 RESULTS 
All ligated rats displayed a significant decrease in PWT (~4 g) three days 
after SNL which remained confined to the plantar surface of the left hind paw (i.e. 
ipsilateral to SNL). Generally, the affected hind paw was kept in an elevated and 
cupped position to minimize contact with the cage floor. These rats were 
otherwise healthy, showed normal feeding and grooming behavior, and regular 
weight gain. Neither intrathecal catheterization, nor sham-surgery had any effect 
on PWT compared to pre-surgical values (data not shown). 
To investigate the effect of spinal NO on the SNL-induced expression of 
COX-1 and COX-2 protein in the L-OH, animals were treated with i.t. L-NAME 
(1 00 1-1g i.t.), 0-NAME (1 00 1-1g i.t.) or vehicle (i.e. saline) immediately after 
surgery. Three days after SNL, there was a significant increase in COX-2 
expression in the ipsilateral L-OH in 0 -NAME, vehicle or untreated animals 
compared to sham-controls (Figure 7.1A). There was also a modest increase in 
COX-1 expression but this was not statistically different (p>0.05) from sham-
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controls (Figure 7.1 B). In contrast, SNL animals treated with i.t. L-NAME (1 00 !Jg) 
prevented the increased expression of COX-1 and COX-2 in the ipsilateral L-OH 
(Figure 7.1). The SNL-induced expression of COX-1 and COX-2 in the 
contralateral L-OH (Figure 7.1) or lumbar ventral horns (data not shown) was 
unchanged from sham-controls regardless of drug treatment. 
To examine whether the SNL-induced synthesis of NO exacerbates the 
PGE2-evoked release of glutamate from the affected spinal cord , animals were 
treated with i.t. L-NAME (100 !Jg), 0-NAME (100 !Jg) or saline immediately after 
sham surgery or SNL. Lumbar spinal cord slices were harvested three days later 
and PGE2 concentration-response curves (CRC) determined. There were marked 
differences in the potency of PGE2 (Figure 7.2; Table 7.1) depending on drug 
treatment. L-NAME prevented the increased sensitivity to PGE2 (i.e. 2855-fold 
decrease in EC50) in slices harvested from SNL animals compared to sham-
controls (Figure 7.2; Table 7.1). Treatment with 0-NAME or vehicle had no effect 
on PGE2-evoked glutamate release from lumbar slices of SNL animals (Figure 
7.2, Table 7.1). There was no significant difference in the peak effect of PGE2 
regardless of drug treatment (Figure 7.2). All results were corrected for basal 
glutamate release, which was significantly greater (p<0.05) in SNL (2.94 ± 0.34 
pmol/min/mg protein) as compared to sham operated (1.50 ± 0.43) rats. 
The effect of spinal NO on the sensitivity of.PGE2 in vivo was investigated 
using BR-evoked behavior as a measure of tactile allodynia. Animals were 
treated with i.t. L-NAME (100 IJg), 0-NAME (100 !Jg) or saline immediately after 
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SNL or sham surgery and i.t. PGE2 injected three days later. For these 
experiments, sub-threshold doses of PGE2 in narve or sham-animals were 
chosen from earlier dose-response experiments (O'Rielly and Loomis, 2006). 
Initially, a single dose of PGE2 (0.01 IJg) was used. Mild brushing of the ipsilateral 
hind limb evoked comparable nociceptive-like behavior (i.e. vocalization, 
defensive posturing, licking the affected dermatomes, and biting the cotton-tipped 
applicator) in SNL animals treated with either 0-NAME- or vehicle (Figure 7.3A). 
In contrast, nociceptive-like behavior in SNL animals given L-NAME was 
significantly reduced (p<0.05) compared to 0-NAME- and vehicle-treated 
animals, and similar in magnitude to sham controls regardless of drug treatment; 
experimental groups in which brushing had no effect (Figure 7.3A). To verify the 
apparent NO effect on PGE2 in vivo, these experiments were repeated using 
PGE2 dose-response analysis (Figure 7.38; Table 7.2). SNL animals displayed a 
significant increase in sensitivity to i.t. PGE compared to sham-controls as 
indicated by a 230-fold decrease in E050 (Table 7.2). This SNL-induced effect 
was significantly attenuated by pre-emptive treatment with L-NAME compared to 
that with 0-NAME or vehicle (Figure 7.38). 
To explore possible mechanism(s) underlying the effect of spinal NO on 
PGE2 pharmacodynamics triggered by SNL, the effect of pre-emptive treatment 
with L-NAME, 0-NAME or vehicle on the SNL-induced expression of EP 
receptors in the L-OH was determined three days after surgery. There was a 
significant increase in the expression of EP1, EP2 and EP3 in the ipsilateral L-OH 
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of SNL animals versus sham-controls (Figure 7.4). In contrast, EP1, EP2 and EP3 
receptor expression in the contralateral L-OH or lumbar ventral horns was 
unchanged {p>0.05) from sham-controls (Figure 7.4). Pre-emptive treatment with 
i.t. L-NAME, but not 0-NAME or vehicle, significantly attenuated the SNL-induced 
increase in EP1, EP2 , and EP3 receptor expression three days later (Figure 7.4). 
There were also related changes in spinal Glya3R of SNL animals (Figure 7.5). 
The expression of Glya3R was significantly decreased in the ispilateral L-OH 
three days after SNL compared to the contralateral L-OH (Figure 7.5) or lumbar 
ventral horns (data not shown) of SNL animals, or the dorsal (Figure 7.5) and 
ventral horns (data not shown) of sham-controls (Figure 7.5). Pre-emptive 
treatment with L-NAME, but not 0-NAME or vehicle, significantly reversed the 
SNL-induced attenuation of Glya3R expression in the ipsilateral L-OH (Figure 
7.5). Glya3R expression in the contralateral L-OH and lumbar ventral horns of 
SNL animals, or the lumbar dorsal and ventral horns was unaffected by drug 
treatment in this study (Figure 7.5 and data not shown). 
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Figure 7.1. The effect of L-NAME (100~g), 0-NAME (100~g), or vehicle (i.e. 
saline) on the expression of COX-1 (panel A) and COX-2 (panel B) in the 
ipsilateral (ipsi) and contralateral (contra) L-DH, three days after SNL. All drugs 
were injected i.t. immediately after SNL and analyzed three days later. Data were 
normalized using total protein content, corrected for non-specific 
immunoreactivity and expressed as ng of protein (see Methods). Each bar 
represents the mean ± SEM of three to five animals. Asterisks indicate a 
significant difference from sham-controls (*p<O.OS) and daggers indicate a 
significant difference from the SNL + L-NAME group (tp<O.OS). 
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Figure 7.2. The effect of pretreatment with L-NAME (1001Jg), D-NAME 
(1001Jg), or vehicle on PGE2-evoked spinal glutamate release. All drugs, except 
PGE2, were injected i.t. immediately after surgery and spinal lumbar slices were 
harvested three days after SNL or sham surgery. Exogenous PGE2 was added to 
the spinal cord slices using a microsyringe (see Methods). Data are presented as 
the mean ± SEM of four to six animals. Asterisks indicate a significant difference 
(*p<0.05) from SNL-controls with or without vehicle or D-NAME. 
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Table 7.1. EC50 values and 95% confidence intervals of PGE2 on glutamate 
release from lumbar or thoracic spinal cord slices from SNL or sham-controls. 
Experimental Treatment ECso (M) 95% C.l. (M) 
Na"ive + PGE2 2.33 x 1 o-11 1.23 x 1 o-n - 4.41 x 1 o-11 
Sham+ PGE2 2.37 X 10-11 9.25 x 1 o-12 - 6.08 x 1 o-11 
SNL + PGE2 8.30 x 1 o-15 1.65 X 10-15 -4.18 X 10-14 
SNL + L-NAME + PGE2 4.13 x 1 o-12 1.80 x 1 o-12 - 9.45 x 1 o-12 
SNL + 0-NAME + PGE2 1.45 x 1 o-14 8.69 x 1 o-15 - 2.41 x 1 o-14 
SNL +vehicle (saline)+ PGE2 3.03 x 1 o-14 9.37 x 1 o-15 - 9. 77 x 1 o-14 
EC50=concentration producing 50% of maximum response; M=molar 
concentration; 95% C.l.=95% confidence interval. 
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Figure 7.3. The effect of L-NAME (100~g), D-NAME (100~g), or vehicle on BR-
evoked behavior in the presence of PGE2. Drugs were injected i.t. immediately 
after SNL or sham surgery and behavioral experiments conducted three days 
later (see Methods). Panel A represents a single dose while panel 8 illustrates a 
dose-response-curve for PGE2. Each bar represents the mean ± SEM of five to 
seven animals. Asterisks indicate a significant difference (*p<0.05 ; **p<0.01; 
***p<0.001) from both SNL + vehicle and SNL + 0-NAME groups. Daggers 
indicate a significant difference from the sham+ vehicle group (ttp<0.01). 
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Table 7.2. ED50 values and 95% confidence intervals of PGE2 on BR-evoked 
allodynia after SNL or sham surgery. 
Experimental Treatment EDso (tJg) 95% C.l. (tJg) 
SNL + L-NAME + PGE2 1.5 X 10-£ 6 .1 x 1 o-;j- 3.9 x 1 o-£ 
SNL + 0-NAME + PGE2 5.9 X 10-4 8.2 X 10-5 -4.3 X 10-3 
SNL + vehicle + PGE2 7.4 X 10-4 8.7 X 10-5 -6.3 X 10-3 
Sham + vehicle + PGE2 1.7 x 1 o-1 1.0 X 10-1 -3.0 X 10-1 
ED50=dose producing 50% of maximum response; 95% C.l.= 95% confidence 
interval. 
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Figure 7.5. The effect of L-NAME (100J,Jg), 0-NAME (100J,Jg), or vehicle (i .e. 
saline) on the expression of the glycine receptor in the ipsilateral and 
contralateral L-DH, three days after SNL. All drugs were injected i.t. immediately 
after SNL and analyzed three days later. Data were normalized using total 
protein content, and expressed as percent of sham-controls (see Methods). Each 
bar represents the mean ± SEM of three to five animals and asterisks indicate a 
significant difference from the SNL + no drug group (*p<0.05). 
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Figure 7.6. A schematic illustrating the relevant changes to spinal PG- and NO-
synthesis/signaling early after SNL. SNL triggers the up-regulation of constitutive 
COX-1 and nNOS expression, as well as, NFKB in the ipsilateral L-DH one day 
after injury. The increase in NFKB induces the up-regulation of COX-2 and iNOS 
expression in the ipsilateral L-DH three days after injury. The resulting increase 
in PG- and NO-signaling further increases the SNL-induced: a) activation of 
spinal NFKB; b) EP1 receptor expression/signaling resulting in increased spinal 
glutamate release, and c) EP2 receptor expression/signaling resulting in 
decreased glycinergic tone. These changes in NO- and PG-synthesis/signaling 
comprise a viscous cycle early after SNL culminating in spinal hyperexcitibility 
and mechanical allodynia. 
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7.4 DISCUSSION 
SNL has been shown to trigger the up-regulation of NFKB (O'Rielly and 
Loomis, 2008) and, in turn, the expression of COX and NOS enzymes (O'Rielly 
and Loomis, 2006) in the ipsilateral L-DH three days after injury. Moreover, the 
pharmacological inhibition of spinal NFKB immediately after SNL prevented the 
increase in COX (COX-2 > COX-1) and NOS (iNOS > nNOS) expression three 
days later (O'Rielly and Loomis, 2008). These results reflect the shared 
modulatory effect of NFKB on COX and NOS gene transcription (Lowenstein et 
al., 1993) and its activation at the onset of SNL. In the present study, pre-emptive 
treatment with i.t. L-NAME to inhibit spinal NO-synthesis prevented the SNL-
induced expression of COX-1 and COX-2 in the ipsilateral L-DH three days later. 
This stereo-specific effect, like the SNL-induced expression of COX-1 and COX-
2, was confined to the ipsilateral L-DH. This is the first report of an NOS inhibitor 
influencing the expression of enzymes responsible for PG synthesis in the acute 
nerve injured state. Spinal NO, generated by constitutive NOS at the onset of 
SNL, has been shown to promote the activation of NFKB in the ipsilateral L-DH 
(O'Rielly and Loomis, 2008) and would explain the results with i.t. L-NAME on 
COX expression in the same area. These results suggest a critical role of spinal 
NO in enhanced PG-signaling early after SNL. 
The influence of NO on spinal PG after nerve injury was not limited to 
effects on COX expression. Pre-emptive treatment with i.t. L-NAME significantly 
attenuated the SNL-induced increase in sensitivity to PGE2 both in vitro (i.e. 
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PGE2-evoked glutamate release from lumbar slices) and in vivo (i.e. brush-
evoked behaviorally-defined allodynia) determined three days after surgery. 
These results, which were also stereo-specific for the active isomer, indicate a 
significant normalization of the sensitivity to PGE2 three days after pre-emptive 
treatment with L-NAME. The parallel nature and magnitude of the rightward shift 
of the PGE2 CRC and DRC three days after L-NAME strongly indicate a change 
in EP receptor-effector coupling. 
To explore this possibility, EP receptor expression in the ipsilateral L-DH 
was determined three days after surgery. EP1, EP2 and EP3 receptors were 
significantly up-regulated in SNL animals compared to sham-controls. EP 
receptor expression for all three subtypes was significantly greater three days as 
compared to one day after SNL (O'Rielly and Loomis, 2007). This suggests a 
sustained and progressive effect of SNL on EP receptor expression over this 
time period. Spinal EP1 receptors, which are located on presynaptic primary 
afferent terminals, are known to facilitate neurotransmitter release through an 
effect on intracellular calcium (Vanegas and Schaible, 2001 ). Spinal EP2 
receptors, which are located post-synaptically, affect the inhibition of glycine-
mediated IPSCs in DH neurons (Saba et al., 2001 ; Ahmadi et al., 2001). The 
contribution of EP3 receptors is more complex due to multiple variants of this 
receptor subtype (i.e. EP3A. EP3s, EP3c) and signaling pathways. Some of EP3 
receptors in the DH are positively coupled to NOS with the resulting NO 
(Matsumura et al., 2005) amplifying PG synthesis and PG-dependent allodynia 
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(Bredt and Snyder, 1992; Mollace et al. , 1995; Hefferan and Loomis, 2004). The 
up-regulation of EP3 variants negatively coupled to adenylyl cyclase explains the 
previously reported increase in glutamate release from slices of SNL animals 
pretreated with the EP receptor antagonist, SC-51322 and evoked by high 
concentrations of PGE2 (O'Rielly and Loomis, 2006). The reduced expression of 
EP3c receptors in neuronal cultures using antisense oligonucleotides also 
abolished PGE2-evoked cAMP production and the corresponding release of 
substance P and calcitonin gene-related peptide (Southall and Vasko, 2001); 
known excitatory neuromodulators. The time-course and pattern of SNL-induced 
changes in the present study correspond with the increased sensitivity to PGE2, 
especially the up-regulation of the EP1 (i.e. increased neurotransmitter release) 
and EP2 (i.e. glycinergic disinhibition) receptor subtypes. 
Pre-emptive treatment with i.t. L-NAME, but not 0-NAME or vehicle, 
significantly attenuated the SNL-induced increase in EP1 , EP2, and EP3 receptors 
and explains, at least in part, the normalization of pharmacodynamic sensitivity to 
PGE2 three days later. This stereo-specific effect, like that observed with the 
SNL-induced expression of COX-1 and COX-2, was confined to the ipsilateral L-
DH. This is the first report demonstrating that spinal NO, generated at the onset 
of SNL, effects the early expression of both the enzymes responsible for PG 
synthesis and the receptor subtypes mediating the actions of PGE2 in the 
affected spinal cord. This points to the robust up-regulation of those elements 
essential for PG-signaling early after SNL and explains: a) the abrupt onset of 
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spinal PG-dependent allodynia (Hefferan et al. , 2003a, b; O'Rielly and Loomis, 
2006-2008); b) the consistent and dramatic pre-emptive effect of i.t. L-NAME 
(O'Rielly and Loomis, 2008); c) the similar effectiveness of L-NAME and S(+)-
ibuprofen as pre-emptive treatments (O'Rielly and Loomis, 2007, 2008); and d) 
their additive interaction in the SNL model, suggesting a convergence of spinal 
NO- and PG-signaling in the affected spinal cord (Hefferan and Loomis, 2004). 
The exact mechanism by which spinal NO affects the SNL-induced expression of 
EP receptors in the L-DH remains to be determined. 
Spinal PGE2/EP2 signaling inhibits glycinergic neurotransmission in the 
DH (Saba et al., 2001) via the protein kinase A-dependent phosphorylation of the 
GlyRa3 subunit (Ahmadi et al. , 2001 ). That the resulting disinhibition yields a 
robust and selective allodynic state is clearly evident after the i.t. injection of low 
(i.e. sub-convulsive) doses of strychnine (Yaksh, 1989). There is also evidence 
that glycine receptor density in the spinal DH is significantly decreased in 
allodynic animals following sciatic nerve constriction injury (Simpson & Huang, 
1998). If the SNL-induced changes in EP2 receptor expression using Western 
analysis are directly related to the increased sensitivity to PGE2 (and not just a 
non-specific response to SNL), and the normalization of EP2 expression is 
functionally linked to the pre-emptive effect of i.t. L-NAME, then corresponding 
inverse changes in the expression of GlyRa3 would be predicted. Consistent 
with this hypothesis, Glya3R expression was significantly decreased three days 
after SNL compared to sham-controls. As with other SNL-induced changes, this 
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effect was confined to the ipsilateral L-DH. These results are in accord with 
spinal glycinergic control of low-threshold afferent input in the DH (Keller et al., 
2001 ; Lynch, 2004; Legendre, 2001 ), and the early development of spinal PG-
dependent hypersensitivity and allodynia in the SNL model (Hefferan et al., 
2003a, b; O'Rielly and Loomis, 2006-2008). This functional relationship is further 
supported by the pre-emptive effect of i.t. L-NAME on the SNL-induced 
expression of spinal EP2 and Glya3R. This is the first report demonstrating the 
down-regulation of Glya3R in the L-DH in the SNL model, and the critical role of 
spinal NO in the development of abnormal PGE2/EP2/Giya3R signaling early 
after nerve injury. 
The results of the present study are summarized in Figure 6. Spinal NO, 
generated at the onset of SNL, facilitates the SNL-induced activation of NFKB in 
the ipsilateral L-DH (O'Rielly and Loomis, 2008). As a modulator of COX gene 
transcription, NFKB triggers the up-regulation of COX-2 and, in turn , the 
increased synthesis of PGE2 . Spinal NO also contributes to the increased 
allodynic effect of PGE2 following SNL. This is related to the up-regulation of EP 
receptors (EP1, EP2, and EP3) , corresponding changes in effector molecules (e.g. 
Glya3R) and exaggerated spinal excitability (e.g. enhanced glutamate release, 
glycine disinhibition). The direct (i.e. PG-independent) effect of NO on spinal 
excitability is also depicted. Clearly, spinal NO represents a critical factor in the 
development of PG-dependent allodynia early after SNL. 
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8.0 DISCUSSION 
The results of this research support the hypothesis that spinal PG play an 
early pathogenic role in the emergence and early maintenance of spinal 
hyperexcitability and mechanical allodynia following SNL. They revealed a time-
dependent shift in the COX isoform primarily responsible for spinal PG synthesis, 
identified the inter-relationships between NFKB, PG and NO synthesis/signaling 
in affected spinal cord, and characterized the nature of the interaction between 
PG and NO in this model of NP. The major results of this research are illustrated 
in Figure 8.1. 
Previous work has indicated that SNL elicits stable allodynia, expressed 
as a marked reduction in the PWT and protective posturing of the affected 
dermatomes (Kim and Chung, 1992; Hefferan et al. , 2003a, b). However, it was 
impossible to ascertain which fibre types are affected by SNL based on PWT 
alone. To this end, A- and C-fiber mediated reflex responses were recorded from 
the ipsilateral biceps femoris of SNL animals. EMG analysis revealed a 
significant increase in excitability as evidenced by the decrease in activation 
threshold , increase in evoked activity to single (i .e. activity before spatial and 
temporal summation) and repetitive stimulation, and the presence of windup; 
sustained input known to trigger the neural generation of spinal prostanoids 
(Millan, 1999; Vanegas and Schaible, 2001 ). These electrophysiological 
changes, characteristic of peripheral and central sensitization, paralleled the 
development of mechanical allodynia. This thesis research indicated that the 
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effect of SNL, including its modulation by spinal PG is reflected 
electrophysiologically in the biceps femoris reflex. However, the duration of these 
electrophysiological abnormalities are unknown as longest time investigated after 
SNL was ten days. The effect on A-fiber activity is especially interesting given 
that SNL-induced mechanical allodynia is elicited by impulses carried along 
surviving Af3-afferents (Kim and Chung, 1992). The results were highly 
reproducible within treatment groups, and qualitatively similar to those reported in 
other experimental nerve (Meyerson et al., 1995; Colvin et al., 1996; Okamoto et 
al., 2001; Kohno et al., 2003), and spinal cord (Bennett et al., 2004) injury 
models. The latter suggests broader applicability of the present results to the 
early nerve-injured state. 
The AFRR and CFRR were evoked by electrical stimulation using a 
stimulation paradigm designed to activate low-threshold A-fibers. No attempt was 
made to separate the A-fiber subtypes in the present study as altered 
conductivity to injured and uninjured A-fibers (Laird and Bennett, 1993) make it 
difficult, if not impossible, to accurately determine the contribution of surviving 
Af3-afferents to the AFRR and CFRR. Future studies should include the use of 
mechanical stimuli (i.e. von Frey filaments, mild brushing) to activate low-
threshold A-fibers. 
The spinal hyperexcitability (and mechanical allodynia) induced by SNL 
was unlikely to be the result of "denervation" supersensitivity. SNL involves tight 
ligation of the L5/L6 spinal roots and, unlike nerve transection, leaves many 
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afferent and efferent fibres intact (i.e. uninjured and functional) (Kim and Chung, 
1992). Moreover, SNL primarily affects smaller diameter primary afferent fibers 
compared to larger fibers including those innervating muscle. This is consistent 
with the protective posturing of the affected hind paw which remained responsive 
to low-threshold mechanical stimulation following SNL. An abrupt and 
coordinated response to von Frey filaments argues against the development of 
significant motor deficits. While an effect of SNL on motor neurons cannot be 
completely excluded, afferent sensory input appears to be preferentially affected 
in this model. 
SNL-induced allodynia consists of two distinct phases: a) an early PG-
dependent phase lasting approximately seven to ten days; and b) a delayed PG-
independent phase lasting up to seventy days (Hefferan et al. , 2003b). The 
former was first investigated using the active S(+)- and inactive R(-)-enantiomers 
of IBU, as well as COX-1 and COX-2 selective inhibitors given immediately after 
SNL (i.e. pre-emptive treatment) or three days later (i.e. time of maximum PG-
dependent spinal hyperexcitability and mechanical allodynia). These experiments 
confirmed the critical role of spinal COX activity in the development and early 
maintenance of spinal hyperexcitability and allodynia, beginning at the onset of 
SNL, and are consistent with a time-dependent shift in the dominant isoform 
responsible for increased PG synthesis (i.e. COX-1 to COX-2) in the affected 
spinal segments (Hefferan et al., 2003a, b). As with all such experiments, drug 
selectivity is an issue requiring caution in the interpretation of the data. 
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The ICso values for SC-560, SC-236 and S(+)-IBU against COX-1 and 
COX-2 are summarized in Table 8.1 . In vitro, SC-560 and SC-236 are equipotent 
against COX-1 and COX-2, respectively, and exhibit comparable potency ratios 
for their preferred target (Gierse et al. , 1996; Yaksh et al. , 2001). 
Table 8.1. IC50 values determined against recombinant human 
cyclooxygenases (hCOX). 
Inhibitor hCOX-1 hCOX-2 hCOX-1 :hCOX-2 hCOX-2: hCOX-1 
S(+)-IBU 3.3 ~M 3.8 ~M 0.87 1.15 
SC-560 -5 ~M 160 ~M 0.03 32 
SC-236 17 ~M 5nM 3400 0.0003 
In contrast, S(+)-IBU is equipotent against both COX isoforms and considerably 
less potent than either SC-560 or SC-236. Accordingly, similar effective i.t. doses 
of SC-560 and SC-236 were used throughout this research . Given that both 
significantly inhibited spinal hyperexcitability and mechanical allodynia, albeit on 
different days after SNL, the results indicate that: a) effective COX inhibition was 
achieved in the spinal cord by each drug; and b) their selectivity for COX-1 and 
COX-2 was preserved at the i.t. doses used. The doses of S(+)-IBU, SC-560 and 
SC-236 selected for our experiments were comparable to those used by other 
laboratories (Dirig et al. , 1997; Hall et al. , 1999; Deleo et al. , 2000; Yaksh et al. , 
2001 ; Yamamoto and Nozaki-Taguchi, 2002). Thus, we conclude that the 
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difference in effect with SC-560 and SC-236 reflects the distinct contributions of 
COX-1 and COX-2 in the emergence and early maintenance of mechanical 
allodyn ia, respectively. 
These results were subsequently corroborated by expression studies of 
COX-1 and COX-2 protein in the affected spinal cord. Western analysis 
confirmed the preferential expression of COX-1 one day after SNL and COX-2 
three days after SNL in ipsilateral L-DH. This validated the results with SC-560 
and SC-236, and is in accord with earlier reports of SNL-induced changes in 
spinal COX expression (Zhao et al., 2000). Recognizing that increased protein 
expression does not necessarily reflect increased enzyme activity (i.e. PG 
synthesis), efforts to measure spinal COX-1 and COX-2 activity directly were 
made. Ultimately, these proved unsuccessful largely due to the composition of 
spinal tissue. However, changes in COX expression are frequently associated 
with changes in PG synthesis. For example, concurrent increases in COX-2 
expression and COX-mediated PGE2 synthesis have also been reported in the 
spinal cord of rats with experimental diabetic neuropathy (Freshwater et al., 
2002). Likewise, the concentration of brush-evoked PGE2 in spinal CSF was 
significantly increased three days after SNL (Hefferan et al. , 2003a) 
corresponding to the time of maximum COX-2 expression in the L-DH. While 
COX activity data would certainly strengthen the connection between enhanced 
COX expression and spinal PG synthesis in the SNL model, we believe the 
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current body of evidence supports the critical role of spinal PG in the 
development of spinal hyperexcitability and mechanical allodynia. 
Apart from its constitutive expression, the dominant role of COX-1 in 
spinal PG synthesis is also explained by enzyme kinetics and the intracellular 
conditions favouring COX-1 activity immediately following nerve injury. While 
high concentrations of arachidonic acid (e.g. >1 0 !JM) shunt production through 
the COX-1 pathway (Murakami et al. , 1999), low concentrations (e.g. <1 !JM) 
favour PG synthesis via COX-2. The rapid and repetitive firing of injured nerves 
immediately following SNL (Chaplan et al, 2003; Han et al, 2000) would be 
expected to generate high intracellular concentrations of free arachidonic acid in 
affected spinal cord cells, including neurons. In this regard, cell activation studies 
using cytokines or lipopolysaccharide showed an initial burst in COX-1 activity 
(10 to 30 min duration) followed by delayed COX-2 activity (Smith et al., 2000). 
This, of course, does not obviate the importance of other factors such the 
subcellular distribution and, as demonstrated in the present study, the time-
course of expression of COX1 and COX-2 protein. 
The ability of PG to effect responses at exceptionally low concentrations is 
well documented. Indeed, discrepancies between the active concentrations of 
PG and their Kd values at corresponding receptors are not uncommon (Garcia-
Perez and Smith, 1984; Sugimoto et al. , 1993; Namba et al. , 1994). While the 
mechanisms underlying this phenomenon remain unclear, PG routinely elicit 
biologic responses at concentrations well below their reported Kd values, even 
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under normal conditions. The results of the present study suggest that PG can 
trigger, either directly or indirectly, their own synthesis in the affected spinal cord 
three days after SNL. Likewise, there was clear evidence of exaggerated 
sensitivity to spinal PGE2 in vitro and in vivo which paralleled the development of 
spinal hyperexcitability and mechanical allodynia in the acute nerve injured state. 
From a pharmacodynamic perspective, the marked increase in potency of PGE2 
argues strongly for amplification at the EP-receptor-effector level. The latter is 
supported by the increased expression of EP1.3 receptors and Glya3R in the 
ipsilateral L-DH three days after SNL. Although the signal transduction 
mechanisms coupled to these receptors were not measured in this study, the 
concurrent normalization of both receptor expression and sensitivity to spinal 
PGE2 (described below) strongly suggests a cause and effect relationship. Spinal 
EP2 receptors, which are functionally linked to the Glya3R, represent a specific 
target by which spinal PG disrupt endogenous glycinergic tone (i.e. disinhibition). 
Collectively, the in vitro and in vivo results of the present research are consistent 
with exaggerated PG synthesis and signaling in the ipsilateral L-DH three days 
after SNL. They highlight the robust up-regulation of elements essential for 
increased PG-synthesis/signaling, and explain the abrupt onset of spinal PG-
dependent allodynia in the SNL model (Hefferan et al., 2003a, b). 
NFKB has a well documented role in neuronal cell survival, apoptosis, and 
synaptic plasticity (Shishodia & Aggarwal, 2002; Piva et al. , 2006; Bubici et al. , 
2006; Albensi & Mattson, 2000). It also modulates transcription of the genes 
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coding for COX and NOS (Tsatsanis et al. , 2006), and is affected by nerve injury 
(Sakaue et al., 2001; Pollock et al., 2005; Bethea et al. , 1998). SNL induced a 
sustained increase in activated NFKB in the ipsilateral L-DH which preceded the: 
a) induction of spinal COX-2; b) development of spinal PG-dependent 
hyperexcitability; and c) reduction in PWT in the affected hind limb. 
Pharmacological blockade of spinal NFKB activity demonstrated the critical role 
of spinal NFKB in the subsequent up-regulation of spinal COX-2, and the 
exaggeration of A- and to a lesser extent C-fiber mediated responses in the 
affected hind limb. The SNL-induced changes in the AFRR, and their sensitivity 
to the blockade of spinal NFKB activity, are especially relevant given the 
predominant role of functional A-fibers in mechanical allodynia (Zimmerman, 
2001). 
PG promote neuronal depolarization by modulating the kinetics of Na+ and 
K+ channels, and by increasing intracellular Ca2+ levels (Vasko, 1995; Chen & 
Bazan, 2005; Baba et al., 2001; Sugimoto & Narumiya, 2007); factors known to 
promote the liberation of NFKB from lkB in the cytoplasm. Thus, PG synthesized 
at the onset of nerve injury could promote the SNL-induced activation of NFKB 
and its downstream transcriptional effects. In this regard , the pre-emptive 
blockade of COX activity with i.t. S(+)-IBU not only attenuated the spinal 
activation of NFKB, but it prevented the induction of spinal COX-2 and the 
development of spinal hyperexcitability and allodynia three days later. These 
results further illustrate the importance of spinal PG to the development of SNL-
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induced allodynia, and indicate possible mechanisms by which th is occurs. 
Promoting the activation and transcriptional effect of NFKB in the affected spinal 
cord also explains, at least in part, how pre-emptive treatment with i.t. S(+)-IBU 
prevented the up-regulation of COX-2 protein in the affected L-DH of SNL 
animals, and how i.t. S(+)-IBU, given up to 2 h after SNL, prevented mechanical 
allodynia for at least twenty-one days (Hefferan et al. , 2003a,b). 
Notwithstanding the clear evidence for an early role of spinal PG in the 
SNL model, the activation of NFKB inevitably triggers many other effects. In 
particular, NFKB directly and indirectly modulates the transcription of iNOS and 
nNOS expression following spinal cord injury (Lowenstein et al., 1993; Mabuchi 
et al., 2003; Miscusi et al., 2006). Their product, NO, is known to positively 
interact with spinal PG early after SNL (Hefferan and Loomis, 2004). The parallel 
increase in NFKB and NOS protein in the affected L-DH, and their mutual 
attenuation by i.t. PDTC indicate that the activation of NFKB is a critical 
antecedent to the SNL-induced up-regulation of nNOS and iNOS protein in the 
acute nerve-injured state. Like spinal PG synthesis/signaling, the stereo-selective 
inhibition of NOS activity blocked the activation of NFKB and the up-regulation of 
NOS isoforms in the affected spinal cord, and prevented the development of 
spinal hyperexcitability and mechanical allodynia in the SNL model. The results 
suggest that spinal NO, generated by constitutive NOS at the onset of nerve 
injury, also promotes the injury-induced activation of NFKB, and underscores the 
importance of spinal NO-synthesis/signaling to the development and early 
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maintenance of SNL-induced spinal hyperexcitability and mechanical allodynia. 
They also explain how i.t. L-NAME, a stereo-specific inhibitor of NOS activity, 
affected the downstream expression of spinal NOS. 
A striking feature of this thesis research is the similarity in spinal PG- and 
NO-synthesis/signaling early after SNL, their comparable but independent effects 
on NFKB in the spinal cord, and their influence on the subsequent development 
of spinal hyperexcitability and mechanical allodynia. One obvious question 
arising from these observations is whether they are simply coincidental, and 
possibly redundant outcomes to nerve injury, or whether they comprise a 
coordinated (i.e. interdependent) response. That pre-emptive treatment with i.t. 
L-NAME significantly attenuated all PG-dependent features of SNL-induced 
allodynia supports the latter proposition. It suggests a convergence of spinal NO-
and PG-signaling in the affected spinal cord, consistent with and building upon 
previous demonstrating an additive interaction in the SNL model (Hefferan and 
Loomis, 2004). It also illustrates the importance of spinal NO, generated at the 
onset of SNL, to spinal PG synthesis/signaling in the acute nerve injured state. 
However, the mechanism(s) by which spinal NO affects the expression of spinal 
EP receptors in the SNL model remains to be determined. 
The results of this research raise a number of other questions. For 
example, can pre-emptive treatment with a systemic (preferably oral) COX 
inhibitor prevent the development of mechanical allodynia, and would it be as 
affective as the i.t route? If so, what is the optimal dosing schedule, and how long 
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after nerve injury does pre-emptive treatment with these drugs remain effective? 
Given that systemic administration requires higher drug dosing, would the 
resulting adverse effects limit their therapeutic effectiveness? Using a 
combination of systemic low-dose COX and NOS inhibitors (or other agents such 
as free radical scavengers) represents an alternate and perhaps more effective 
pharmacologic strategy. Including a non-selective EP receptor antagonist in the 
cocktail would also warrant consideration based on the results of this thesis 
research. 
The evidence for a PG-dependent phase in SNL-induced spinal 
hyperexcitability and mechanical allodynia is largely pharmacologic (Hefferan et 
al. , 2003a, b). It is unknown, whether COX-1 or COX-2 deficient mice develop 
PG-dependent spinal hyperexcitability and mechanical allodynia following SNL, 
and how this compares to the results obtained using the rat. Given the striking 
similarity of SNL on spinal PG- and NO-synthesis/signaling early after nerve 
injury, it's possible that spinal NO effects spinal hyperexcitability and allodynia 
indirectly by enhancing spinal PG-synthesis/signaling. In future studies, this and 
related hypotheses could also be tested using COX-deficient mice. 
The cellular actions attributed to spinal PG in the acute nerve injured state 
also require further elucidation. Apart from Glya3R, what other downstream 
targets meditate the pro-allodynic effects of spinal PG, and on what cell types are 
they expressed? What other spinal PG contribute to the development of spinal 
hyperexcitability and allodynia in the acute nerve injured state? Two obvious 
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possibilities are PGF20 and PGb which have been implicated in normal pain 
processing in the spinal cord. Given that the cellular effects of NFKB are 
influenced by specific co-factors (including those which control apoptosis and cell 
survival), what co-factors are up-regulated after SNL, and how are they affected 
by pre-emptive treatment with COX and NOS inhibitors? 
A more complete understanding of the critical signaling events occurring 
early after nerve injury, their interaction and relevant pharmacology is essential 
for effective pre-emptive treatment strategies in humans presenting with nerve 
injury. 
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Figure 8.1. A summary of the SNL-induced changes to spinal PG and NO 
effecting early hyperexcitability and allodynia in the rat. Nerve injury-induced 
synthesis/release of PG, NO, glutamate and other mediators (e.g. cytokines, 
growth factors and neuropeptides) from presynaptic elements in the spinal cord 
drive dorsal horn cells through their respective signaling pathways. This includes 
the: a) activation of NFKB-mediated transcription and subsequent induction of 
COX and NOS; b) concurrent up-regulation of spinal EP1-3 receptors; c) the 
brush-evoked release of spinal PGE2; and d) a marked increase in the 
pharmacodynamic sensitivity to PGE2. These adaptations to nerve injury underlie 
the early development of spinal PG-dependent hyperexcitability and allodynia in 
this model. Acting in concert, these adaptations serve to amplify afferent sensory 
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input and are conducive to an early "vicious cycle" between presynaptic and 
dorsal horn cells. The exaggerated synthesis and release of PG and NO from 
both presynaptic and dorsal horn cells initiate an early "vicious cycle"; an 
outcome reinforced by the concurrent up-regulation of spinal EP1-3 receptors and 
a marked increase in pharmacodynamic sensitivity to PGE2. The time-dependent 
increase in spinal PG/NO, COX/NOS, and EP receptors is depicted by the 
enlarged font or box size. Also shown is the transition from primarily COX-1 to 
COX-2 and nNOS to iNOS synthesis of PG and NO, respectively three days after 
SNL. Comparable SNL-induced changes in presynaptic cells have been omitted 
for clarity. 
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